Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Bacillus cereus E33L, E33L

>BCE33L3525 conserved hypothetical protein; possible carboxyphosphonoenolpyruvate phosphonomutase
MNDILMKSKIFNDYHHDSSILILPNAWDVMSAKIYEDLNYRAIGTTSAGI
AASLGYSDGEQLPFESMLDVIEKITQSVNIPVSADIESGYGETIEEVLEN
VRKIIASGVVGINLEDSKKNHVYSLYDTAYQQKKIESIKNVSISEGVPLF
INARTDAYLLNNNRFEETMKRAQAYKDAGADGIFIPGLAKKEHIHMFTEK
INLPLNVLVNNSTPSILDLEYLNVSRISFGSGAYRATISTLRKLASEVIT
KGQYETMTNEVMSYENMVGFLHKN
>BCE33L3773 sugar ABC transporter, ATP-binding protein
MAELKLENIYKIYDNNVTAVTDFNLHIQDKEFIVFVGPSGCGKSTTLRMV
AGLEDISKGEFSIDGKLMNDVPPKDRDIAMVFQNYALYPHMSVYDNMAFG
LKLRKIPKEEIDRRVKDAAKILGLEQYLDRKPKALSGGQRQRVALGRAIV
RDAKVFLMDEPLSNLDAKLRVAMRSEISKLHHRLGTTTIYVTHDQTEAMT
MASRLVVMKDGKIQQIGTPKEVYETPENIFVGGFIGSPAMNFFRGKLTET
DFVIDNVTKIKVTEGKMKILREQGYVNKDIVLGIRPEDIHDELLFLEASQ
STAFTTKIEVAELLGAESILYMKLGNQDFAARVDARHTFSPGDQIKLAFD
MNKAHFFDSQTEQRIR
>BCE33L4240 transporter, drug/metabolite exporter, EamA family
MTRTYILLFICVVVWGSNFIFGAILVNTFHPVFLTTLRLLFINLFFLAYA
IMCKKDLYIEKSEMKSVLLIGIIGVAINQWSFYEGLQTADPTTAALILAL
TPVMTSILAVFILNEPLTAKLVIGGGIATFGVFFVIGVGQRFVFSEGLIW
IFITMLSFSLSIVLIRKLGNRDDMFFITFFSSIFGFLIMLPFLAFTFSHI
TLKYSIESWSLLIVTAILMHGICTLVWNNQLRKAQASTAAMFLNLEPFVT
MVVGYIILQKSVTAIQIIGAVFIVCGVYTATFGYGKKSKGQKELFRKAT
>BCE33L4455 transcriptional regulator, DeoR family
MKPTTTRMLTRIKSIYMYINENGTVTTKDLVDEFGITPRTIQRDLNVLQF
NELVYSPCRGKWTTTGKKVRMTS
>BCE33L4313 glucanase/ deblocking aminopeptidase
MTKLDETLTMLKELTDARGIAGNEREPREVMKKYIEPFADELSTDNLGSL
VAKKVGEENGPKIMVAGHLDEVGFMITQIDEKGFLRFQTVGGWWSQVMLA
QRVTIVTRKGDVTGVIGSKPPHILPPEARKKPVEIKDMFIDIGASSQEEA
MEWGVRPGDQVVPYFEFQVMKNEKMLLAKAWDNRIGCAIAIDVLKQLKDE
KHPNVVYGVGTVQEEVGLRGAKTSANYIKPDIAFAVDVGIAGDTPGVTSK
EAQSKMGDGPQIILYDASVIGHTGLRDFVVDVADELQIPYQYDSVAGGGT
DAGAIHIAVNGIPSMAITIATRYIHSHAAMLHRDDYENAVKLIVEVIKRL
DKEAVHNITFN
>pE33L466_0275 uncharacterized protein
MKKVILAGALGIAVLSGMNLPGTEAPKASAATTNLEMQEVTKYYSMNSYE
VSQKESFNLNKGDELTVFVQNSGFPISYTVFDADNQVIGTYNANSPYGRV
LKAQKDGNISIQFQAGVNSSYMKKMNFTAKFAVSKLNQQ
>BCE33L2707 macrolide efflux protein
MKLKNVLKNRSFFFMWIGSAISELGGGFGTLCNSILVYELTGSEMALSSM
WLLYFIPSLILQLISGPFIDKWSRKWIMIFSQWIRASVFLLPLIMLVSGS
LEVWHIYVVQIVVGLITPLYTPASQAITPSIVRKEQLQDANAYIDGMTRL
MMFLAPVLGGVVIHFIGTELALSFVCICLFVSGTFLLYIKENRASQPIRK
TWLEQFFHGFTYFFTKPIIVWLGIFLTFVQFGVGVTMVTNLPYIKGELSA
GYAEFGYFMAGFPLGYVVGSILVGKVTYKSRRILMLGGLFIGGLTYISLG
FNHSIIIAIIVEVIAGICIAFFNVHNTTICQQSVPNNMIGQVFSVRLFFI
RSAMPLGVLVGGILSEMWGVRALYLIIGAIICVTSLIGMLLPYFKFLDEA
IEEKTA
>BCE33L0494 probable transporter, DMT family
MNNSRRIGLIMIITGATLWGLSGPMIQWLFQHTNVSSVDFLTIRLLLAGL
FILSFLLVKKQNIFQIWKHPRHSIQLIIFSILGMLGAQYAFIETVHISNA
VTATLFQFLGPVLITIYVAFEQRKFPASMQLLAIITALTGTYFIITNGSI
ENIVLSKAAITFGLLTAVGFAFYTLHPASLIKECGTTVVIGWGMLIGGIA
LLICNRSFGWNQFSQTLTLKTFSMLILIIISGTLSFLLYIGSLKYLAATE
TSILSSIEPLVAAIISIAWLNESFGAYQLLGGVCIVLSVIFLTLPQKERE
PAYSTEQI
>BCE33L3565 possible polysaccharide deacetylase
MKARILAYICIFFLYVSVGSYSVFAQDNLYEEIQKHAKQYEIAPQNAMID
KIWKATPGYNGRQVDIEASYNNMKKLKKFDQKHLEFREVSPSVHLEDLSP
APIYRGHPNKKMVGLTINVAWGNEYLPRILEILKKHDVKATFFLEGRWVK
ENLRFAKMIVDANQEVGNHSYTHPNMKTLSSDEIRDQLQKTNRMIEAATN
QKVRWFAPPSGSFRDEVVKIADDFQMGTIMWTVDTIDWKRPEPDVLLQRV
MRKIHPGAIVLMHPTSSTTEALDTMITKLKEQGYKVGNITELLDEKRVD
>BCE33L0762 hypothetical protein
MGILIDLNSFRTEILAKHVLHMMIENDFFYQGSQLVENVWVNDSTIFINN
VKILTKGIEIYKKNNEYYLTHQADNTRIILY
>BCE33L2232 indolepyruvate decarboxylase
MIHLKTQYTVSTYLLDRLSELGIEHIFGVPGDYNLAFLDDVLAHKNLEWI
GNCNELNAAYAADGYARIKGIGALITTFGVGELSAINGIAGSYAENVPVI
KITGTPTTTVMENGELVHHTLGDGKFNHFSNMYREITVAQTNLTPEHAVE
EIDRVLRACWNEKRPVHINLPIDVYNKPINKPAEPILHKPILSNKETMDK
MLLHAISKINSAKKPIILADFEVDRFHAKEYLYQFVEKTGFPIATLSMGK
GIFPEKHPQFIGIYTGDVSFPYLRKRIDESDCIISIGVKLTDTITGGFTQ
GFTKEQVIEIHPYTVKITDKKYGPVVMKDVLQQLSDIIKHRNEETLDIKP
FISESLSMTEEFNPKAHMVTQKRFWQQIYHFLQENDVLLAEQGTPFFGSA
AIPLPNNTTYVAQPLWGSIGYTLPALLGTQLANLSRRNILIIGDGSFQLT
VQELSTMLRQNLKPIIFLINNNGYTVERAIHGQNEPYNDIQMWEYTKLAN
VFGTEEKSQTFKVENETELQEVLTKISIDKDQLTFVEVVMSQGDQPELLA
KLGKRFGQQNS
>BCE33L1125 conserved hypothetical protein
MEFPSKKDAWLYPTLFIVVGACFAPIFAGREYFLLFFTIPLAILFMWSWF
STKYIVGEETITIRSGFVKKRIFIRDIKQISNTKNPIAAYALSFDRLEIV
YGAHQTEIISPKDKEQFINHVKNKNPHIEIK
>BCE33L0369 conserved hypothetical protein
MEGGNSMDWLDGFGIFYIIGGITIILVFAISYLLKKRFPDKQFDIIFALS
LILLCLASFPVTMMVIGGWEGMGYGFIGFFVLLGTLIGMIAHQLVKISRK
SYV
>BCE33L1496 permease
MFMKNKLLLLSGTGISRLGDFMYLIALNIMVLHSTNSPAAVAGLWIVGPI
ATVFTKIWSGSIVDRLNKRSIMLITDIIRAALIGCIPLFDSIWAIYIFIF
LTRIATSFFDPASFSYKTMLIRAEERAQFNAWSNFCTSGAFIIGPALAGI
LLTTHSATFVIYCNSLSFLLSTILIYFLPNITLQTKQSEEVANTFVQTLR
SDWKQVFSFARTETYIILIFVLFQATMLVAMALDSQEVVFTRQVLFLTDI
EYSMLVSITGAAYVSGSFLVSLFAKRLPIQYCIGLGTIFTAIGYVIFAFS
NSFIVAAGGFILLGVSSSFAGTGFVTFYQNNIPVHMIGRIDSVFDSIKSF
IQVFFILAIGASAQFLSVQITVISSSLLILFLSCLLAIRVMTPSREKYFK
ATGSSLEY
>BCE33L1842 conserved hypothetical protein; possible oxidoreductase
MNKRTALVLGASGLVGQEITRLLLESDYYDSVTIFVREPMQWQHEKLQQK
QVDYLALEEYKEFFAVDDVFSCLGTTIKKAKTKANFKKVDYEYTLRAACL
AEKQGVQNFLVVSSMGANPKSFFFYSQVKGRMEEELQKLVIGGIHIFRPS
LLVGNRQEFRFGERMAEKLSRIIPFIFKGAFKKYKPISAKDVAKGMYITA
LREESGIHIYNSNEITTIE
>BCE33L5095 conserved hypothetical protein; possible membrane protein
MLSTPIGRLRAIGLIEGISFLLLLFVAMPLKYFAGFATAVKITGMAHGVL
FILFIFAVIQVTIVHRKSIAWALGAFVSSVIPFGTFVLDAKLKNEQQ
>BCE33L2448 group-specific protein
MNRFVRYWCQLMIENNGDFVHKRKLSLANKVVITALMSALATMFQAAGNL
IPGIGLFISPFATLPIFLAICYSIREGVLSYLLTILLLFIIEPSELIVFP
FTTGLLGIALGFSFIQFKRRIWVISFSAICLLIGITIVLDIFRFPVLGPT
IHTTMDIKIILSIFILSFLYCWIYAGLCRILLNRLYKVLF
>BCE33L5143 conserved hypothetical protein
MMKLKKVLVLGGTRFFGKHLVEALLKDGHDVTIATRGIKEDSFGGTVKRL
IVDREDEKQLASCLEGKSYDIVYDNLCYSSNAAKIICEVLRGKTRKYVMT
SSMAVYDPALNLSEEDFNPYEYAIAYGGRNDFNYGEGKRVAEAVVFQQAT
FPVVAVRFPVVIGENDYTKRLQFYVEHIVREEPVAVNHLDGELSFIHEEE
AGGFLAWCGMKDIEGPINACSNGVVSSREILHFIEENTGIKSLVQEVGDH
VAPYNEVTNCTLHNGKANELGFQFRELKVEIEKVLRYYIHVMK
>BCE33L2780 transporter, Drug/Metabolite Exporter family
MKRWQMEWLLVSVALVWGANYTIGKYGVAFMSSIQFNSLRFLVASPVLLL
ITFLMKRSLRIERKDWLRLVAVGIVGTTMYQTMFMLSVKYTSATNASLLI
AMSPIFTGILAVLHKQERFSMKVQIGSIVAFIGAAFVLLTGHTGGATYEY
AWLGNIIGLVAAIAWGWYPILAQPLITKYSAMRVTSWSTLIGIVPLVIYC
LFNVNTLTWPIDMLSWGSLAYSIIFATIFGLAMWYVGISQIGSTKVMVYM
YLVPLFAVIFAAVTIGEQINMMQLVGGLIIFIGLYVVKKGGIKKPALNLK
KVS
>BCE33L5068 multidrug resistance protein; possible permease
MESKQKLGRLITVLATFLAFSGIGVVDPILPIIAEKIGASHWQVEMLFTA
YILTMAIMMLPAGIFASRFGDKRMMTIGLAIVTVFAFICGISQTIAQLSL
FRAGWGLGNAMFFATAMTLLIALSKEVHEAVGLYEAAIGLGMAGGPLLGG
ILGGHSWRYPFFATSILIFLAFILVFFFVKEPERKVKRKAAGVGELLNLV
KYKPFMQGAISGMLYYYGFFVVLAYSPLIMHLSAIQLGFVFCGWGLALAY
GSAILAHKLEGKYEPKALLKASLLVFAIFLIALFFVKVMWLQIVLIVLSG
LASGLNNALFTSYVMDISPYERSVTSGVYNFVRWLGGAIAPILSGIIGHT
VSPQSPFLVGGIVVLVGCIMILIPIRKPVEIETKALS
>BCE33L0302 possible polysaccharide deacetylase
MRKYAAIALCTSAILAGCNTSNVNQEPKKEKKVQETKKQAETVQEQGKIS
YNPITHESTNTTIHMTDIKDTLTEVQYKIWRTADGKETAKSLSSKEKEKQ
FSLPFDIKEFEGKHGEFQIEAIGIKEDGKTIPLTKSAITFEQKVPVLMYH
AIDDYHGQGIKDLFVSPANFEAQMKYLKDNGYTLLTFERWGDINKVNKPI
FVTFDDGMKNNMNAFHVLQKLKDDTFKPAATEYMIVNNVDAEGSLSTSDI
KEMVDSGIFSMQSHTATHADLPKITNYEEELKESKEKLEKITGKPVIAVA
YPFGHVDDKVVAETKKYYQFATTTKPGKFITKGEPDELLKMKRVRIHHTT
TVEQFASSIK
>BCE33L2149 permease; possible ABC transporter, permease
MIAGVSLMFYLLDQYGKQPVYATMTQIMIALPALIFFLLVGTVVDRFDRQ
HICTVSNICCSLCNIGILISLYYGMIILVFLFLFLENACIQFFSPSEQSM
IQGVVESDQYGAAAGINQMVNSLYALFGVGIATMVYWTFGIYGSILVNTL
TFIMSGILIQTISIPEKVRLPNGRTKWKEVNLKMLITEFQGGIKYIYQNE
TLKKLLLGFIVFGLLNGILSVSTTYILKYKLAPAMYESLAIVGGVVGGVS
LLIGSIVATSIGKKYAPKPIIVFGMAGSGIFFGMCYFVNYVWSFYVCIAF
ATFFLPFINVAIMSWMYEIVEESFMGRVQSLLSPLTTGFQLLSLGAIAML
FPKWIRADTLYIILFGLLLFVTCLYQAILPSGQKRVHVVAKEI
>BCE33L4491 permease; possible multidrug resistance protein
MPRKVWLLVAGMIINVTGASFLWPFNTIYLHDHLGKSLSVAGMVLMINSL
TGVIGNLLGGVLFDKWGGYKSTLVGIVITLVSILGLVFFHGWPLYVVWLA
LIGFGSGMVFPSMYAMVGTVWPEGGRRAFNAMYVGQNVGIAIGTACGGLV
ASYRFDYIFLANFILYFVFFLIAFIGFRGMEDKKEPGVQKEVEAKKGWSL
TPGFKALLIVCVAYALCWVTYVQWQGAIATHMQELNISLRHYSLLWTING
AMIVCAQPLVSMLIRWMKRSLKQQIMIGIIIFAASFIVLSQAQQFTMFLV
AMVTLTIGELFVWPAVPTIANILAPKDKLGFYQGVVNSAATVGKMFGPVV
GGAIVDLYNMEVLFIAIMVMLVVALIATSIYDKRVKVEETVEEKIAV
>BCE33L1636 sugar ABC transporter, permease
MNKRVGAVNKNKIMIHTMLIIGALLTIGPFIWMILTSLKTYAESVQVSPV
IIPSQFMWSNYTEIFNLLPFLKFMMNTVIVTIARTIGQLFLCSLAAYAFA
RIQFPGRNVLFLLTLSVLMVPAQVFLLPQYLIMVKLDWLNTLQAVIVPGL
FSAFGTFLLRQFFMGVPKELEEAARLDGCNHFQIYWYVMLPLAKPGLIAL
GIFTTLWSWNELMWPMIVNNSPDMMTLSVGLSSLQGQYATNYPVLMAGSF
LAILPMLLLFIFLQKQFIEGITITGGK
>BCE33L2498 transcriptional regulator, DeoR family
MFTEERREKILELLKKNGRVIAKDLAESFDMSIDSIRRDLSIMEKDGLLK
RTHGGAIELARVRNLAAKPLKRYSNGSVYEDAIAKIAASYIQEGDSVFIG
GASIHYAMLKYLPETSFTVITNALEIASTLREYKNIDMYLIGGMVKPSGN
MTDTLASELISRFSIDLNFSTGDGISLNGISTATPEIAFFSKSVSKIARR
NICLALHNKLGIDYFIKGESLIEIDLIITDSEASKETIQEFEKQGKEIVI
APIDCI
>BCE33L2187 group-specific protein
MLNILLMIVFIIFLAVSMYIAYQKRKKAEIKGLKSALTSICFFSLAIFNL
FAYWFQFGGMLTVLFSIVLLLVGAYFTKYIPISKKVH
>BCE33L0556 HIT (histidine triad) family protein
MDCLGCKLANEEEKIYKIYEDDYVTCFLDHEPFYPGHTLIVPKQHVVEVD
ELDDVVAKAIMDASKLITKAIKALYKPDGVTVCQNGGVFNELTHYHMHVV
PRYKERSFAEFYMVQPGEKQNHNFEETKHLLKEAIEKILHIEKV
>BCE33L0598 conserved hypothetical protein
MNRLVFSYMLNVLLMVLAGWAFIELYYFTIEVANFIQTKRVPFEVSVSLM
PLGLLLIFGIVSTVLYKVQKKKYKELSYWMFPLLFPQEDEREKAITEKAC
RTTFMSLWYVLPCAVGFLTLSPIANLYVPAYPIYIAFSIFFIQMTIFHVS
LYRNKIA
>pE33L466_0089 membrane protein
MTIFMYIFCLIVWGLNFIAVKIQGTPVSLELSLTYRLVMTAFLFLMLVCF
LRPSGIPTKKDIPFVIVFGICNFALSYLCLYYATILSSAAIVTLVFSLKV
ILTPVALRIFLKEKLHSRVLVGGILGVLGVCILIYPKLNDFQGFNDLKGI
MIALLGTVLTAIGDASSARNASHKVNPIYANAIGFTVGSLLMGVIVLFQG
QEFTFPTSFSYVFMLLYLTLFASFVAWLFYLKLVEKIGGARSGYMVALFP
VIGGIASVLIGESDPSLYLFVGCFSSCIGAAIALGFKTQKQDSKLTLKKV
N
>BCE33L2057 macrolide efflux protein
MSALYKDSRLYYILGANSLSAIGSGIVMITIPWLLIKESGGETTFGYVSI
ISTFIMFLLTPFIGQSIDRFSRKSLLLCNEGIGIAVIGIMVIWGFAGQPY
HSIHYILIYIAGSFYYLLFYPTIFAFNQEIFQVEHYKSLSGTMEIQGQLT
QVISGAVASFLIEIVSLKWILLVDMLTFAGAFFLFLCIPYVKKKEIKKKI
TFKKQLFEGIHFMKKRPKLFWFLLATYMPFIGVMMANYLIPVYISDILKA
NASVYAIEGMMYGVGAVVAGICIPLIMKYVKTEVSIVMTMCIYVISITAM
IIEPSVIFLYGLAIFHAIGNAGTRVARNVLMMEEIPNEVMGRVDSLFRLI
GTGIRIVLLMLFTVGVSKVGVMVQFYLLSFILILSSGIAINYVISKRKFE
ASISNKSIV
>BCE33L3120 conserved hypothetical protein
MNVSEAKKDLAIKTKRGLPIILAGVLFWIVMSIAGFVLSEKQVVWVYLIG
MGCVFPFGLMIAAILKIDMFAKGNPLGVLAGLIGGINVLNIPLVLLAYFQ
FPEWLPFVVAMLIGVHFIPYVWIYESKSYGLLSVGTVFVTSVCGILFAEK
GFTVIPLSVTLVYLLTCISLLIENKKANQYQQKSA
>BCE33L2694 sugar ABC transporter, permease
MEGRKEDESMKYVYRWEGVLIVLLLIEFILFSLINSDFLNISNLLFSTND
FLFIAIAAIPMTFVIVTGGIDVSVGSIMGLTSILIGVLWMNGISILFAVI
ISLIISCLAGALNGLIIKMTDVEPLVVTLGTMFLNGGIALVISGGAGASG
YEGISGLPDAFVQLASGSFIGIPNLLWLLIVLTVLCAVLFHRTIYGRHVK
LTGANENAAKYTGIKTKKVVIIAYMLSGLGGGLGGTFLTAYFGSARADMG
SETILPIITAVVLGGTLITGGKGSIIGTVLASIFIGLMQYGLQMTGLTNE
QSNVVIGIILILSVIMRHFKLHQFTLGKRKNLHKGEMS
>BCE33L0617 conserved hypothetical protein
MKKIHVLALIPVFCLVVGPVFANSVTPYILGMPFLLFWILLSVLITSLCM
GIVYVFDPANKGDVK
>BCE33L0218 permease; probable multidrug resistance protein
MKNTWRELREMDRNVWIRFIGETLNGIAMMMLMPFFALYLKDKVDSLLQV
GVIMALSPIAASFGSIIGGRIADIYGRKPIMIFSMTSNALLMLGFLFIEG
FIPYAILSIFLGLSNSLFHPAASAMVADVTAPEKRTEAYGLLRMGHNIGA
AIGPIMGASVVMLSKNLVFIIASSTMLFYALLVFVLIQETMPKIANKEED
NEKESGVVWKIVLRDKALMIYLLAGIIISMGFSQTEGMLPLHFDNEMKDI
FGTNNPYPYLMALNGLLVVLFQFQISKWATDKPVGKTMLYGACLFGIGLF
FIGWLPKWFGGLDTNATIILITLLFVYAIYTLGEMIMSPVQMTFVANLAP
EHLRGTYMGAASLQWITGNAFGPLLGGGLLDRLLGHFLFTILAIGCVVAG
VVYISLDRLVEQRQKGTLTKQSS
>BCE33L4597 conserved hypothetical protein; possible 4-Hydroxy-2-oxoglutarate aldolase
MTNIQKRFYKGRVALNVLANNIENAKDIFEAAEGYVVVGVLSKDYPTVEE
AVTAMKAYGKEIDDAVSIGLGAGDNRQAAVVAEIAKHYPGSHINQVFPSV
GATRANLGGKDSWINSLVSPTGKVGYVNISTGPISAAGEEKAIVPIKTAI
ALVRDMGGNSLKYFPMKGLAHEEEYRAVAKACAEEGFALEPTGGIDKENF
ETILRIALEANVEQVIPHVYSSIIDKETGNTKTEDVRELLAVVKKLVDQY
A
>BCE33L3694 phosphoglycerate mutase family protein
MSMTEICLVRHGQTDWNFQEIIQGREDIPLNEVGKKQASQSAAALQAEAW
DVIISSPLIRAQETAKEIAGATGLQSILLDERFVERNFGEASGKPVSTVR
ELIAEGKVEGMEQDEEIVARCFAAVKDVAETHSGKRIIIVAHSHAIKAIL
HAIAPEDITFKTPLKNACISYVNENSGKWDVLKYNIAEHIHV
>BCE33L0797 hypothetical protein
MKKIIGVIVIILLTYYALHSTPSLAVRTALFFEGHPIVAFSGEVEKERDV
KKEAIPDEYQTLYGDKKEEPEHYFFPAVRAHGSGIDMLSACVKKEWLFYK
AELGCY
>BCE33L3758 multidrug-efflux transporter
MESQLLKKDSNKTKFVVAGLLLGILMAAMDNTIVATAMATIVGDLGGFDK
FVWVTSAYMVATMAGMPIFGKLSDMYGRKRFYIGGLILFLFGSALCGTAS
SIEQLSIYRAIQGIGGGALMPIAFTIMYDIFPPEKRGKMTGLFGAVFGTS
SVFGPLLGAYITDYISWHWVFYINIPLGLISFFFITKYYSESLEFRKQKI
DWAGAITLVISIVCLMFALELGGKEYAWNSTVIIGLFTTVVIMLIIFFFV
ERKATEPIISFHLFKKPLFAASQGVAFFYGAAFIICTVYIPIFVQGVLGG
SASNAGLILTPMMVGSVIGSQTGGQLASRTSYRNIMMVSGVFFVLGIYLL
STLTMDTPRLLVTLFMVLAGLGVGFSFSVLSMSSIHKLEMRDRGSATSTN
SFFRSLGMTLGVTIFGTIQNHIFTDKLNTLFPPELAKLAPKGGDTSFLLS
PGATDKIPAEILTGIKEALATSIASTFFWALIPAVLSIICILLMGNERLF
TGPKTKQKQKQVS
>BCE33L5139 transporter, MFS superfamily (major facilitator family transporter)
MNVTTDVQSTTEETKEKRYKTLFGSALGYAAEGLDMLLLSFVLVYILKEF
HLSPVEGGNLTLATTIGMLIGSYLFGFIADLFGRIRTMAFTILLFSLATA
LIYFATDYWQLLILRFLVGMGVGGEFGIGMAIVTETWSKEMRAKATSVVA
LGWQFGVLVASLLPAFIVPHFGWRAVFLFGLIPALLAVYVRKSLSEPKIW
EQKQRYKKELLQKEAEGNLTTTEAEQLKQMKKFPLRKLFANKKVTITTIG
LIIMSFIQNFGYYGIFTWMPTILANKYNYTLAKASGWMFISTIGMLIGIA
TFGILADKIGRRKTFTIYYVGGTIYCLIYFFLFTDSTLLLWGSALLGFFA
NGMMGGFGAVLAENYPAEARSTAENFIFGTGRGLAGFGPVIIGLLAAGGN
LMGALSLIFIIYPIGLVTMLLCVPETKDKVLE
>BCE33L2420 transporter, drug/metabolite exporter family
MHNKKWDLRIICAHAFTILIWGSAFPAIRMGLESYTPEHLTLLRLLIASV
ILLLFSFIYKLRLPDLKDIPAIFIFGALGFTFYHIALNYGEKTVNAGSAS
LIVSVTPIVTAIFASVFMNEKMKLNGWIGGVISFIGIAFISFSQGDAIQL
NSGALFILLAAISESLFFVFQSSYLKKYGFLPFTIYTILSSTVCMLIFLP
GMYQEILAAPLEVNLSVIYLGVFPTVLPYIALAYIISRAGASEATSSLYL
TPITACFVAWIWLGEVPTLVSIIGGGITILGIVIAHIPVLRKEKHNNLAN
NQSV
>BCE33L2986 permease, major facilitator superfamily
MNSKEKMMTILKHTHIHSSVHATISRYMTLLFAIACGMAVANIYFAHPLL
DSLSNEFKIRHSTIGIVITITQVCYALGLLLLVPLGDLLNQKKIIIVQML
LSVFALIIIGCAPSSTVLFIGMALVGVLATVTQTLVAYASILANPAERGR
IVGFVTSGVVIGILLARTFAGTLTDLAGWRSVYLTSAILLLFVTVLLHKN
LPTLEHKKVTTMSYRKLIHSVLLLFVEERLLRVRGILALLIFTSFSILWT
SLVLPLSVTPHNLSHTAIGAFGLAGVAGALAATKAGQLADKGFGQRTTGI
ALSLLVLSWLLIKFINHSLLLLIFGIILLDLAVQAVHVTNQSMLFTVRPE
ARSRLTASYMIFYSIGSATGAILSTNTYAKYGWDGVCILGVSVSACALLF
WTMTLRQSSKLKEE
>BCE33L0482 probable glycerol-3-phosphate ABC transporter, glycerol-3-phosphate-binding protein
MSLVKKGAALLMVATMALSSAACSNSKTEGKPEAQAKVAPVEKNGDKTVI
RFWHAMGGKTQGVLDGLVADYNKSQNKYEIKAEFQGTYEESLTKFKTMSA
TKEAPALVQSSEITTKYMIDSKKITPIDSWIKKDKYDTSKLEKAITNYYS
VDGKMYSMPFNSSTPVLIYNKDAFAKAGLDPEKAPKTYAELQEAAKKLTI
KEGGNVKQYGFSMLNYGWFFEELLATQGALYVDNENGRKDAAKKAVFNGK
EGQKVFGMLDELNKAGALGKYGASWDDIRAAFQSGQVAMYLDSSAGVRDL
IDASKFNVGVSYIPYPEDSKQNGVVIGGASLWMTNMVSEETQQGAWDFMK
YLTKPDVQAKWHTATGYFSINPDAYNEPLVKEQYEKYPQLKVTVDQLQAT
KQSPATQGALISVFPESRDAVVKSLEAMYDGKNSKEALDEAAKATDRAIS
ISARTSEK
>BCE33L2738 glycine betaine/L-proline ABC transporter, permease
MQQNNDLNFEPQDVNIVNPKQARKAVVATGIGNAMEWFDFGLYAYLAVIL
SQLFFSGVDNSGLQLVLTFGTFAAAFLVRPIGGVFFGRIGDKYGRKIVLS
TTIILMAFSTLFIALLPTYEQIGVWAPILLLVARMIQGFSTGGEYSGAMV
YIAESSPDKKRGILGSGLEIGTLSGYIAASVIVTILTLLLTDEQMLSWGW
RIPFLIAAPIGLVGLYLRRHLDESPIFEEMEKAQEESEDNEQFSFMDIIK
YHKKDFLLSTVIVAFFNITNYMILSYIPSYLTQVLKVEETTGLLIISITM
ALMIPLALYFGKLSDKIGNKRVVQIGLLGLTVFAIPAFLLIGNGHIAAIF
AGIFVLGFFLSVYEGTLPSLLPSLFFTDVRYRALSISFNISVSIFGGTTP
LVCSYLVHATGNPLAPAFYLTGVSIIGLVVFSVLFVTTSGRALKGSYPTV
ETKKEAHQIAKEDPEETLWWHEESLEIEAGKNASI
>BCE33L1468 transporter, Drug/Metabolite Exporter family
MSVKKDWIAPLALLFVSFIWGATFVVVQNAMSFVGPFTFNGIRFLFAGII
LLFVQILFSKKASKQHIKQSSLAGLIVGFFLCIGYVLQTFGLLYTTSSKA
GFLTGLSIVMVPILSFIFLKQKATIFIVIGIAVATAGLYLLTAGDSFQLN
IGDILVLGCAVAFAAHILVNGFFSKKISPLLLSTSQVLAVGLFSSICAFL
FEDWEKLFSVALWTNSSFLFALFLTSLFATSIAFFIQTSAQKHTSPTRVA
IIFAMEPVFAALTGVLVANEQLSISAIIGCLCIFLGMVFVELPSKTKKEA
QAA
>BCE33L3210 major facilitator family transporter
MEERLNSTYKWVMLIVATIAQTTATLITYGVGVFALFWKEEYALTNMESG
LLVSVVNVGPLFCMLFVGRLLDQYNEKILISISSFLLGSSLLLTNIVSGF
NGLLFVLLLIGMFYSVSQPGGSKVILKWFPKENRGLAMGIRQAGIPIGGA
LAGVLIPFLTVQYNMTYAINSIACICIIGGVLFFVFYKEPYVQEEARKGH
NKISFWMELKVVICKKELYPIYITGICMISLQMVLVGHFMKFLAGEQSIT
SIVAGTVFSVMFFSGMIGRIALAAISDVFYKGNRRIPLFIAVCASIGLIL
LLVMNIHTITSGVLYSISALLGFVSIGWFSLFIAEVAELASEESVGITVS
VALTLNQIAIIVAPVLFGYIVDEKGYAYAWLCIVVLLSISAVSLYRKNKK
IKES
>BCE33L1568 conserved hypothetical protein
MGSSGYVPDNKNLKKSSGNPNLFFDSRKNVFFKRDKKNVAYEVTSTQLPA
MIGGAFVDLFMTKGHMREPHWHPNAWELDVVVSGEAITSILNPETNQLQN
YHVKAGQTVFIPMGWWHWITAVTEEVQLHLFFNNDQFETAEGSDILRLTP
PEVFQAAYGVSAEKLEKDLSPIKESVVIGPPNSNRISSVKESDESNIVVT
LNGQITPCEIE
>pE33L466_0228 hypothetical protein
MELLGLDMVAQQLPAITNAAVLSNINFGVNIKDWLVAQLGPIFLVCAIIG
VIILLVKRQMAGLIGWLVLCAIVSVFVFTPDVFKDLGTKLYNLIFK
>BCE33L3369 transporter, drug/metabolite exporter family
MLRYSLLVLLGACSYGILAIFVKLAYAEGFSLGEVIGSQYLFGWIILLAI
TLLFSRHRVPLKQALILFVAGTSASFTGIFYYASLKTVPASIAIILLFQF
VWVGIIIEAVATKTLPSREKVISVIFLLAGTFLSSGLLEKSAGDFDTTGI
ILGLLSAVTFATYIFVSGKVAVEVPSLPRGVLLMAGALTLVMIVFPPTFI
FNGAISEGLWKYGLGLGTFSIVIPSIAFTIGIPKIGSGLATILGAAELPV
TTIMSVFVLKEAVLSSQWFGVSLILIGIAIPQIAYAMRGRYRKHHTHKKL
AA
>BCE33L0260 probable permease of the drug/metabolite transporter (DMT) superfamily
MWEIMKEICMLLVAVILWGTAIAPTKWALESIQPFTLLFIRLLFASGICL
LFSFKQLKRSVEHKQVPWKRMSLLSFTGVAGYFMFTSYGISLTSGLHVSI
IDAALPLVTILFSAFFLKEKIQLNYWIGIALGVVGVLLITIPSSNVDQEV
SLIGDILILLSTFLFAFYTILLKRPKQEQYLSNKVFTTLTLIIGAVILLP
FAMAEAFYYGFPEIETWKTGFSVIYLVIGATILAYWFWNRALETVSASVS
GLYLNALPLISIVASIVLLDESVTWKIVIGGSLVLIGVGWADKQKISKLL
KRDNLNKKTPNI
>BCE33L5033 fructose-1,6-bisphosphatase, class II
MERSLSMELVRVTEAAALSSARWMGRGKKDEADGAATSAMRDVFDTIPMK
GTVVIGEGEMDEAPMLYIGEKLGTGYGPRVDVAVDPLEGTNIVAAGGWNA
LAVIAIADHGNLLHAPDMYMDKIAVGPEAVGAVDIDAPIIDNLRAVAKAK
NKDIEDVVATVLNRPRHQAIIEEIRKAGARIKLINDGDVAGAINTAFDRT
GVDILFGSGGAPEGVLAAVALKCLGGEIHGKLLPQNEAELARCKKMGIED
INRILRMEDLVKGDDAIFAATGVTDGELLRGVQFKGSVGTTQSLVMRAKS
GTVRFVDGRHSLNKKPNLVIK
>BCE33L0725 permease, drug/metabolite exporter family
MPYFYVFLLLLTSLLWGGNFVVGKSLVDHASPMTLTSLRWIIAIVCLLPM
VWFKEKKIIPPRAAILPLILMGISGVALFNIFQFLALEKTSATNVGLIST
LNAISIALFSVLFLKEKVNTLQILSMILSFFGVILVLLKGNFALLFSLHF
NSGDLWMIAAVCIWGIYSVCSKWATKTTTPLMATLYSGIFGVILLLPFNI
GSFTVTNINTSFITSLLYTGLISTVLCMVFWNIGVQKLGATTSGIFLNFN
PIFTAILAFLFLGEELTWIQIVGTMIVVTGCYLFSHFKTVTVQPTGALLR
KHS
>BCE33L5144 transporter; possible acetamide transporter
MGYVGLLLSGAALFLNSLVILGKAEMKSAGVFNLFVGALQIIIPFYLIMI
SDQSNWTVYSYAATFLFGLTYLYVGVTFIKGMDSSGLGWFCIWVAIIALF
YMVVSFVQFHDVVNALTWFMWALLWYLFFVLNTQKKNINQYLGRIAFVQS
WVTLTLPSLFYFMGVWGEGFVYELWVYVSVISILYFCYCIYKYRVR
>BCE33L1864 possible oxidoreductase
MKVCILGATGRVGSNIIKLALKDSAEVTALARDSSRVEINHERLRVIEGN
VLNENDIKKAIEGSDIVISALGTDQNGTLVKSMPQIIKKMEEEGVRKIIT
IGTAGILQARTNLNLYRFQSTESKRKSTTAAEDHLAAYKILSSSNLCWTV
VCPTHLIDGDVTGVYRTEKDVLPEGGAKITVGDTAQFTWNLCSENKYENS
RVGISY
>BCE33L0252 UDP-glucose 4-epimerase, C-terminal region
MEKITERKVDFIYYKQKQENIRKVILNIDRVRQECNWEPKVDFKSGIRLN
KLWIEEFLYSENNKPCPTYTEVGHGLLFYFFLYYPKVLMFPPKTIGL
>BCE33L3079 possible gluconate permease, GntP family permease
MNMYLLMITLLSIVIVILGVSWWRWHAFISLTIASLFLAIMSGMPMDKIV
SAYETGVGSVLGHLVGILVLGTILGKMMAESGAGMQVAEFFIKSFGIKNL
PWAMLIAGFIIGIPVFFEVGILILLPLVISIHKTTKQNILLIALPAIAGL
SVVHGLVPPHPGAIVAIGIYKANLGKVLLYSLIITFFAAIIAGPLFAKWI
HKRVIPENEPELIRVNTKSTKLPGIGVSFLVILLPVLLMVLAAAAPYVPL
STTLMKMVTLIGSPIIALLIACFAAFYFLGFRQGIDKKAIKKVTEDSLLP
IGSIVAIIGAGGGFKQILIDSGVGNAIAQMSEHLALSPIVLAFMVAGLIR
IATGSATVALTTAAGIVSPIVENTTGVNLELLVIATGAGALMFSHVNDAG
FWMVKEYLGLTVKETFKTWTVLETLLSFIAFGGVLLLDMFV
>BCE33L1917 conserved hypothetical protein; possible sugar phosphate isomerase/epimerase
MLRVCNEIGDLAFRFGGFFAIETGSEKAIVLKRFLENINSKGLAINFDPA
NLISDINENLIESLLLLKDYIVQTHIKDCTKVKSDSSSKYIEVAAGNGEV
DFDIFFKVLDKIGFEGFNMIERNDYFDELDGMSQSINFAKKYIPTQKE
>BCE33L2318 macrolide-efflux protein
MKLIQERSLTVKTTFSKEYKIFIFGLLISRIGDSLYTFALPWIAYQLTGS
AVIMSSLFAINVLPIVLFGPLVGIIIDRYDRKKLLLVADITNIILVSFVP
ILHSLHLLEIWHLYIITFMLAVMSMLFDVTTVTVIPQIAGASLTKANSFY
QMVNQLASLFGPMIAGVFISFIGGFQLLWINVLSFIATLVAVMLLPSMKT
TNKKCEDKNTLQNVLYDLVNGFKWLKNDRLNLVLSFQAMIGNFGASAVLG
VFMYYLLSTLQLTPEQSGVNYSLIGIGGLLGSLIAVPLEKRLQRGILIPL
LLFVGAIGLTFALWSTYWLAPGIAFGVAMTCNIAWNTIVATIRQETVPSN
MQGRVLGFSRVLTRLAMPLGALVGGIISAYNPAFVFALAAFTKLIEVFIA
LYSPIRKL
>BCE33L2412 permease
MASLRLHIENKKSNQELRNICLYSIAKTVSIFGSSIYSFALGLYVLQITG
SALNFAITLILGTIPMIVMNPFAGVIADKVDKKKLVVCIDVLSGCLLITV
YILSNYYGLNLFIIYTTTFLMTVFTTFFGIGLEAAKPNIVSKERLMSLNS
ISKIIDSISLILGPMLGGIVFAVFDMNTFIIINGISFILSAISILFINFK
LCEQYINKECSIREINFIKDIKEGYSYLMERESLKNTFRILISLNFFLGF
SVTVPLPYIMNTVLNLSSKQFGLIQGTFPIGMIVGAIIVKKITNRFSYSY
LLKKTSFMVAIFMIVSGAPVLFKSIEVNKIVFVTMYCAIMFFLGLMIALI
DIPLIYFMQREIPDEYRGRVLSIGLSLGKMMQPIALALSGLLLNHIPSYT
LPIGGGIVFLILNQAYSNKLNLEIHSKGYSVERN
>BCE33L1069 glucose epimerase
MERVLIIGALTFVGYHLVNKMIAEEVEVYGLDFDEFDSMTKINEEKLLLI
GRNALFTYYSIRDEDGWRSVEEEKFDAVYFCLYEPNQQSGFRNERVILQY
LKRIIRLCEEHKVKLNLISSIEVGNADESENKRLFAKVEEGLKKGEVQYS
VFRVPTLYGPWQPSFMMYHQLILSELGEKECHYASQENGSDLLYVEDVCE
YLWENGRNEEQLGIYNLLSGKKSLWKKGMNLLRAEDKVKKENAEERERAA
EDISIKRNTPLEYGLNKQLAHMKKYKELYEG
>BCE33L1791 polysaccharide deacetylase
MEKAFKIKRVVFVLIAIAAVAIGYFMFQSITSPAKAVAKQENVVQLASEQ
PKVEMNKTAPSRFNGKERKVAYLTFDDGPGKYTAELLNTLKQHDAKATFF
LIGANVKEFPDLVKRENAEGHYVGMHSMTHNFAKLYKNGEYVNEMKEDQS
LIANIIGKSPKLTRPPYGSMPGLNEGLRNKVVEGGFKVWDWTIDSLDWKY
NKMQVDAAAAQIAQNVLTNATKPQEVILMHDIHPQSVAAVPAILKGLKEK
GYEFEAYHEESHFPVNFWHDNRM
>BCE33L2393 permease; possible macrolide-efflux protein
MKNLLKGWKYPLLLLSGVGIANLGAWIYLIALNVLVYHMGGSALAVATLY
VIKPLATLFTNAWSGSMIDRLNKRNLMIHLDIYRAVFIAILPLLPSLWMV
YVFVFFISMANAIYEPTAMTYMTKLIPVEQRQRFNSLRSLIGSGASVIGP
SIAGALLIASTPEFAIYMNAIAFLLSGVITLLLPNLDKKSDSHTSNDTLS
LAVLKKDWNIVLNFSKKSLYIVFVYFLFQGMMVLAAANDSLELSFAKEVL
LLTDSEYGFLVSIAGAGFILGAITNAILSKKLTPSLLIGIGSLFIAIGYI
IYAFSNEFLIAAIGFFILSFSMAYANTGFNTFYQNNVPVHIMGRIGSIYG
LFIAGITILITILFGVATQFISIQLVVIIGSLVMLFITIILCVFTLLPSH
SKVHSSESIHSK
>BCE33L1123 possible membrane protein; drug/metabolite exporter family protein
MKQERSIALPLAISIIAISFAAVFVKMSSAPSSILSMYRLWIIVLIMLPI
VWKKREEFSKIQIKDWGFLIGSGFFLALHFLLWFESLKHTTVASSTIILA
LQPIVSLVGGFFLFKERTTYSAIVTMGIAILGVVCIGWGDLGLSEQAIYG
DILSFLSVIAVVGYLFIGQTTVKKVSHWIYSFTVFAFAGIFMGMYNIVLQ
VPFTGYTKWDWTVFLLLAVVPTVSHVINNWLLNYVNATTISMSILGEPVG
ASILAFFLLGERLNAMQMIGSMLVLFGVSVFLLQQQKRTAKNVVNEPAYT
QEL
>BCE33L3795 class II aldolase/adducin domain protein
MKQLFRQWYDLSEIKKELTTRNWFPATSGNISIKVSHEPLTFLITASGKD
KTKTTPDDFLLVDHLGVPVLETELRPSAETILHTHIYNNTNAGCVLHIHT
TDNNVITNLYSDAVTLQNQEIIKALDIWEEGATIHIPIIENHAHIPTLGE
NFRKHIQGDSGAVLIRNHGITVWGRDSFDAKKRLEAYEFLFQFHIKLLSI
QGGVSNGANSYS
>BCE33L3321 possible polysaccharide deacetylase
MLLRKELEPTGYVTWEVPNNEKIIAITFDDGPDPTYTPQILNLLRQYKAE
ATFFMIGFRVQRNPYLVKQVLKEGHEIGNHTMNHLYASNSSDEKLENDIL
DGKKFFEKWVKEPLLFRPPGGYINDAVFKTAKEAGYQTVLWSWHQDPRDW
ANPGVQSIVNHVLKNAKSGDIVLLHDGGNNRSQTVAALAKILPELKKQGY
RFVTVSELLRYKH
>BCE33L3177 drug resistance transporter, Bcr/CflA family
MKKVSVPSLLLMIILVAFPQISETIYTPSLPDISKALHVSNNEVQLTLSV
YFAGFALGVFFIGWLSDIIGRRPAMLFGIVVYGVGSFLCFIANSIEVLLV
SRFIQAFGASAGSVVTQTILRESVEGHKRHVMFAQISAVIAFTPAIGPLI
GGFLDQMFGFKIVFLSLVVMSVGIFLYTFVSLPETKTDSVTNKINVFAVL
KKLITNPKVVTYGLLIGGANGVLFSYYAEAPFIFMEYFQLSPSMYGFLGI
VVASASIIGAKVSKRLLATYKPEKIIYIGCLVMVVGAVALSIITSVGSNP
NIIYMIGFLVAMFILLLGIGIALPNCLSLALVDFQDVIGTAGALFSLGYY
VIVTMTIWGMSQLHTGSLLVMPLYFLAIVVIMMVFTKVFILGKQTSKAI
>BCE33L0303 polysaccharide deacetylase-like protein
MKKYTYIALLSSAILVGCNTSSTSDKQIQETTAKQAVEQKKAKAVELPLT
QGVITWDPYEYNAQNTTIYTKDLRDSFKEVRYTIWRTADGPESKQTFTSQ
EKERDFALPLHLKTFHLKRGEFQIETVGIKEDNTETNLVTSKITFQQHVP
VLMYHAIEKYPGPSDGDYGLYVPPEQFEKHMQYLKDNGYTMLTFERWNDI
NRVNKPIFITMDDGRKNNMNALHILQKLKDDTFQPAATEFLTANEIDKPN
RLSTDDIKQMMDSGIFSIQSHTANHTMMAHSNNYDEELRGSKEKIEALTG
KKVIALAYPVGSYNDPAVEETKKYYEFAVTTDHGNHITKGMPNEQYLIKR
HFVGPNTSMEKFLSLIK
>BCE33L1629 S-layer protein, four SLH domains
MKKVISNVLAVTVALQVVMAPATSFASTKEFPDVPKNHWALEAINDLTSK
GVIAGYDNGKFGFGDVVTREQVAALMYRALKPEVKSDYKNPYSDISAGTT
MFQKEILALTDMGIFVGDGKGTFRPKESLTRAEMSVILQKAFKLEVKAPH
TFDDIDATYWWAKEAISALQSNGVAAGNGLGGFDPSGVLTREGYAQLLYK
AMQIKKDVPVEQPSYMNLDVTLPSNITAQEIDGFIKEWHPDSPLIGTGQD
FIQAQNEYGVSALYLAAHAILESGYGKSEIAYRKHNLFGLRAYDRDPFAY
AKYLPSYKDSISYNADYVRKNYLEKGADHFNGYTLPAMNIKYATDKEWAG
KIANLMERIKPFNKKDYENVKRLPKNPNTLNVEALGKEIPYKDYAKDATA
TVQLVGSYYQVPYPFGYTIKSVPNITQNEVGKLESGKKVNVYREDPNGWV
EFSFENAQEKYWTLKKNLKI
>BCE33L2905 conserved hypothetical protein
MKWLSWERNLKTRLIGETMFNTLFWVYFPFMEILTIGELIRSPVVHSFVS
KYAPENARGQYMAASNLQFTIGRFIAPIMIVFSTWLSPSVVFGIILLCAL
VSAVFYVKVFLMISNTTMHNE
>BCE33L4685 4-nitrophenylphosphatase (p-nitrophenylphosphate phosphohydrolase)
MYKGYLIDLDGTMYRGEEQIEEASDFVKALGERGIPYLFVTNNSTRKPEQ
VAEKLVRFDIPAKAEQVFTTSMATANFIYERKQDATVYMIGEEGLHDALV
EKGFELVDENPDFVVVGLDRDITYEKLAKACLAVRNGATFISTNGDIAIP
TERGLLPGNGSLTSVVAVSTGVDPIFIGKPESIIMEQALKVLGIEKNEAL
MVGDNYDTDILAGINAGMHTLLVHTGVTTVEKLTEYEVQPTQVVHNLTEW
IENM
>BCE33L4099 probable phosphoglycerate mutase family
MKLIFVRHGEGEHTKDSPSSLQVPHPPLTDEGRNQAKLLQCNVPLQETDI
LIASPTIRTLQTATIWSAKVACQKIVHPYVSPRIFPYREGATTLPCDHIV
DQGRIKKLFSNFSIEKSTNKQLWTEGINTISENSFQRIVEEFLLWCYELG
AERICIVSHDGTITAYRQYLQKVVLTRADFLQETGIYEMDVSFKSLIGEI
>BCE33L2770 possible isoflavone reductase
MKILILGGTRFLGRAVVEEALNRGHEVTLFNRGTNKEIFPEVEQLIGDRN
GDVSSLENRKWDVVIDTCGFSPHHIRNVGEVLKDNIEHYIFISSLSVYKD
WIPHHIKEDYILQPEPTKEQIKAVENGEISPYEHYGALKVLCEKEAEKYW
PRRVLHVRAGLLSGMFDYTDRLPYWIGRVAKGGKVLVPGRKNRPVQIVDI
KDVANWGLNMVENNKAGIFNATGPNYELTMEELLNTCKKVTNSDAEFVWI
EESFMNEHKVQPWTEMPLWLPETFPLEGETKPWKGGFSISIESAIKVGLT
FRRLEETVTDVYEWMESTDEWELKAGISGEREKELLEKWYQ
>BCE33L4085 group-specific protein
MNMLLKGTLFMLTLDRLLNVTIYLGVFLLFISFITFVIKKGPDLLFFQFG
ISLFFGAQIIIGMKFFHNYGFSFHSKLELLIFIFYVIGFITCILLFFHFQ
NPYRIFLLICSFLFLTGSNYYFKETLKFSKKIPKQHKTFLNTQEEDSFPK
EVRKFSEDYNNIIRNDFYEIPMIPTELQITSKKDSSHSTSFLVELHNMED
KITDDSVQLTPSDRFYILLNTQKTKISKIVYEGRDFFTLTVTLKALNLQQ
EPEIHNMFLEIDKRRAMNLLDFEIKAHSKEWKVTFKSDSSPSNLPITFTF
EKRTGKL
>BCE33L5035 fructose-bisphosphate aldolase, class II
MPLVSMKEMLNKALEGKYAVGQFNMNNLEWTQAILAAAEEEKSPVILGVS
EGAARHMTGFKTVVAMVKALIEEMNISVPVAIHLDHGSSFEKCKEAIDAG
FTSVMIDASHHPFEENVETTKKVVEYAHARNVSVEAELGTVGGQEDDVIA
EGVIYADPAECKHLVEATGIDCLAPALGSVHGPYKGEPNLGFAEMEQVRD
FTGVPLVLHGGTGIPTADIEKAISLGTSKINVNTENQIEFTKAVREVLNK
DQEVYDPRKFIGPGRDAIKATVIGKIREFGSNGKA
>BCE33L2693 sugar ABC transporter, sugar-binding protein
MKRKLGIVFIVCICLIGLIACSSQIADKKKADDVKFAFIPKLTGVGFFTS
GGEGAKEMGDKLGVQVKYDGPSEASVSGQVKYINNFINQNYDALMVSSTS
VDGLSQSLQRAKKKGMTVLTWDSDVNPKDRSFYISQGTPDQLANLLIEMT
SKQIGDKGKVAFFYSSPTVTDQNQWVTKAKEIIKEKYPNWEIVTTQYGEN
NAQKSLSVGENILKTYPDINAVICPDATALPAMAQAAENLKMDKKVVVTG
FSTPNVMRDYVKRGTVQQFGLWDVKQQGALATYVANEIVVKGKKLKVGDS
FEVKGIGKVKVEPNSIQGYDYEAEGNGIIVLPERVVFTKDNIDKYNF
>BCE33L2449 conserved hypothetical protein
MTKVKVRLRPIVHNINLPTVIKTAILPGESAEKLFIATQLGEVFHIGDSV
IKTFLNIRQRIINLGTSEEGVSSSGYDERGLLGLAFHPQFYQNGLFYLHY
SVAGTQGSGALSEQFKPNPCDPKTLNLKWLNRDTQYDHIDTIEEWILQSN
GHPQKRRTLLNIKRPFFNHNGVNTLNFSPETGKLVFTNGDGGSGYDPFNL
SQDDLEIAGKIIEIDVSKNTFINNPPVVTRFNELPLSIQETLTVIAKGVR
NITGISFQRFYNQYIKYAGNVGQDIVESIFSFVQYKPIPVTELVQMHVMR
LTPNQDGFINFGWRGWEGELPTSFIKHCSENPTLDERTMAYYNETIETST
KRIQPLISYFHKDPRPDKFGGTSLTGVQPYRGTAIPNLNGSVVFTDLARK
EESRPPVKGVLAYTRAGTDGKHTDFHVIETDYDFGTQAAYYMSLGTNLDQ
TRLYLGVYGSMKVTEFNKGTIFEIIP
>BCE33L0583 probable multidrug efflux transporter
MKYFIYFIVIVAFLDTFSQLPIMSTFAQSLGGSPLIIGLVVGMYSFANMI
GNIIAGAAVDKFGAKKILYISMGLTSFIVLLYTVVQSGEQLLVVRFMHGF
SDGFLIPAAFTFLSKQTNAAKQGKAMALSGAAVGTAAIVGPAFSGIMKAT
AGIEWVFITISILMVLGTIVSLFFLPNNVSRKDTSRTQMMNKEDMFELLK
SEPLLQAYIGAFTLMFSQGIVTYMLPVKVEALALKASTTGMMLSVFGITA
ILFFLLPTNRIYDRFNRSKLMLIGIAVMALALSLLGLFATKGMLFIVMMI
YGIGFAILFPSINALLVENTTDDKRGKAFGLFYAFFSLGVVAGSFTVGAI
GASPSVSFVIGTAFLLTFAGMIYVRSKVKGKDKVKKTMIG
>BCE33L1881 phosphoglycerate mutase
MQILLIRHGESEADILNVHEGRADFELTEKGREQVQRLVKKVKADFPPDF
IWASTLKRARETGETLAEGIGCPIQLEEELMEFNNGVQAGLSFEEAQKYP
EPKFLHDRFENGESFIEFRMRIEGIFSKIVTENTYDRIAIVAHGGVINSL
LRAFFKMPISMDYYFKMGDTGISLLEMDGEQKTVHFINDTNHLDGM
>BCE33L3060 possible membrane protein; TGF-beta receptor, type I/II extracellular region
MKSFSTPIRFMLISSFFMSFGYFAVYAFLAIYLLTFLHFSAFQVGTVLTV
MIITSRVIPLFSGLIADKIGYIIMMIAGLLLRGIGFIALGICSDFYTISI
SSALIGFGTAFYEPAARAIFGSQPAHTRKNLFTYLNLSFNCGAIIGPIAG
GFLLLLDPIYAFSLTGSLMLLFAFIFYLLKNHFQVTTENTSITLGIQAIL
QNKSFLLFSFIMIFFYIMFTQLTVALPLHMKNISNSNQLATLVITINAIT
GVIFMVLFRKPFLKYNTLSFIKYGVLLMSISFLLIPLFQHPYWLFICVIF
FTIGETLVLPNVDIATANYSNESYTATYFGFYQLSLAFGFIIGNYIGTWF
TSNLNEMYTPWLIFGGIGLTGFISLHILNIKKVASKEDRYIPM
>BCE33L1726 group-specific protein
MNNHNLIIENIDNPHELERMYRKDPKAFKKSFSQAWSQKPDSQVLAAWYE
RLHFKETANAEKKSLFQKGFLFMGMLAILAGISTRIIFYFVEQEAIAPIN
LAFGVIPFIVAYFVYKNTPKKSIIYSLIALFLISGIYLNTLPLNYKDSII
LAYLHLPIFLWILVGLAFTGNEYSKGNTRLAYIKFNLEYALLYASMAVSG
MILAVFTMRLFSFVDLDIGEFYFSNVVLFGAAALAIVAAYLVSMNLKLAK
NITPYISKIFSPLVLITLLIYLITVIWVGKNPFLDRNFLMAFNGILLGVL
AVTIFSIVESDSDEKKNISDYINFALIVLALIIDTVALSAIVFRLSSYGI
TPNRLAVLGVNILIWANLIWIMFSYIRFLQNKSGPTAIQDAVTKYLPIYG
FWAAFVIFTFPLIFN
>BCE33L0480 probable glycerol-3-phosphate ABC transporter, permease
MIEVSKLPVQTKVSKKKNLWGRTKDLRIGLLFLAPSILLFSIFLFYPLFR
TIYYSFYLTDIHGEANLFVGLENYQYLFSDPAFYKSIKSTLLFVLYTVPT
SIIFALFLALIANGKVRGIGLFRVLFSSTMGISVAASAVIWLFLFHPSVG
LFNNILASMNLPAIAWLTSPDWALFSVSVTTVWVNTGFAFLVILGGLQNI
DTSLYESASIDGASYLYKLRRVTLPMLSPTLFFIVTVTLISAFQSFGQID
ILTHGGPNDATNLIVYSIYKEAFVNHQFGTASAQAMVLFVFIFIATLLQF
KFAERKVHYK
>BCE33L1574 conserved hypothetical protein
MHFLVKVIVSALIIGVITEVAKHYSTVGGFIAALPLVSLLSLFWISFEGG
NKQELSQFALGVLYGFPASALLLFIVYIGLKNSFSLSTSVLFGIGVWCIV
FACQKLFQA
>BCE33L2382 glycosyl transferase
MLNILMINFPAEGHVNPTLSLVKAFTERGDHVHYITTEHFKGRIEDLGAT
VYTHPDLLKDISIDTETSYGLNSFFHVHVQTSLYILEITKQLCESINFDF
VIYDIFGAGELVKEYLQIPGIVSSPIFLIPTDILEALPFHPNAEIPFQPD
EISEQLLYRMEHEFGVKPKNNLQFMHNKGDITLVYTSRYFQPNSDLFGEN
NIFIGPSISKRKTNVEFPLELLKGKKVIYISMGTLLEGLEPFFNTCIDTF
SDFKGVVVMAIGDRNDHSKIKKAPDNFIIASYVPQSEILNEADVFITHGG
MNSVHDAIYFNVPFVIIPHDKDQPMIAQRLTELEAAHRLLKEHVNVQTLK
EAVTDVLSNEKYRHGIRKLNDSFLECGGAKEAISVIKSLLNK
>BCE33L3727 group-specific protein
MRILHVIFYHFLLWSGFSVVLSLSNGDKLHYKVILFFVFLYLAYVIAYFV
LQIRKQALFLTCSNCILFLIIFSIF
>BCE33L2955 major facilitator family transporter
MKNKFRYYVFTMLTFITMVNYIDRGAIAYAQSFIIKEYGFDPKEWGAILG
YFGYGYMIGSLLGGIFSDKKGPKFVWIVAATAWSIFEIATAFAGEIGIAV
FGGSALIGFAIFRVLFGLTEGPSFAVSNKTAANWAAPKERAFLTSLGFVG
VPLGAVLTAPVAVLLLSFTSWKIMFFILGTIGIVWAIIWYFTFTNMPEDH
PRVTKEELAEIRSTEGVLQSVKVEKEIPKEPWYSFFKVPTFVMVTIAYFC
FQYINFLILTWTPKYLQDVFHFQLSSLWYLGMIPWLGACITLPLGAKLSD
RILRKTGNLRLARTGLPIIALLLTAICFSFIPAMNNYVAVLALMSLGNAF
AFLPSSLFWAIIVDTAPAYSGTYSGIMHFIANIATILAPTLTGYLVVSYG
YPSMFIVAAILAAIAMGAMLFVKPGQQTKTESLFNWRGKKRLEEPRANFE
>BCE33L3203 phosphoglycerate mutase
MKNRETDSNVVTLYVTRHGKTILNTNHRAQGWADSPLVEKGVEVATNLGT
GLKDIHFMNAYSSDSGRAIETANLVLKYSEQSKLKLEQRKKLRELNFGIF
EGEKLDNMWDAVGKAAGVASTEELMKFSIQEVIDLIRAADPTKQAEDWEL
FSTRIKAEIDKISEEAAKDGGGNVLVVVHGLLITTLIEMLDSSKTKLGVE
NASVTKIVYQDGIYTVESVGDMSYVAKGKESVEI
>pE33L466_0259 transporter
MKNTLLGSLYLILASSIWGGMYVVVKVLVSVIPPLELVWLRYLVAIVALL
IIGFVTKQKWRIEKRYFLIIITIGVIGYAISIVTQETGTMLSLAQMGAVI
TSSTPAFMVLFAWLILKERLTFKKGISVCLATIGVIIIVGIGDLNTSSVL
GGISLLIAALTWALMSVLVKRLPSDYSQIVVTTYSTLVALIVLTPFVLPR
LHAIDISQLTRPTIWGGLLYLGIISTAVAFLLWNRGLQMLNASSGGLFFF
FQPVVGTLLGWLILGEKIGVTFWVGSALILIGVLLVIREKQD
>BCE33L3318 group-specific protein
MFMNSFEKITLYILSFLLYPIGIITWIISLFSKDIEKKKVGRICLYISLV
SFVLFIILGITTFLMTATFNVDLNHSESIEYQINDAE
>BCE33L2348 group-specific protein
MFIIIWFRHLPQISMDLSEWTPFIKNNWHRKHYMKFVYVLQIIIFLIPYY
FGADFTHINIFYLIIIGICVFIIHEFLHVIVIKKKGDISLTCSGIFFWLN
TNAILSKIRFWIFMSLPIIVLSVVPAVISFYISGNIKSIILFICWINAII
SASDIYNSFLITIKPKNSIFCRGYYKVK
>BCE33L3047 ROK family protein
MLIKVVNDLSEQFVTQKSIKETILRGIRTALLERGSATKVELSNALEISF
PTISKFIENMKQDGEVTLVGLDDSSGGRRAKRYAYNPEYMLGLAIFLEKN
ETNYTIFNCLGEVKEQGSTSSVLIDTGLTLLSKHIESFIATFPKISSISI
GVPGSVDNGRIFYIPGYEKFQNFNLKSHLENLFSIPVVIENDMNAAVLGY
YKNTGNYDNSSLVYLYSGQNGPGAGIMINGDVVRGSTFFSGEVSFVPQYD
NKNFLQALRSEDSNNPEEYNIDAITRLIATCIAIINPHAFIFCDDEVNQF
VIEQIVKSCPQYIPTEHIPKITVSNWKEDYLYGLKSLGLNLMITRTNKEN
>BCE33L0343 alpha-glucosidase
MNKTWWKEAVAYQIYPRSFMDSNGDGIGDLQGIIAKLDYLKDLGIDVIWI
CPMYKSPNDDNGYDISDYQDIMDEFGTMEDFDALLDEVHKRDMKLIIDLV
INHTSDEHPWFIESRSSKDNPKRDWYIWHDGKDGAEPNNWESIFNGSAWE
YDEVTGQYYLHLFSRKQPDLNWENKEVREVLYDTVNWWLDKGIDGFRVDA
ISHIKKEDGFKDMPNPKGLKYVPSFDKHMNVDGIQPLLEELKENTFSKYD
IMTVGEANGVKIEDAELWVGEEQGKFNMVFQFEHLSLWDAEKKKDLDVVG
LKKVLTKWQKGLENKGWNALYIENHDKPRIVSTWGDDKQYWRESATALGA
MYFFMHGTPFIYQGQEIGMTNVQFPNIEDYDDVAIKNLYREKIAEGVSHQ
DMMEIIWASCRDNSRTPMHWDDEINAGFTTGTPWFDMNPNYKEINVAKQK
NEENSIFNFYKKMIALKKEHDVLNYGTYDLLLEDDPQIYAYTRTLNDEKI
VVISNISKEEAVYNEDLFALERKRLLLNNYEVAEHEEVTTIALKPYETRV
YRIS
>BCE33L0364 sugar transporter
MNALFKNRAFMLVMASDILQQFAIWIRNMALLYFIMERTNNDPVSVSLLS
VMEYAPIFIFSFIGGALADRWNPKRTMVAGDVLSVLSIIGIILLLKLDYW
QAIFFATLISAIVGQFSQPSSSRIFKRYVKEEQVANAIAFNQTLQSLFMI
FGPVVGSLVYTQLGLFTSLYSLIILFLLSAIALSFLPKWVEQEQVARDSL
KNDIKEGWKYVLHTKNLRMITITFTIMGLAVGLTNPLEVFLVIERLGMEK
EAVQYLAAADGIGMLIGGIVAAVFASKVNPKKMFVFGMSILAMSFLVEGL
STSFWITSFMRFGTGICLACVNIVVGTLMIQLVPENMVGRVNGTILPLFM
GAMLIGTALAGGLKEMTSLVIVFCIAMALILLAIGPVLRMQIKKEDVANK
EELTNSLAPK
>BCE33L5128 probable membrane protein
MERFSGLFSTFSTRAIYGIYSFFVAILIFDYFSDTQKYNYVMILVGVLLL
CTIGNFILSSGSLYLERVNEKICFFVLLIICLAVKTAWIVTYKIDPIGDY
EAFFNTAKALGDNFVIHDRYVALFPHIFGYASFLSIFLKIFGANFMIPPI
INVVLTTISMGLIYFIARRIGGVRTAVTASVLWILLPSQTMYNMFALSEP
LYCTILLLAWAIMIIVYDKIENMTIAKVLMYSILLAALLVLINMARPIAA
VPIIALAIWMFIIDTKHIGNKKLLINKLAYVGVIIIGYLMMSSAANHYVT
LRLGEEIATVPGYNIHVGFNKGASGTWNPGDSALLYHYSGQPGWSAQDVQ
KQMLEEAKKRIKNDDIDFGKLMYDKFIIFLGNDDQAVKYADPIMDHKVRY
TIISNVFYYFLLVTSLFGALVAIKNKNKSSLLIICLYVIGLTMAQMIVEV
APRYHYSATIPMIFLAAFGIKHIYNKKRI
>BCE33L2215 possible ATPase family protein
MKYMIGVDGGGTKTEAIAFDQDGKEIIRGKGGFGNILIDFEEALVHIMEA
IDHCQKALINNNCVCICLGLAGISGANTNELILRLQKKYGTPIEVFNDAM
IAHAAALKGKDGILTIGGTGAICIGKKGKVYEYSGGWGHILGDEGSGYWI
ALQGLKRMANQFDQGVTLCPLSLRIQDEFQLLTSSHIKRLVYSSSKDKVA
AIAPLVIREARNGNDAAHEIMMQAGNELGRITVNVYNKMQFDLSTSIAVS
GSILRFVPEINAEFKKYCEKSIGEVTFVSQSESAAKGTYYLMKDIYFKK
>BCE33L2696 sugar ABC transporter, ATP-binding protein
MENAPLLQVKKMSKAFLNQLVLKEVNIQVERGDIYALVGGNGAGKSTLMK
ILTGLYSYDDGEIYVKGTKQQFSNPSEAHRKGMYLIPQEPLIFPHMTIEE
NICIGLKEKKKKLRVQIQQLISSLGWGIDLNELGGSLSIAQQQLVEIVRG
LIREAEILILDEPTSTLTTHEIKSLFVLMKSLQEKGIGMIYITHRFPEIF
EIANKVAILRDGMIVSQGDVCDYTYDMLMEGLLPKGYKQKEKIEVVQETT
RMKKILEVIDINGHAFENISFTVHAGEIVGIAGIVGSGRTELAEAIFGLK
TVKTGSILLDGKSIDTCSLHKRLDEGLVYVPEDRARNGIFSIASVKENIA
AASLQQNNRFFINQEKESALVNSFIEQFRIVVQDMNEEMASLSGGNQQKG
VLAKYLACNPKVIILDEPTRGIDAKARLEVYETIGKMKREGLAILLISSD
VEEIVQLVNRVYVMRNGRFVSHMEKEQLSVNEVTRLAYGGVAE
>BCE33L2183 multidrug resistance protein
MYMELKSMIRILAIVAFFVGLDSLLVAPLLPVITETISIPDGSGGLLITI
YALCYGITAPVFGMMSDRVGRKRMIIIGFIIFSISTFCTGLAKNFEILLL
FRGLTGLSGAMIMPSIFALVGDKVTYESRGKAMGTIMGAMIGSTVIGVPI
GAFLSEIGNWQWTFYSIGLLTLFLTLLINHILRNEKERDDVHVSLTETVD
APLKMTVVNISVLFALLATFLWTIGLHGMFSYIGVYYENNFGISVGKIGI
VIFLAGVGSVAGNILGGKLADKIGKKNVIVIASIVSSISVMLFSLSTGNL
VIAIIVHIIWSLFIGFGQASLTALISELKPAVRGTVMALNSSAMYIGMTI
ASGVASLAISNGFPFSSLGTICAIASLLVLPIIFVLVKEKALSNKKKMTI
>BCE33L0251 UDP-glucose 4-epimerase, N-terminal region
MISKNLITREDIRGKNNYLIVGGNSFIGINLTLGLLKQGQNAKVFSRHIN
NFPQNIISEVEFIKGDLANVEDIYKALVNVDIIIYLAATSNVATSIEDVF
RDRNSSFFS
>BCE33L1470 lacX protein
MIATIQNEKVIVSISDKGAELQSVRLKEDNTEYLWQGDSTYWGRRAPILF
PIVGRLVDNTYYVDDKPYSLTQHGFARDLTFTVKEQSETKITYIVTSNEE
TLKKYPYEFELLVSYELDGQIVHVTYEVNNPTSKEMFFSIGAHPGFNFPL
LEGESFTDYHLSFNGSERLETSVLEGPYLSNKKQLIAESTNELPLTYDLF
KNDALIFENMNTDEISIRSHKHNKFVKVEFDGFPFVGVWTSGENAPFLCI
EPWYGIADEVNPAKDFKEKKGIQSLQANETFTCRYSITIG
>pE33L466_0428 uncharacterized protein
MKNKLAYLGFLGFLGFLGPLTFLGNILWAYYFFGFFFFFAYARVVPDELF
MLHVRIAATRAFFVTIVLGSILLLSVFIFENVHIIRLFVIISFSIPLGTF
IINLEIFERREKKGMQDAT
>BCE33L4434 group-specific protein
MNFPIQRSKSVVFFVCLTLAFMFVYPLVMIVANKEQWMSALIGMGLCFIV
NVPLVWEVFIKKHKVENGVLKYGILNDDIVLKEIRIIRQVGKSLEITTNS
YKVHLLAMPQHMKQFLSLVEKENPHVKIEMVGKK
>BCE33L1154 conserved hypothetical protein
MNYSQKYFLIMGIIFFIMSGTMVFAGIMTHSAPPTPTYTVLAMMIMCFCL
SYLHPQFKEKDERMKLIRYKGMFFSFFALTAYYLLFSIGLNLNVITLSAV
ELLNILMALTMSTVFISFVVLAKRY
>BCE33L4526 transcriptional regulator, DeoR family
MNQEERLIKIMEYLNEHRTMSLKIMCELFQVSRDTARRDIVKLTNETTIV
RTHGGVALSSFHHKISDYVNREEKEIEYKISIGKRAASFVEDNEVIYLDV
STTVNCMASFLTASNITVVTNSIDTVNHLMDMENVNIHILGGELNKHSRY
MTGFSAMEKLKDYHFDKVFIGSPGLTEDGVYYAYEEDIHFKRQIVKQTNE
VFLLADETKMNQRQNFKALSLESIDTIITNDVIPGDLERVVKEYGIELIV
GVK
>BCE33L1800 conserved hypothetical protein
MKYSLCTISFRHQLISFTDIVQFAYENGFEGIELWGTHAQNLYMQEYETT
ERELNCLKDKTLEITMISDYLDISLSADFEKTIEKCEQLAILANWFKTNK
IRTFAGQKGSADFSQQERQEYVNRIRMICELFAQHNMYVLLETHPNTLTD
TLPSTLELLGEVDHPNLKINLDFLHIWESGADPVDSFQRLRPWIEHYHFK
NISSADYLHVFEPNNVYAAAGNRTGMVPLFEGIVNYDEIIQEVRDTDHFA
SLEWFGHNAKDILKAEMKVLTNRKLEVVTS
>BCE33L1802 permease; possible multidrug resistance protein
MKNYVPAGLLYGKKYMMKGFEANMLKKENCCLIALASVPLVMTLGNSMLI
PILPTIEKKLHISSFQVSMIITIYSIVAILLIPIAGYLSDRWGRKMVMVP
SLLIAAIGGAITGWVSWKVDNPYTWILIGRAIQGIGAAGAMPVVIPCVGD
LYKDEKQVSTGLGIIETSNTFGKVLSPILGSALAAIVWFLPFWAIPVLCV
VSIVLLLVLVKAKKQEGEAPPLKEFIKSIVATFREKGRWLIAIFALGAII
MLILFGILFYLSTILESKYDIHGIWKGCVLAIPLLVLSLSSYMAGKKIGD
NQNVMKKCIYIGFLMAAASVIIPLFIKGIYLLLLCLVIMGIGIGMALPCL
DALITQGIEKEQRGTVTSFYSSMRFIGVAAGPPLYSFFMKGADHEVFYLT
SIFAGIGAAIAIIWIKPAKDTKTVNQKPEPTS
>BCE33L3077 conserved hypothetical protein
MKMKDNKEFIGYVGTYTKENSEGIYKFTLDTEAKKISNVTLAAKLDNPTY
VTINRNNEYLYSVVKEGESGGVAAYSINSKTGELIEENRQVVEGASPCHV
SVDSGNHTVVTANYHKGTIESFEVNEDGTINPATSIMAHEGSGPNKERQE
KPHAHYAGYTPDEKYVVGVDLGIDKIITYEIKDSTLTEVNRLSVNPGSGP
RHITFHPNGKYAYVMTELSSEVIVLTYNPAEGSFTELQYISTVPEEFDEN
NQGSAIHISSDGRFVYAGNRGHNSIAVFSVDQNTGKLTFVAHTSTEGNWP
RDFVLDPTEKFLVATNEKSHNLVLFSRSESTGELTLLQSDVVVPEPVCVK
FLNV
>BCE33L0171 probable membrane transport protein; possible multidrug resistance protein
MTYRRFIASQSMIMMAGSMVFPFYILLLRNVGNSFSQFGWAYGLFALTSA
LVYPLVGKLSDRVGDQKLLIIYAWSMAILMLCFPIATEVWHVYILQILMG
VLGAVQRNTEKTSLARKVVQENAGYEIGKYHVWTSIGGAVAIIATGYLVD
FFTIGTIFYIASILYVVSGVVLSSKKI
>BCE33L2947 macrolide-efflux protein
MDILKNRDFLLLFLGRIFTNIGDSLYYVAAMWLVYKLSGNPFYSGLAGFL
TLLPSALQFLTGPFVDRWPIKNTLVITQVLQCILILIIPITHYFDLLTVQ
LLLIIMPIVAFIEQFAYPAQSKALPLLLHKTQLLKGNSLFSFAYQGIDLI
CTTLSGILVALFGAITLYVIDSFTFAITALLFFSLKMPKQTETGTTLSTK
QYFSDLKEGFSIVFRSLMGVFLIGSVVANFSIGMTMAILPSFADSLGGVK
SYGFFLAAISAGSLIGALFSSWVGKRNVGRISIISFATGATFWFLSTVVP
FQWLSIFLFGLAWVPIGATNILFATISQILIPNQYIGRINSVMRSMGTIA
MPFGSLIGGYAANVFSSQLIFALASIGILFISLVWLLHPKLRALPKADEI
TADTFGVQFKEERGKGAAL
>BCE33L2213 group-specific protein
MNIKFSYKGVFLLLFGVICANLLFVPILRMLHLSQMHSIWLVTSIAASIL
LTVVVSFIDGSFASKAQLFFRFILFSIGCTFVTYMIVF
>BCE33L0386 permease, drug/metabolite transporter superfamily
MKTEKFFTHPIGVFIAAIVATFLWGSAFPFIKLSYAELGIQPQEVGEQIL
FAGYRFFLSGVMLLFFFKVLGKDMNFKKGTGKQLVQIGLFQTFLQYICFY
IGMSYSSGIEGAIISGTSSFFQIILAHFLYKDDALNMRKIIGVSIGFCGV
VLVNVPSDGSLSFHFGIGSLLLLSAAMLYSYGNILAKEGSKTLDVGYMTA
YQMIFGSIGLLCIGTLQVGIMPFTFSVHAILMLIYLSFLSAAGFCIWNTI
MKYNKVGKVSMYMFFIPVFGVLLSSMILGEAIHSFVLFGLACVAAGIIVV
NRTPATQKIEQEKQVA
>BCE33L2698 sugar kinase
MLMSNLLAFDAGTGSIRAVLFDLHGNQIAVSQKEWIHKSDPRYPGSMNFD
VIENWKLVQECTKEVLQKSNTLASSILAISATSMREGFVLYDQDGQEIWA
CANVDGRASAEVSELKEIRSHLEKDLYTKSGQTFSLGALPRLLWIKKHEP
DVYNSIHSFTMLNDWILYKLSGVLQIDPSNGCTSGIFDLQNRVWDNDVAK
ECGLSLPFSPKVNEAGTVIGNVTKECAALTGLREGIPVVSGGGDAQMASL
GTGVVKPNQTLICGGSFWQQEVNVTEPITDPCAAIRINCHVVRNLWQYET
IAFFPGLVMRWFRDAFCQEEKKLADKLGVDAYELLEEQAKDVPVGSHGII
PTFSNVMNYISWRHAAPSFLNLSLDTDKCGKKELFRAIEENAAFVTLGNL
KLIENLTGIFPSEVIFAGGAAKGKLWPQILSDVLGIPVKVPVVKEAAALG
TAIAAGVGAGIYSSMEETAEQFVQWEQTFEPVTENHELYKEFYETWKTVY
DSQLALADNGLTSHMWIAPGAL
>BCE33L1588 group-specific protein
MKFKAKKNPFHVIFITLFIMFFVISLFFQNENSIFFTLMMLINIVNLSSF
YFSHYHITASSLIVKHGFIFHTEILFKDIRHVKYAGKKLHSKKWTRQQLE
IHYNLFDSVTVFIPQEEEKFLSVLKENCPHMKVLNMPANK
>BCE33L0573 multidrug-efflux transporter
MEQQENINRKLLLIGLIIAMLFAALDGTIVGTAMPRIVGELGGLSLMTWL
TTAYMLTSTTVVPIAGKLADLLGRRNVYITGLVIFMVGSALCGMANGMTE
LIIFRGIQGLGGGIMMPMAMIIIGDMFTGKERAKWQGIFGALYGLASVIG
PQVGGWIVDAVNWRWVFYINLPVGILATIFIAMGLKSHKQTGPIKIDIAG
IFTMILGVVSLLLALTFGGKDYAWDSWQIIGLFALALIGIVSFVIVETKA
EEPILPMHFFKNRTFTLLNAIGFFMSIGMFGAIMFVPFFMQGIVGVSAAE
SGTIMTPMMITMIVMSIIGGQLVLKVGVKPQIITGMLIMAGGFWLLTTMD
MHTTKLTATSYMMVIGLGMGLVMPTLTLALQESFPKKDLGVVTSSSQFFR
QIGGTFGITILGSIMNNTSGTTLTKNLVPVLDTFPKEAGQMVTKFKDMIH
TDPQGLYSMLFSPEALKQMPEAFANSIVPILKNSLVDSLHTVFLTGLVFI
VVGAIFTIFLQKIKLSDRKKDAEEPAAEEKEQTVSYS
>BCE33L3102 major facilitator family transporter; chloramphenicol resistance protein
MIGIIGKRGNQLNSYTASSSEVQTNRRSIFALLALAISAFGIGTTEFVSV
GLLPSISEDLHVSVTTAGLTVSLYALGVAFGAPVLTSLTANMSRKTLLMW
IMIIFIIGNGIAAVATSFTVLLIARIVSALSHGVFMSIGSTIAAALVPEN
KRASAIAIMFTGVTVATITGAPIGTFIGQQFGWRTSFLAIVVIGIIALIA
NSILIPSNMKKGTSVSFRDQFKLITNGRLLLVFIITALGYGGTFVTFTYL
SPLLQEVTGFKANTVTIILLVYGIAIAIGNVIGGKLSNHNPIRALFYMFF
IQAIILFVLTFTAPFKVAGLITIIFMGLFAFMNVPGLQVYVVMLAERFVP
SAVDVASAINIAAFNAGIALGAYLGGMVTNSLGLIHTAWVGGIMVVGAVI
LTAWSMRLEKRDQVK
>BCE33L2471 transporter, Drug/Metabolite Exporter family
MVIFNYILVCIIFGTTFLTIKIGIEAGAPPLFSAGIRFFLAGVILMIIFK
LKRKEIMPHVFSKRIMYAGFCLTFMTFATLYWAEQYISSGLAAVLSATGP
MMILLLQAKRNKSKLQKEQLLALIIALIGVVFVSLPGMHQEVSFIWSIAC
FVLIIGEFFYGIGSIRSKEILSDLQSVSPFLINGIQMFYGGILLLIVSII
VEQPNVTILTSWSVQWPILYLIFIGSIGGHGLYYWLLSKTNPVFPSTWLY
VSPLIAIIVGYIILGEPLNPTMGIGACFILVGVFLANRSTLRSYFKQGRL
FEKEM
>BCE33L0372 ROK family protein; possible glucokinase
MKEYIAFDIGGTQIKYGIVSETGIVLKHKTVLTEIHLGGEQIIQKLILLS
KKLMSEHTISGIGISTAGIVDVNKGIVTGGADHIPGYSTIPIINRLQEVL
KVPVSIENDVNCAALGEKWNGSGREKGNFIMLTLGTGIGGAIFIDGELYR
GHSFSAGEWGNMLIEGKTFEEVASISGLIHLVRNYKGEGNWNGKTIFKLY
DKGDREVTQAVEVFLKHLAIGISNLAYIFNPETIIIGGGITDRGNQFLKE
VKEGVERYLNKEIYSTCEIELAQNGNHAGMIGAIYHFLHHHK
>BCE33L4024 membrane protein
MKWKHIIGDVEVNRDLVLLLLIGGLYTLAISLSNTFVNIYLWKQTQNYVN
LGLYNLASVVLQPLTFLIGGKLAKRIDRSILLRIGVGTLATFFIVVLVAG
KSASHYILLMGALLGVGYGFYWLAFNLLTFEITEPETRDFFNGFLGLLTS
FSGMIGPIAAGYTISRMEKWSGYTVIFFLSLVLFAIAVVLSFFLSKRECE
GRYEITQVLKERRIDKNWGRITRAHFFQGLREGTFIFVISVYVYLATDSE
LALGKYSLVNSAVSFVCYYLVARMLKKEWRKKAILLGGIILYAVVFLVIF
NVTYTKLLIYAACIAIAYPILLVPYGSMTYDVIGRAKNAREWRVEYVVVR
ELWLNAGRICSVLSFLCAVLFFPPEKSLPFLLCILGAGHFLIYFAVKNVK
YDGGNAGKTSVVAQGTTQNQTEPEG
>BCE33L2624 macrolide efflux protein
MWRNKNVWIVLIGEFIAGLGLWLGILGNLEFMQKYVPSDFMKSVILFIGL
LAGVLVGPMAGRIIDQYEKKKVLLYAGFGRVISVIFMFFAIQFESIAFMI
AFMVALQISAAFYFPALQSVIPLIVREHELLQMNGVHMNVGTIARIAGTS
LGGILLVVMSLQYMYAFSMAAYALLFLSTFFLQFEDKKSTTPSKQAAKDN
SFMEVFRILRGIPIAFTALILSIIPLLFIAGFNLMVINISEMQHDPTIKG
FIYTIEGIAFMLGAFVIKRLSDHFKPEKLLYFFAVCTAFAHLSLFFSDIK
WMSLTSFGLFGFSVGCFFPIMSTIFQTKVEKNYHGRLFSFRNMFERVMFQ
IVLLGTGFFLDTIGLQYMVLIFGVISLFIIFISLSKQKQYEKQPSQSANL
>BCE33L4363 conserved hypothetical protein
METVNLIELTKDIQDQHKNFVVSNVNSHCLRIAVFTGEYDWHYHSNSDEL
FIVLEGELLIDFEDGETAVLKSNDSILIPACTIHRTRALKRTVNLCFEHI
EADTIKVEQL
>BCE33L3048 sugar (and other) transporter, C-terminal region
MEKKVLLLGLFVLGMAFAEGSANDWLPIVMVDGHQQSVVTGSIMYTIFVL
AMTLARMCSSYFLDRFGRVAVVRATIMMASIGMTIVIFGSNSYFLAFGVV
LWGIGAALGFPIGLSVAGDGGENATSNVATVSIIGFTAFLVGPPFLGILG
EAFGIRNALLAVLLFVILSGIVSSVTRENTSS
>BCE33L3075 possible transporter, EamA family
MKQTILGAICLSLAASIWGGMYVVSKYVLDFIPPLTLVWLRFIIAFVVLY
GILKIAEKKQKKKVTIHKQDWLLFAWIGFIGYFISITCQFIGTKLSDAHT
GSLVTSATPAFIVIFAAIILKEKLTARRLLSTIIATIGVIIVIGWDIEIG
SYFIGTIILVGAAITWALLSIYVKIASAKFSSLVITTYAIFFSLFFITPF
MVWEFQSSPIEPISLYVLLGVLYLGIVSTAGAFFLWNKGLELMDASIGSL
FFFFQPIVGSLLGWFLLNEALSSNFFIGGILIICSVFITTFEKK
>BCE33L3770 maltosaccharide ABC transporter, maltosaccharide-binding protein
MKKALSLLTVSALSIGMLSACGPKDSGEKEESKAKKDYDLLVWEDDKKGV
GLEPAVKSFEEKYKVKVKVVEMQMTDQVKKLRLDGPAGTGPDVVTLPHDQ
IGNAVTEGLLSEVKADDAVKSKFTDSSIEAQTYNGKLYGLPKAIETPVFI
YNKKLMPKAPETMDELFNFSKEFTKDGKYGFLALGDNFYFANAFMAGMGG
YVFGEKDGKPNASDVGLNNSGAVQGAEYLQKWYKEKLFPKGIIGESGGPA
ADGLFNEGKAASIMNGPWAFQAMEKNGIDYGVAPMPKLPNGQPLKTFVGV
KGWHVTSFSKQNDLATKFTEWVTNEENAKIRFEKTKEIPPVKAVMEDPII
KDNEAAKAVATQSENGIPMPNIPEMQEVWKPAGDALQLVVTDKEAPKAAL
DSAVKQIKGNIEANHSKQK
>BCE33L4098 group-specific protein
MKWLTILIGMIIWGYINGFFSSDKTANPWITDDERETKIKQKAIIASWSG
VFMFCTINLLNKWLGIETSNTSPYLPTSVATILKENVELQILFMLFITYG
IFYVYYRRKLSA
>BCE33L4742 major facilitator family transporter; chloramphenicol resistance protein
MGKDLNFRVYILAIAAFVVGTVELIIGGTLDLVADDLGVSISAAGQLITI
FSVVFALSGPVLLALTGKFERKTLYVGALSIFLIGNIISAFSVNYGMLMF
SRVICAASGSLIIALSVTLASSVVEPHFRARAIGIIFMGISGSLVLGVPL
GLVLGNAYGWRAPFVLISILTVMAIACISLFLTKVPPTSVLSIREQIATL
KDKKIVSAQLTSFLFLTGHLTLYAYLTPFLKDVMHVEANWISVFYFIFGI
AAVIGGGFGGWLADKWGSKKSIISIIIVFACAIFLLPLMTFSFPLFIIMM
GLWSMLSWAISPAQQNYLIEIAPESAGIQQSLNNSALHLGIALGSTVGGV
VIEKSSVIYNAWVGGGFIILALLCAIFSITRGRSARFAKEESIV
>BCE33L2428 oxalate:formate antiporter (permease)
MKQTSINPLLIVLGTIIVQIGLGTIYTWSLFNQPLVSKFGWNLNSVAITF
SITSFSLSFSTLFAGKLQQKLGLRKLIATAGIVLGLGLILSSQVSSLPLL
YLLAGVVVGYADGTAYITSLSNLIKWFPNRKGLISGISVSAYGMGSLIFR
YINGSLIDSLGVSQAFLYWGIIVLLLVLIGSFFLREAIVSNAVTETLHND
YNPREMMRTKQVYLLFFMLFTSCMGGLYLIGMVKDIGVQLVGLSAVTAAN
AVAMIAIFNTVGRIVLGTLSDKIGRMKIVSATFVIIGLSVFTLSYIPLNY
GIYFACVASVAFCFGGNITIFPAIVGDYFGLKNHSTNYGIVYQGFGFGAL
AGSFIGALLGGFQPTFITIGVLSVISFIISIVIRPPKTEKKKELKHLHRK
VA
>pE33L466_0087 hypothetical protein
MNALYPKQPTSMFRAIISMFVVCLAYIGLVYTTIPFRFTFLAIAGAMALY
LNYGFYGIRSAFGPLQKGATKIIVIGLIWNIIQTGLVAYLVQCVFHFSVA
SNGKSTIFVDNSPLQFMYHLLQIICSLLGEECLILVPSILGIYFLKKKRG
KRKMVDDPYNTCWCIFVWYGALLYL
>BCE33L3049 sugar (and other) transporter, N-terminal region
MKKDFTENDTKTLLASRNALFLLFALPGVAFATWISRTAAARDILAVSNA
EMGWILFGLSVGSIIGLLSASHFIDGKGARDVIIGSMFFMIVGLFCLGIT
IYFASSMGAFGSLLVFGVGYGLAEVALNVEGSSIEQKLGTTLLPKFHGFF
SVGTLVGALSGSAAISLHIPIWYQFLAISVVFVLLVCMLYRFLPHGTGKK
EKSRNKK
>BCE33L1734 transporter, drug/metabolite exporter family
MTQLSRTKTAIILTFLVFMWGINWPLSKFALHYTPPVLFAGVRTLIGGFI
LLLFALPKYKELHLKETWHLYVISSLLNIIIFYGLQTVGLQYMPAGLFSA
IVFLQPVLLGIFSWIWLEESMYGLKIFGLMLGFIGVGVISSSSLTGHISI
IGILLAIGCAIGWALGTVFIKKTGHRVNSIWMVTLQLIIGGLCLIGFGSE
FESWSSIAWSMPFVSVLLFISFFVIAMGWLAYFTLVGAGEASKVGAYTFL
IPLIAIIVSSIFLHEAITISLFIGLLFIVVSICFVNIKPKTLAVGQRVEV
K
>BCE33L3784 conserved hypothetical protein; possible membrane protein
MLSQESRDFLANTGTYLTAKGISEKDIESFLEDAELHLTEGEKRGKNVED
IFGDSPKEYANQLVKEMQVDYKRNLGWLATAVMSILCYWTIPDLLFRNLN
EPYTISLIGLIGYPVILLLMIMGGVLFLRGASFQRSMLKKGLLLFGAVIL
TYLPILIMFLKGWYSFPLYELPQLGRYLIGGVMLLITTIVNVRSLGWIGL
LVLGIPIFMIFMVEQIVRVYF
>BCE33L1658 polysaccharide deacetylase; possible chitooligosaccharide deacetylase
MKKKIIITIVTLFIITVALFGTYKLMNARSFQLFGDLTNRVETNEKVIAL
TFDDGPTNNVKQILPLLDTYNAKATFFLIGNELEKNLSLGKSIVQSGHQV
GNHTYSHNRMVFKTPSFIKEEIEKTNSLIRRIGFTGEIDFRPPNGKKLIG
LPYYLNKNNIETITWDLEPDTFYKSAADKIDYVSKNVKPGSIILLHSMYD
ESNENLQTIEGILDSLSKKGYQFVTVNELQKSAK
>BCE33L2306 conserved hypothetical protein
MESTNKIAILGANGKAGKILVNEALEKGYQVKILTRNSTNTEKINENIET
IIGDARNFSTIQDLLQGCSAVINAVGQPKNESYIFSTVTKHILEAMKESK
IKRYILISGGSLNVTGDQKGIVNKIGATLFKLFLPKMMQDKYKELQIIQN
SEVDWTIVRLPFVIEGNGIGSIKESLVDMPGIKIQNGDIAPFVIKQINSD
RYVGKCPFISN
>BCE33L4395 possible transporter, EamA family
MNKKQMLLGSLLCLLAVTAWGFMFPVMANALQFIDPFFFTTIRYGSAAII
FLILLLMTEGKKSLRLEKKTISLLFYGTIGFAGYGFLVFYGQQLAGPSGA
IHAAMIQSLMPLIALLLQWITKNKRPQNYTFLCMFVALFGVMLVISKGNI
HLLFGAASHLSTNILMLCGVTCWVIYTNGGASFQSWSPLRYTTLTCLFGS
ISLIVIVTFLTYTNVVTVPSLSTIMNVRLELLYMSIIAGVIAVFCWNAGN
RYISSINGILFMNLVPVLALIGSIFRGYTVDKIEIAGASLTIIALLCNNL
WQRKESTKIPTSVR
>BCE33L3953 conserved hypothetical protein
MSGGVDVSQEQLGTRNFVQIGLFGGLFWGGIWYFLHIFSFTEAGPNYLLL
PFAFGSWKEGVWGNVLGIVCMALLSILIAFLYKAFLAKFEGILPGMIYGL
FWWALLFLGVALIAPAIKSALHLPKETIVTTICIFILYGVFIAYSVSYAV
NTNKAEREGEEKTNYSNK
>BCE33L1583 transporter, drug/metabolite exporter family
MMDPNRLKGIIMVVIGACLWGLSGTAAQQLFQYDNISTEWLVTIRLLISG
IILLIIASFGTSKKEIFGIWKQKSDAYKMILFGLFGMLAVQYTYFASIKE
GNAAVATLLQYLAPIFITVYLLFKWNVRPSKIDFISITLSLVGTFLLLTN
GSVHNLAVSTPAIIWGILSGLSLAFYSLYSKGLLERWSSSVIVGWGMIIG
GIGVTIVHFISTKEFILLSTMKYVKLSTLPLITFVIIFGTLIAFYLYLDS
IRYLTPKETTLFGCTEPLAAIISSVLILHVPFQSFQLVGAFCVIVMVLIL
SQKPDEGKQKLKLVTAKKENIQ
>BCE33L1498 macrolide efflux protein
MSVSYRTLLKTNKNFNKLFYGQTLSVLGDWFHTVALLTFVYSITESPFMI
ALTFISKGLPQLLLSPFIGGVVDRFSKKNIMIFTDITRGILVLTYILANY
KIEIIFIANICLSVLSCLFEPAKQATLKNIVHENHFVTANSLSSTMNGFM
SIMGASLGGIIAQSLHIEFAFLVNSLSYFISAYFIYNMSIPAHDTCNKKK
VFLTDIKDGYTYILQTKIILTLILVGISWGLIGGAYQLLLTIYAEKIFHT
NIGILYTVQGAGLMIGSLLVNLYISNNKEKMKKAFGWAYFLQGFFFLGFI
LSNQLIFGIITLLCMRIAGGIIVPLDTTLLQAYTHENMIGKVFSFHYSIY
GSLIQLSMFITGWLLEILSPQMIGSLLATCCIFVSFIWLYLFYRGKLSEE
SIST
>BCE33L3160 group-specific protein
MKRFLNTLLQFVVLSIALHVLFDIVGWLVFNAPIENKQIIISLITASWLM
YMYRDKFFKAFTSN
>BCE33L2922 multidrug resistance protein B
MSETLHKRKPPYVMLVILFIGAFVSFLNNSLLNVALPSIMKDLDIKDYST
IQWLSTGYMLVSGILIPASAFLITRFSNRSLFITSMVIFILGTALAAVAP
NFGLLLTGRMVQAAGSSVMGPLLMNIMLVSFPREKRGTAMGIFGLVMITA
PAIGPTLSGYIVEYYDWRLLFEMILPLAIISLLLGIWKSENVMRQNKNAK
LDYLSLLLSSIGFGGLLYGFSSASSDGWTNKVVVTTLTIGAIALIAFIIR
QLKMNEPLLDLRVYKYPMFALASVIAIVNAVAMFSGMILTPAYVQNVRGI
SPLSSGLMMLPGAVIMGIMSPITGKLFDKYGPRILGIVGLSITAVSTYML
ANLQLDSSHTHIILIYTLRMFGMAMVMMPLMTNGLNQLPTRLNPHGTAVN
NTAQQVSGSIGTAILVTIMNSVTKTKAESLMAHVDPTNFTEATKIMLTQK
ALLSGIQHSFYVALGMNVVALLLVFFVKRVDTSPEAVERLNR
>BCE33L0633 group-specific protein
MPRNIPLLIEYLAFLGLICCLIIYNTNTVFLSIIIAFVALEIMMEAFQVQ
LKQKIAHIYNAIFLLSALITNIISNGFYLTTVFPVFFMAILLFIARYIHV
PNNKKHEQEA
>BCE33L4423 group-specific protein
MIVLWIITLCMTAIFAYMTLKQNGLKRFVPGSILAGIALITYVTSIFIES
VSVDMSTSLMFMGITLFASSIMVLMVAGIILFIHMNSETL
>BCE33L2613 peptide permease, major facilitator family transporter
MNHLLLRYNKPIIIRLGGELLTRTTESMLALIMIIYVNKMLNGNIMITML
IFGLQPLSDIVFTLIAGGITDKYGRKKIMLLGLLLQGVAIGSFVFAQSVF
IFALLYVINGIGRSLYIPAQRAQIADLTKQGQQAEIFALLQTMGAIGTVI
GPLIGAVFYNTHPEYLFMMQSITLMVYAVVVWTQLPETAPAITMPEQKLE
VSSPKQFVRNHSAVIGLMVSTLPISFFYAQTETNYRIFAEDVFPNFIFIL
AFISTCRAIMEIILQIFLVKWSERFSMAKIIIISYACYIVAAIGYGLSAT
IVSLFFTLLFLVIGESIALNHLLRFVSEIAPSDKRGLYFSIYGLHWDVSR
TCGPVIGAVLLSKLNGSMLFYICACFLTIGGIIQALFVRNLERKKRREVI
QKDVLEHPHHIL
>BCE33L1646 multidrug ABC transporter, permease
MEQSKGIKIVFLMCLGIFLCMIDTTIMNIALPAIQTSVNTSLEKMSWVLN
VYTMTIAVLAIPLGRIADIFGKAKMYILGLIIFGGGSVLCAFANTGDFLI
FSRFIQSVGAAILFPTSMVIGVSAMPLAKRHVALAILGVTQGLSAAMGPV
IGGIITQNFGWRWVFFVNVPICILGIILCCIMLQIKNEERIISKIDWVGL
LLSSLAIFSFTLVLIKGNTWGWQSNIALSCYAISTISLILFVLVERKVHN
PMVNLNLFQDRMFVGASIVVILSNVFLIGVTVLLPTFLTKIQGRTEIEAA
FLVTPISAMIFFVSPIAATLIKKLGKVTIILSGFLVMGLSYYWLQMIDVN
STNIEIIIPCMILGVGYGLVVGPITVLSASSFEGELLTASQSVVSMLRQV
GIVLAVAIFVSNLTHNLTINKENVYRYAEEKVRNIPVSSAEQAEILQVTK
EKIENQSIETNVEKHQNETFVGLHKEKKDELIHQKVDKVLREVPVEYRDV
KREEVMSQVTNEVEKQEESIKKEVLAFSNDVHHYAKNQMAMSFTDLYKAS
VPIILICALVSLLFSERKVLSKKKSGRVVEEV
>BCE33L0650 major facilitator family transporter
MKKFKLTFILYVVCISALLGSFAQNIYTPILPMIQNSFHTSLYLVNVTVS
LFTFVLAIMQLIYGPLIDTKGRKSVLIPSLIISTIGSIGCAFSPNVYLFL
FFRAVQAIGIAAIPVVSATIIGDLFEGKERGEAMSLYQMLLALAPAIGPL
IGGYLGSINGHLSVFLFLSILGILLLIINISLLPETKPTVMKQPQAKKNY
WLILKNKTGYSITLIGFIQFCIYFCFLIFLPSILANSFHLAASEIGLMFV
PMSLSIMIGSYYYKFLQKRLTTKQALFITSFFNIICVVLFSFTYSINIPF
IIIVTSLYGFSIGLSMPTHTTLLTEEFVQERATAIGMYNFIRYLGMGTGP
IVGGFLLFSQNYFWIFFLGAIMFLIIILYAMKMLRFPVTQKVK
>BCE33L2126 oxalate/formate antiporter
MKKSAVNPWLVVLGTVIVQMGLGTIYTWSLFNQPLVSKYGWSLNAVAITF
SITSLSLAFSTLFASKLQEKWGLRKLIMIAGLALGLGLILSSQASSLILL
YVLAGVVVGYADGTAYITSLSNLIKWFPERKGLIAGISVSAYGSGSLIFK
YVNAQLIESVGVSQAFIYWGLIVTAMIVLGACLIHQAADQSAVQETKTHE
YTTKEMLGTKQVYLLFIMLFTSCMSGLYLIGMVKDIGVQLVGLSAATAAN
AVAMVAIFNTLGRIILGPLSDKIGRLKIVTGTFVVMASSVLVLSFVDLNY
GIYFVCVASVAFCFGGNITIFPAIVGDFFGMKNHSKNYGIVYQGFGFGAL
AGSFIGALLGGFKPTFMVIGLLCVVSFIIAMLIQAPNQKKEQEEEYRSVA
>BCE33L2695 sugar ABC transporter, permease
MKRMLKMHETSIITLLLIYIAIVGMINPSFIQFNSLSLMVKSSVILVVLA
IGQSFVLFTKNIDVSVGSSMGLSAAVCGMLLTNEYSASLSIFAAITLGAI
IGFVNGMGVAKFRVPAIIMTLGMLGIIRGAMLIFTGGKWIEDIPNDFKQL
SSIVILGLPITVWFVLIILLLLYFFLRKVPFGRYFYAVGDNEDGARLIGI
PVNKVKICAFMISGISAALAGCIFVMNIGFIPNQTGTGLELQVIAAAVLG
GIHLKGGTGSLFGAALGAFFLETISSSLVFLKIPAFWNNAISGFLLLLII
ILDSVMKKWKAERRMNL
>BCE33L3217 group-specific protein; possible membrane protein
MEKYHGKSTEQIIQKVMPGSVKSSVVMVWVVINFMILTPFLFPPTFTIYL
YIILPFLLIANIWGVWVFFYKPNELRLVHILYNGFMGITFSFGSFIVIQK
IAYTFIKIETPLFFIVTFLLYILTNYKLISIGMKSFLRRLNNEENDNIKI
SPIVYVSGLGYVIGQICIGTLSQNGLATVLILVFSLFAVVLSISGVYIWV
YVDLKRKEMDGMHNGQI
>BCE33L4446 deblocking aminopeptidase, M42 family
MNKETLQLFRTLTELQGASGFEHDVRRFMKQELSKYADEIVQDGLGSVFG
LKKGDETGPRVLVAGHMDEVGFMITQITKNGMLRFQPLGGWWSQVLLAQR
VQVMTKNGPVIGVVGSIPPHLLSDAQRAKPMDIKNMLIDIGADSYEDAIE
IGVKPGQQIVPICPFTPMANEKKIMAKAWDNRYGCGLAIELLKELKDETL
PNTLYSGATVQEEVGLRGAQTAANMIQPDIFYALDASPANDASGDKTQFG
QLGKGALLRIYDRTMVTHRGMREFILDTAETHNIPYQYFISQGGTDAGRV
HTSNSGIPSAVIGVCARYIHTHASILHVDDYAAAKELITKLVRATDKTTL
ETIKNNA
>BCE33L4661 conserved hypothetical protein; possible transporter
MEELQQNKSALEGSGKPLLKNTNFLFLWAATLFSSFALAFFTFSQTWYIA
KTLNLEASLGVVFVALSVPRLIFMIIGGAVADKFPKKNIMFYSNIIRAIL
VATILTWFIVGDVTLYTFALFALFFGLADAFFWSADGSILPELVEKSRLT
QANSLTQMTNQASVILGPVLGGILIKFTNYETIFSITILLLIVAAILVQK
IQFTMPEQQNTDKGMFTSIKEGILYVKESPFLSTFLICSAFLNLFLIGPM
QVGFPLFVKNVLHGDSLQFSYLEASVGGGMAIGAVIVGLKNINRRRGLFC
IIMMLLSGVFFLSINFSTVLWQALLAGMFYGITIAMAIVPLMAMIQSTVK
EEMMGRVMSLLMLSSMGFIPLSYAFTSIALAIGIPIVTVMKSGAIAVIVF
VLFVAIRVPVVRKFD
>BCE33L2374 macrolide efflux protein
MSINVEMKQNNGVSQVLKNRFVQGILASALFLQIGIWVRNFAVLLYVMEM
TKGDAFAISMISVAEFAPIFIFSFIGGTFADRWKPKKTMIWCETLSSISV
FAVLITLMFGTWKIVFFVTLISAILSQFSQPSGMKLFKQHLSAEQIQLAM
SIYQTIFAIFMVLGPILGTFIFHSFGIYISIIITGIAFLLAAAVLLFLPK
DRENDNEKKEITLLQEMVDGIKYVKKKRALTLLGLCFMAAGLGIGLIQPL
GIFIVTEQLGLSKESLQWLLTVNGAGMIVGGALAMVFAKNVAPQKMLIIG
MLGQAIGIGIIGYSTNLWVTLTAQLFSGLALPCIQIGINTLIIQNSDTDF
IGRVNGILSPLFTGSMVVTMSIAGSLKEMFSLSMMYEGTAFLFIIGLLFI
LPIYNLKPTIAIESEISGKGSAIQNES
>BCE33L2202 conserved hypothetical protein
MSSNIDYTSPSINFTYDLNKSNFFQKDAQNYINVLGMKQLNTLENTSLLD
IYLSTGNVVEPHIHQNAAELVYCISGSAVVSLLNPFTNQILNLPIKPGQV
ANIPQAWWHYEIATADNTHLLAIFDAPTPEVIFGSDMLRLTPTNIMAHTY
CLNEQQWKQAVSPIQSTTVIGPPANCNQKRGTINPATQPPNPQQNLYYPD
SYYFPLYWGY
>BCE33L1912 conserved hypothetical protein
MRRKRNHHFKSGEKNEEYAAEISPAGLPIRHKRKEIANEIEGTNTGAMIG
YVALFLSLFSIAFYPVTLGSLAILVGLLAVNFGARTLGYTAIGFGSFSVL
FTLLYPLALSAF
>BCE33L0799 glucanase; deblocking aminopeptidase
MAHHAKETMELIKELVSIPSPSGNTEKIIRFIENYVSEWNVETKRNNKGA
LILTVKGKNDAQHRLLTAHVDTLGAMVKEIKPDGRLSLSMIGGFRWNSVE
GEYCEIETSSGKTYTGTILMHQTSVHVYKDAGEAKRDEKNIEVRIDERVF
SADEVRELGIEVGDFVSFDPRVQITESGYIKSRHLDDKVSVAILLKLIKR
LQDENVTLPYTTHFLISNNEEIGYGGNSNIPEETVEYLAVDMGALGDGQE
SDEYTVSICAKDSSGPYHYALRKHLVELAKTNNIEYKVDIYPYYGSDASA
AIRAGFDVKHALIGAGIDSSHAFERTHESSIAHTEALVYAYVLSEMIAE
>BCE33L0949 permease, general substrate transporter
MNAQTAPVSSQSNEFDNVKRLPILISMIIGAFFTILNETLLNVAFPQLMI
ELNVTPSTLQWLSTGYMLVVAVLIPASALLVQWFTTRQVFIGAMVVFTFG
TLVSAIAPGFSILLMGRLLQAAGTGLMMPVLMNTILLLYPPEKRGAAMGS
IGLVIMFAPAIGPTLSGLILETWNWRWLFYIVLPFAIFSIVFAFIYLKNV
SEPTKPKVDVLSILLSTIGFGGIVYGFSSSGEGWDSFQVYGIILIGLVAL
LFFVLRQLKLKEPLLDLSAFKYPMFTLTTILLTIMMMTMFSTMTLLPFLF
QGALGLTVYATGLIMLPGSLLNGLLSPVSGKLFDKFGPRALIIPGTILLA
GVMWFFTQVTADTSKITFILLHVTMMVSISMIMMPAQTNGLNQLPKRFYP
HGTAILNTLSQVAGAVGVAFFISVMTSGQKKYLDASSNPTDPAQLTEAMV
SGVHNAFTIGFGLALLAVVVALFIKRSQTSES
>BCE33L2938 3-beta hydroxysteroid dehydrogenase/isomerase family protein
MKMLVTGGTGFLGQKLAFRLKNMGYEVTATGRNKTIGKVLEQNGIEFVHC
PLEDRERVLQVCKDKDYIFHSGALSSPWGKYEDFYNANVLGTKHIIEGSQ
KYGIKRLIHVSTPSIYFYYDERQNVVENAKLPDTFVNHYATTKYMAEQAI
DQAFAHGLPVITIRPRALFGPGDNAILPRLIKVCEKGALPRIGTENVLVD
ITYVENVVDALLLCMHSPKHTLGQKYNITNDERINLYEVIENVMKRLDKE
VRYKKISYKTAFTLAAILEGISKTILFGKEPILTKYTVSVLSKSQTLSID
KAKEELGYAPKVSIEEGITKFVDWWKIQ
>pE33L466_0080 polysaccharide deacetylase
MSNNWGAVQKPVGKVVYLTFDDGPSTLTGKFLDVLKENDVKATFFMQGSN
LQNASYQENVKRAVKEGHYIGAHSMTHNSDKLYKDGQFVPEMKETLSLIQ
DITGTNPKLVRPPYGSALGLKSEEVRNQIVEAGIKVWDWTIDSYDWKLKN
NPNEIKDARWNN
>BCE33L2514 HIT family hydrolase
MNLRNINPVFPFFMILYMKRMVMNMSTNDQVKLNCFICEKHKGNIIVPGG
AIYEDELVYVGHVHWDSEETYLGYVMIDIKRHVPGLAELTDEEAKAFGLI
TSRVSKALKASEGAEHIYTFVSGNGVPHMHMHIIPRYENTPKEFWSPTEV
AKWNGAPYGDAEKIKKLCERIRKYMVSEYAYNK
>BCE33L1816 permease; probable multidrug resistance protein
MKRVLAVFFTIMFMIGTDTFLISPLLPTLQQVYHISTELSGWMVSSYALG
YAGFALIAGPISDGLNRKKVMVIGMSFFALSTFLCGMAPSFLWMLAFRFL
AGVSAAFVSPQVWASMPLLIEKEQIVKAFGIATAGLSISQVLGLPVGSYL
AMIHYTTPFFVVGILSALLVILIYVVLPEIQPVHISGNKTNILKRYKQLL
SDSKVLLSYFAYFVFQTGNFAAFSFFGVWLSIQFGLQVHEVGTAMLILGL
GNLTGNILGPRIVNKMGYNLSFHGGIIFTAVLYVLLPHVKNIVLVELLFF
VLFFVTGILFVLMMRHLQNMSNVARGTGAALANASMYIGQMIGAAIAGML
FATSHNFIFVGSFTALLYIIALFLFRKSEKLTENSETGIAS
>BCE33L1057 alpha-amylase family protein
MRVGKIHTRKLFICFCLAVVLFVPIHTFADEKREWRDEVIYSIMIDRFNN
GEPKNDKQLEVGNLEGYQGGDIRGIIKRLDYIKEMGFTTVMLSPLFESVK
YDGVDVRNFQKVNEHFGTENDVKELVQEAHAKGMKVIFQFPLGENEQQVI
DSMKWWVKEVDLDASYVMHSEKKSPAFWDDVQKDMQVIKKDFRVMTKEDS
EYNEKIVESFSKADVSVKSLYDVSKKDEEFITFLDNQDTKRFARIAKENM
NYPPSRLKLALTYLLTSPGIPNFYYGTEIALDGGDTPDNRRLMDFKSDEK
FMQHITKLGELRQTRPSLRRGTFELLYDKNGMSVLKRKYKGEVTLVAINN
TKETQKVALPASTIGEKQELRGLLEDEIIREENGKFYLVLKREESNVYKV
NRETGVNWLFISLIVGVNVLFITFLIAVKKRRK
>BCE33L1888 glycosyltransferase; possible macrolide glycosyltransferase
MANVLVINFPGEGHINPTLAIISELIRRGETVVSYCIEDFRKKIEATGAE
FREFENFLSQINIMERVNEGGSPLTMLSHMIEASERIVTQIVEETKGEQY
DYLLYDNHFPVGRIIANVLQLPSISSCTTFAFNQYITFNDEQKSREVDET
NPVYQSCLAGMEKWNKQYGMKCTSMYDIMNHPGDITIVYTSKEYQPRSDV
FDESYKFVGPSIATQKEVGSFPIEHLKDEKVIFISMGTVFNEQPELYEKC
FEAFKDVEATVVLVVGKKINISQIENIPDNFKLYNYVPQLEVLQHADVFV
THGGMNSSSEALYYGVPLVVIPVTGDQPLVAKRVNEVGAGIRLNRKEFTS
ELLRESVKKVMNDVTFKENSRKVGESLRNAGGYKRAVDEIFKMKMNSYLK
LK
>BCE33L1709 conserved hypothetical protein
MNAVISKKETIISYTIAILFILAMVTAGVLLNDPEVILPEIAAMAIALWA
YREPGWLRQPEKIFVAPSITALIGFAVNQMDLAYIGKVSVTLVLMMLFLR
VIQSNLAPSIATGLLPLVTNATEWSFVISVFALTFILMIGVLIFKLNNGI
KRKVHIQYKYMTVFLILNFVWISLCWITGYEQLAVIPPILVVVYESLQKP
MYNEKMAFKQILVLTTSATVGTLLYFAIDSWIVVTFLNMIVMLILLKIVG
VRIPAAYAFPLLPLVFPDEMIKMLPVGSFGVGVFLFGAVLLYKKWEMKQK
GMQKS
>BCE33L0864 hypothetical protein
MNRQNSSHNKDDSSNKIAAFIAALGALLVSVEVLSNFFIIFWLMIIAVTN
LIVIFYLQISVFSLVTTILFVIFYFIYKKLFAHSKFVETFSKYNIIITII
SLFILNMLYIYQKMFNGALITPVVIIITWLIYKVMFKKIKNKKN
>BCE33L0357 conserved hypothetical protein
MKTIEKIVDELTADNLEERKAVLKNHILLMKYGMEHHELKEKEVTEILKW
VQGRDQLRKDVPELRNLHLIKKFQAVLDEFIHSIILNGYVEDAVEILESV
LKSMGAVAHIVKVMFVGKMKVDRNSLEMVEVLKRECYNLMEQRAVVGLHA
QIFHVLGFVHSIQFDLEERSQEHGRVVIGLLTNFKTGELKSVQQFQTEDH
IPEVKSMVSKGYGIELQRRIYMWKSLTLIFTSPYALEKMYKEIYVENDNM
GKEQKEK
>BCE33L4765 membrane protein; possible DMT superfamily transporter
MEKFKYSLLVLFGACSYGVLSTIFKLGFINGFSAHQLLGGQYVFGWIGLL
LLVLFASRHKVTKKQFFSLLTVGTTMSMTGIFYAISVEELPASIAVVLLF
QFTWIGVVIEAIANRTFPSREKVISIIILFTGTLFAGGVFEGLGQSFSTK
GIIFGLLAAVSFSFYVFASGRVATEVPPYTKSFLMTTSATLIVCLFFPPT
FLTDGALQAGLWKYAFFLGLFGVVVPVICFSIGVPKVGTGLGTILGAAEL
PTAIIASITLVHEVVTFMQWIGIIVILLGIFTPQLLIARKEKKRTRVYSA
>BCE33L4502 ABC transporter, permease
MFALIRYHFLDYTKSYKYVPPIAMYFMSLLFVYAYKPTPIVPTYLETALA
LYLLSAWITVTIFHTEDPVQEQITISHTNNISALYVGKYITALLICTVLS
FISVIYPIILQMFNEKMTASLFLVGFLAHMSFSILGISIASLFTRNMIPK
ASTAWLSLTFILLITIASIRFKKELLWFLPPVESFLMLGQYKYNILTHTL
WLTAWAIVYSFLLFTLFLFIVRKKRF
>BCE33L4976 conserved hypothetical protein; possible deacetylase
MELRARKRKQSKLKFIGITLFIGIVLVWSTLTVFKMGNKEVIGSGITDQK
IPVLMYHHLLKNNEKQSQPNFKNKGTVLTVEQFEKQMKYLEDNDYHTLTL
QEFEDFIERGRKLPEKSVLITFDDGLKSNYIYAYPILKKYQMHAVAFVIT
SRLTEETENFNPRKLQSLSKTELDQMRDVFEIGSHTNNLHNRSNREVDLI
DKEQETVKKDIQESKEILKTDYFCYPFGIYNQKSIEILNDLKFHLAFTTN
EGYATQENKRLEINRFGISPQVDMKKFEDIVSGKVKVTKVNHVSIQQNSG
NMLRVESKATGEELKYAYYIYKDNEILEKINYSSESSLTYKIKKSGEYKI
KVFIQDKNGDKDSKETPKLQVSI
>BCE33L2227 permease; possible macrolide-efflux protein
MIMISISIKPSMQDFYLMVSGQIITILGSTLLRFALSLYVLDLTGRADIF
AGLYAITSIPFLLAPLGGAIADRFNRRNLMVIFDFINTAIVLSFIVLLFT
GSVSILLIGTIMFLLAIVNAMYAPVVMASIPQLVPEKKLEQANGIVNGVQ
ALSNIVAPVLGGILYGIIGLKMLVIISCLAFFLSAILEMFITIPFIKRVQ
ESHIIPTIVRDMKGGFIYVLKQSFILKSMLLAALLNLILTPLFVVGAPII
IRVTMESSHTLYGIGMGLIDFATIIGALSIGFFAKKLKMQTLYYWMILIA
LLIIPMALSVTPVILNLGYYPPFILFILSSILIAMIMTVVSIYVITVVQK
KTPNENLGKVMAIITAVSQCMAPIGQVVYGFMFEKFSMKIYLPILAISFI
MILLAVVTKKILSNEGN
>BCE33L1878 permease
MYLLQKRSLTYYLGSKICITLADIVYIMIITTHMYITTKSATLTALFPLL
QVITNLIANTSAPLIMNRFSSYSLLFTLQWSKTALLILLMLLFPVLSTNI
VTLFIFIFFISLCSGWSAPLLYGILPRLTPKENLVKVNSIFSFSTQIAQA
AAYSFTSVIVLLIGATSTLMMNNILMIFGCVALHFSLRSIHNERVIEPSS
SKAAALLEGWKLLFQNPALRTVTCMDLIETFAGTIWIGAITMAYVTTVLH
KGKEWWGFINTSYYVGTLIGGLLAWKMSTYIQNNLIRSMAIGSLLFSILT
FLYGITSSGFIALFLCILMGPCYQIRDISQTTVLQSSVAPSLLSKMYTAH
GALLSTASGLSMLSVGIITDMFGVRTIYIIASFLILCSACLSFSLLKCHK
TNQKDISM
>BCE33L4159 conserved hypothetical protein
MDGTKKLSTAIGFGIITLLILASITSMVMALLLKFTDMTEGTLAVTIFIL
ALLSMLISGFTAGKKAQGKGWLVGFTTGLTFTILVFLVNYLGFSQTLSNS
QLLYQLALMGASTLGGIFGVNMSKQNN
>pE33L466_0171 polysaccharide deacetylase
MFIKNYKKLISVLCLIIILICGSLWWLQNKKPWIFADGIPILMYHAIGNP
PEGTSENMTGWYVSKENFKEQMEYLKANNYTLITFDELENAKNYKKPILI
TFDDGYENNMDAFEVLKNLEDNKFKPKATLFMIASLINEPNYLDSKQLKR
LSQSGIFSIQSHTTSHMNLTNSDVDFQTEYGEANKKISSITEQNIDTLAY
PLGAFDEKSLIEATKYYKYAVAMGHNRFKMNGEKNELFKIKRLTVSGHDS
MRKFIFMVR
>BCE33L4459 multidrug resistance protein B
MRKKVMMSLMLMTFLSAVEGTIVSTAIPRITSDLSGVELVSWVYAIYMLA
TAVSTPIYGKLADLFGRKKVLLIGATIFLVGSALCGVVTSMEQLIFFRAL
QGIGAGAVMPITMTIIGDLYSEAKDRAKAQGWMSAVWGVSGVIGPLVGGF
LVDSLSWRYIFFLNVPFGIIACLMIAIYYKESIKPAKHHIDYLGATVFSL
STIALLYALLTGSSKQNWGDVTIIGLLIFAVVSFIIFLFIEKKSPEPLIP
LALFSNRTLSTINILTLIAGAMIISITMYLPIWSQGVLGKNATEAGLILM
PIPVMWTFGAIFSGNLVGKLKTKQIILLGASILSVATFLLFTLSTNSPSF
LIYVAVGLFGLGMGLVTPIYMVTIQAAVPAHTRGTAVGLNTFINTFSQTL
GAAIFGTIFNTMIHARGIKNLDLVSGGHGGATANVVTESQSALASSVHVI
YMSTFVLAVCTLIIAWLLLKPATQTSEQ
>BCE33L5115 major facilitator family transporter
MSKVKEISKRKLLGIAGLGWLFDAMDVGMLSFVMVALQKDWGLSTQEMGW
IGSINSIGMAVGALIFGILSDKIGRKSVFIITLLLFSIGSGLTALTTTLA
MFLVLRFLIGMGLGGELPVASTLVSESVEAHERGKIVVLLESFWAGGWLI
AALISYFVIPKYGWEVAMILSAIPALYALYLRWNLPDSPRFQKVEKRPSV
IENIKSVWSGEYRKATIMLWILWFSVVFSYYGMFLWLPSVMVLKGFSLIK
SFQYVLIMTLAQLPGYFTAAWFIERLGRKFVLVTYLIGTACSAYLFGVAE
SLTVLIVAGMLLSFFNLGAWGALYAYTPEQYPTVIRGTGAGMAAAFGRIG
GILGPLLVGYLVALQASLSLIFTIFCGSILIGVFAVIILGQETKQRELA
>BCE33L1630 probable transporter
MQGEIPTEKSLSYIGKLLLPVKASPHFKFLWIGQLLSTLGSSITMVILPV
VVYSLTGSTVVMGMTMAMYMLPNILALPFAGLVVDRMDRVKVMLFTDIIR
CILMLLLATLIFMDVLTIPLLYVLIALYGLMEGIFQPAYASVRAKVFVPD
IRNAANALTQMSNQGIRLIGPALGGLIVSVASAGIGFGLDAVTYLLSFFC
LLFLREIKFKKVKTIEKRKIDYKQEFMEGVFVLKSHPWLWITILVFSFIN
ICYAGIIVVLIPWLFNVHHHFEAYVYGLGMASSGVGAVIAALIFGGRERW
HKRGLLAYGGVLISGCALLIMPFIAWAPALIALMAIEGFGMMIFGLIWET
SLQELVPEEAFGRVASLDMLGSFALLPLGYVVVGWLANVIGGEITIITLA
ILVLITIGLALAVPSIRRFN
>BCE33L0196 integral membrane protein; transport protein, DMT superfamily
MIIGALACLIASMSWGAMFPVADHALEYIDPFYFSLIRYGAVAIMLIILL
LMKEGKHAFRLEGRGKLLVFFGTMAFTVYNVLIFLGQMLMGKSGVMVASI
MEALMPMISICILWGYKHVKPKKYMITSMVIAFVGAVFVITKGDMSFFLT
LKDNMFSLACIFVGVVGWVIYTMGGQTCSDWSTLRYSTLTCVFGTTVTGI
ITIIITAFGYVSVPSMGTISIVKYDLLFMMTLPGIVALLAWNYGVKILSS
INGILFINFVPITTLVIMMMQGYQITMFDIVGTLLVIAALIRNNVCQRKG
ENINKRILEEEQLRQAV
>BCE33L4861 conserved hypothetical protein
MSMLAEYRWYFLIGAEIVFWLSAIGFFLLRYGFRLKKASFIMGIVLLVNE
VFILTLGVVDYYQTGKFSNFQIITVIILLYAVFYGKKDLKKLDMFAQKLV
AKRRNEPAPIMEEQIELTGTAYAKQEIKNWVLHLSLFVVVHIFFFFLYGF
VPFEQWGNWLESGIVLNKAASRVSQVWAIILLVDTAISFSYVLFPKKEKG
EEKLLS
>BCE33L5019 protein-N(pi)-phosphohistidine-sugar phosphotransferase, PTS system, IIA component
MFKKLFGLGSKTNEETIVAPLTGAVKNIEEVPDPVFAGRMMGDGVAIDPT
EGVVVSPVDGEIVQLFHTKHAIGIKAKNGTEILIHVGLETVKMEGEGFEA
HVSEGQAVKAGDKLISFDLELIREKAKSTITPIVITNTDAAESIKTTVGV
TATKGSTEVMKVTMK
>BCE33L3524 major facilitator family transporter; possible multidrug efflux pump
MDNTNVVINRKLPLFSEKLVILIAGIGMFLSTLDTGIINIALPYLEKEFH
STVTITAWSVTIYVMALSATILLFGKISDRVGRFRICLYGFFIFLISSIL
CGLAQEMWQLIVFRAIQGIGAAALQATSAALITTLVSPENRNHALGTLGV
MIGLGPILGPTAGGLFISLGSWRWIFWINIPLCLIGLWACYKISRFIKEE
KHPAPIDVLGNIYFTLSALLFLFSLSHGANKVMGSIPTWGYIIASIILLG
IFIFHESNTKHPIIDVHLFLNSTFIVPILATIGFGVASAIIFIVPPYFLQ
KFTSLTPLQTGFVLLSAPLGLVIFSRISGKFMGRFGTTLFMSIGLGVMFI
AFVGLSFIEAQWSPYLLASVLFLYGIGGGIFQPANIASIMASVSKEKQGS
IGAVQRMLQNVAIAFGAAVAATFMSTQSYLGTDGLIQAFRYSWYIAGGLL
LFNTLCFLGYRKS
>BCE33L1634 probable sugar ABC transporter, sugar-binding protein
MKKWFIFFLSTLLLAIVGCSNSGEKVNTSSKDEKIELRYALWDKKQLPAV
EKVVQQFNEKHPNIKVKIELTAYGQYFQKLETAATGNALPDVFWMNGPNV
VKYASGKVLMPLDDKAKKDKYKLENYPKSLVDLYTVDNKTYGIPKDFDTT
ALWYNKKLFDEAGVAYPDDSWDWEKMKEAAKKLTKKEKDVWGFAAAMGNQ
GGYYDLIYQNKGYVLSKDKKTVGFNKPQAIEAFNYNISFIKEGLSPTFAQ
MTETTASDLFLSGKVAMIFDGPWMVPEYKKNPDLNIAVMPKGKERAVMIH
GLANVISAKTKYPDAAWEFVKYLGSKEAADVFAETGTVIPAFNGTQEAWV
KSVPNLNLQAYITGLEYSYPLPSVKNTGALWEQETKVLKRVWGGELNVED
ATKELTEKANEVLSKK
>BCE33L2994 multidrug-efflux protein
MSIRFTFWIMVGIVAISGLSQGMLLPAIAMIFEQEGVSSSINGIHATALY
IGILVISPFLEKPMQKFGMKPIIVIGGFLVIISLFFFTQTFSFWVWFILR
FLVGVGDHMLHVGTQTWITTTADPSKIGRQVSIYGVFFGIGFAVGPYLAS
TVQYGLATPFIISTILCLIGWLLLLPTKNAFPAQDEREVKSESSFSRYKQ
VVGLGWIALLGPLAYGVLEAMLNSNLPVYALRKGWSVSEVSFLLPAFAVG
GIITQIPLGILSDKYGRDRILTWTFCISTGIFLLAAVFDHYYWIVFACML
LAGMVIGSCFSLGLGFMTDLLPRHLLPAGNILSGIAFSLGSILGPVLGGV
FIEKIQYTSFFVAVMIIIGTLAILYMIYMKNQFASRKIESRLGHDKTT
>BCE33L0335 sugar transporter; possible benzoate transport protein
MNTMQPSAPPHLESTKTIFSNSITKLVVFICWLAILADGYDLGIYGAVLP
KLLEDNSWALSPAHAGTIASYALFGMFIGAILVGTITDLIGRKWTLICCL
ALFSITMGLAALAPSPELFGLWRFIGGIGLGGVIPTASALTVEYSPKKRQ
SFIYALMFTGYPLGIVLGAILSMFMLEDFGWRIMFGIGMIPLLLIPFIIR
YLPESIQFLLSRNRQEEVDKILNRFQIEFHAKEKTHQAPSNIRKKNGFLT
LFSKEYIKATLLFWITYIMGMFLIYGLNTWLPQMMRQAGYPLGSSLSFLL
MLNITAAIGALFAGAIADRIGAKIVISISYLMAAICIGLLTIKPSVSIIY
LLIGLAGIGSVGITQILNAYVIQYFPSHIRATSLGWGLGLGRVGAIAGPI
LVGIIMTMQYDLAWNFYLFSFAGLLSAISVFFIPTK
>BCE33L1382 conserved hypothetical protein
MEGSTFYFVAWLGWIVVTFFMKKDSIRWKISACILIFIICSPLHVTIASF
TVSINALLLSVVAFVGITLYSIWKKLYSLLSALIIAMLYTSFHLLEVYDP
IWIVVDRLFLLSSALVYAAVLLHEDRILRLCSLYIGMLQGELFVTIIFRK
LHFPYDYGSLAFFDSVAVSTFFMAILFWVAKASVYMEQFKRKTRKRKARV
IHD
>BCE33L0866 conserved hypothetical protein
MNRKIWYVFTCFALLVSGYIVVQYSIMDGFQTGLVKAKLMYGSKLSEFWY
VMLFIHITTSIVALVIGPFTLSTKFRERNINRHRIAGRIYMVGILLGGVS
GLYLSFYATGGLVAKLGFGLLSVFWLTSAYEALHRVKNKKMKDHRNWMIR
NYSLTFAAVTLRIWLPLFIVLFGIEQFELSYAVIAWLAWVPNLIIAELFI
RQRLNKGKYEENEDLHF
>BCE33L1223 conserved hypothetical protein; probable aldolase II family
MLFFLKKWNELKDVKSELALRDWFYGTKISLSLCTSKEPLTFLVNVEGRD
KGLFSEEDFIVVNCMCEPVFENEEKPAAESFMHADIYKKSSAECILQVQT
VDSHLISELYGETGEVTFDKRSVERVFGKEGITEMTIPIVEDEKKFANLL
ENNVPNFIEGGGVVLVHNYGMIVWGKTPEEAKKWLEGIEYLMNYHVKLLM
IKGAKSSVI
>BCE33L4521 transporter, EamA family
MRKWGIELLILAVVIIWGINFTIAKYGLLEFTAIEFTALRMISAAPLMLL
LTFFIEKSVYMERKDIPRLIIVSVVGIVLYQTLFMETVKYTSATNASLLI
SISPIFTTVFAIFLKQEKFSSRKLIGSIIAFGGAALVLVAGHSLASSFYG
NGIGLITSICWGLYPVLAGPLIKKYSALRVTAWSALVGAIPLLLLSGPHV
FTMPFHITHGMTLFALLYSIFFVTVFGLVMWYVGVQKIGASHTMVYMYIT
PLIAVLFAAVWADEYVSFQQIIGGIIIFFGLWFVKSEKVNIHSTAGEPIS
K
>BCE33L4793 major facilitator family transporter; possible chloramphenicol resistance protein
MSSYTVPSSEVQTNRRSMFALLALAISAFGIGTTEFISVGLLPSISKDLN
VSVTTAGLTVSLYALGAAVGAPVLTALTASMSRKTLLMWIMVIFIIGNGI
AAVATSFTILIIARIVSAFAHGVFMSIGSTIAAAIVPENKRASAIAIMFT
GLTVATITGVPIGTFIGQQFGWRASFMAIVVIGIIAFIANSILVPSNLKN
GVPVSFRDQFKLIKNGRLLLVFIITALGYGGTFVTFTYLSPLLQEVTGFE
ASTVTIILLVYGIAIAIGNMVGGKLSNHNPIRALFYMFFIQAIILFVLTF
TAPFKVAGLITIIFMGLFAFMNVPGLQVYVVILAERFVPSAVDVASAINI
AAFNGGIALGSYIGGLVTNSLGLIHTAWVGGLMVVAAVILTAWSMALEKR
DQVK
>BCE33L3947 conserved hypothetical protein
MKQWLAAMETSVLVMGLLRLFSGSAEIFAALLMLYVNDAKKALFINGMLA
FVGPTVLILTMTIGIASVASEISFLKLFFLALGIGCIFIALLK
>BCE33L2663 possible sugar phosphotransferase component II B
MKKVLVVCGNGLGSSFIVEMNVKKILSELGLQAEVSHTDLASSKSEQADL
YLGSKDIICNLEDGNRIVAGLTNILDLNEIREALQKHLM
>BCE33L0481 probable glycerol-3-phosphate ABC transporter, permease
MIVKQWKQNFLLYMLLIISAVMVFFPVLYAFLISFMTPDDIQMRRIFPTQ
FTFDNFINIFQKVPLFTYLYNSLVVSTVVMIGQLIVSSLAAYAFVFLQFK
GRNLIFFLFISTMLIPWEATMVPNFLTIQNFGWINSFAGMTVPFFATAFG
IFLLRQHFMTLPNELKEAAFIEGIGNVRFLFSVVIPYCKTSFITLGVYSF
LTTWNMYLWPLLVTTDETVRTVQIGVKQLQSQEVATDWGSVMAGVTVIVI
PTLILLFLGQKQLQQGLTKGAIK
>BCE33L1220 transcriptional regulator, DeoR family
MSVVGEERKRTILEKVEFKGKVKVSELAREFAVSTETIRRYLEELDREKK
LKKVYGGAVQLPGAGIEAPMLEREMLHIEEKKRIGYKAATFVEDGDVIAI
DDGSTPLQMVPYLVHRKNLTIVTSSFPVATQLISSINKKMFHGEVLFIGG
KVSPKHSRVSGSISQQVIQQFHFHKAFVSIDGLLPSFGVSSFELEKAKLS
EAMMKLAEKTYILCDHTKVGVKGNYRIAAFSRIQHVICDKKMPYSFEEEV
KKHNIQWTIC
>BCE33L0398 polysaccharide deacetylase
MKYKWLYIGLIFSIMMALVPVSALAYTNTPHNWGIPRPKNETVPDAGKLY
TDLLQKNGGFYLGDTKKKDIYLTFDNGYENGYTGKILDVLKEKKVPATFF
VTGHYIKTQKDLLLRMKDEGHIIGNHSWSHPDFTAVNDEKLREELTSVTE
EIKKVTGQKEVKYVRPPRGVFSERTLALTKEMGYYNVFWSLAFLDWKVDE
QRGWQYAHNNVMTMIHPGSILLLHAISKDNAEALAKIIDDLREKGYHFKS
LDDLVKSNQP
>BCE33L0479 ABC transporter, ATP-binding protein; probable glycerol-3-phosphate ABC transporter, ATP-binding protein
MDTRRKKECNLVIELKNVSKVYQNAEETAVKAVSVHIKKGEFFVLVGPSG
CGKSTLLRMIAGLEEISSGDLIINECVANDLEPKDRNLSMVFQNYALYPH
LSVEENILFGLKVRKVQKEERQKRLMEAVEMVGLKEYVKMKPGQLSGGQR
QRVALARAIVSQAPICLMDEPLSNLDAKLRAQMRIEIREIQQRLGITMIY
VTHDQIEAMTMGDRIMVLNKGSIQQVGTPLDIYNKPANEFVASFIGSPSM
NINDGEVDKEKGVLHIGQLQIPLSIGQLKQLPAGTVRVGMRPEHIALSEE
GQEVTLQSVEVLGNESILNFVINGTTWSAKVIGQLLLNKGDKVKLLFSEE
KLCFFNQNTNERLKVVAVEELKVVAK
>BCE33L1647 probable multidrug ABC transporter, permease
MLDRAGALISNRMYTEEEQRKLYKRTLITVSISQMFGGAGLAAGITVGAL
LAQQMLGTDAFAGLPAAMFTMGSAVAAFFVGKLSQKHGRRIGLASGFMVG
GFGAIGVVLAALTNSIILLLISLLIYGAGTATNLQARYAGTDLANKKQRA
TAISITMVMTTFGAVAGPNLVGVMGRFAHSIGIPELAGPFILSAAAFILA
GLVLFVMLRPDPLLVANMIETYKQEHTYKGQPVTEEATENKRGITVGAIV
MILTQIVMVAIMTMTPVHMGHHGHGLSAVGLVIGFHVGAMYLPSLVTGML
IDKIGRTTMSIAGGVILLAAGVIAALAPSDSLILLIVALSLLGLGWNLGL
ISGTAQIVDATIPSTRAKTQGKIDVFIALAGASGGAMSGMVVVNSSYAAL
SLAGGVLAFMLIPVVIWSRKG
>pE33L466_0110 permease, probable multidrug-efflux transporter
MSEPFISQQVQPKYTSMSLFKNRAFLFLWLSSTSSFLALSTYLFAEQWYV
IRALGQESALGIVMMVTLIPRVLLMTVGGVWADRFKRSKIMLVSSFTRFL
LVFVMITLLHLHLLNLWSLLFFALLFGILDAFFSPANQSLLPLLVPKEML
TRSNSFIQTSNQVAMFAGPMIGGWIITVSSFSVLFLFVACFLLITSAFTL
CIKEKKLSISSEQASAKQELLSGFHYVWNMPFLKSILFILMTINVFFFGP
LLMGIPLLANEVLHGKAVEVSFLQSSYQGGMLGGALLIGLLNIRKKRGLS
ILILISFLGISLSFLGQIYVLWQGILLLVIMGFMSSMINVPLVSIIQENS
ETDKLGRVMSFVSASSNGLVPLSYAFVSICLTFGTSISNILLCCGLLITI
LSILFITKYKIVRDTN
>BCE33L1559 multidrug resistance protein; possible tetracycline resistance determinant
MEDVSIGQTDSRMKIATRNIILMMIGKMTSLLGAGIYTFAMGLYVLKTTG
SGMGFATTLVCGSLPRMICGPIAGAVADRVSRRWLVVGTDLLSSLTMLIM
FILATIFGPSLLFIYISAALLSICASFYSVALTSSIPNLVDEGRIQKASA
LNQTAASLSNILGPIIGGVVFGFLSIQSFFLLNSITFFLAVILQLFIVFD
LYKKEVAESKEHFLTSIKEGFSYVKRQHEIYGLMKIALWVNFFACGLTVA
LPYIIVHTLHLSSKQLGTVEGMLAVGMLMGAITLSVRKEVNNPFRSIYTG
LFLFAGLSLCTVFPLLVTIPKVASFIYYIAFMMLTGIAIMIVNIPMQVHM
QKTTDPSYLGRVFGLLETIATAIAPLGMIVYGLLLDMLPTSIVMMTIGGG
LLLVVLVGVRQHMAKKQVDVSA
>BCE33L2339 conserved hypothetical protein; possible regucalcin homolog
MDSNIELVVDAKAILAEGPCWDEKKQLLYWVDIVEKQLCIFSPTANTNRV
IALNQQIGCVVPYLDDVLLLAMENGFYSINVETEKLTHIFDPEPHLFKNR
FNDGKCDPAGRFWAGTTDTYGINAAGSLYCLNNNLKVEKKVSHVNTSNGI
AWSPDHTYLYYIDTPTKKVVRFHYDICSGVIRNPSDVIIFHENDGLPDGM
TIDEEGCLWIAHWGGSKITRWNPSTGEQILSIPIPALYVTSCTFGGPNLT
DLYVTTARTRMTDDELKQYPHAGGIFRIQTNVKGCPTRSFCNNNIGAETL
>BCE33L2169 permease; possible drug/metabolite exporter family protein
MKSPILSYCILFFGVFALSTSAIFVKLADAPATIIAFYRLFFAALILLPL
LLFNQNNRSELKTITRRQWGFGFISGLFLAAHYVLWFESLQYTSVASSTV
IVTLQPLFSMIGGYFLFKERFKKGAVIGCLIAISGSIVIGWQDFQISGEA
LYGDILAFIAAGIITAYFFISQYVRKDLSLIPYSIISYGSSACFLGVFSY
MQNESFTHYSTQTWLCFIGLAFIATILGQTIFNWLLKWMSATVISMSILG
ETIGTCILAYFILNETISLQQGLGITVIFIGLALFLMQPKLPNN
>BCE33L2686 possible permease
MDLLIVLLSLGLLIFVAYRGFSVILFAPLCALLAVLLTEPAYVLPFFSNV
FMAKMVGFIKLYFPVFLLGAIFGKVVEITGIAEKIAKIIIRFIGVKRAIL
SIVLMGAILTYSGVSLFVAVFAIYPFAAQLFREADIPKRLIPATIAFSAF
TFSMDSLPGSPQIQNVIPTTFFKTDIYAAPTLGIVGALFIFICGMLYLEW
CRKKAAAKGEGYFGKGDATSELAATTSVQPVQATIASSDVIPASYWVAFL
PLVLVGVMNKIFTVFIPVWYTKGFDFTSIGLKEYGTIDMGQVIGIWSVEI
ALLMGILSAIILNFQAVKEHFQSITSVGVSGSILAAMNTAAEYGFGAVIA
ALPGFVMIQNYLTGTFSNPLISGAVMTNILCGLTGSGSGGMSITLGLMAE
KYIEAAANFDIPLDVLHRVIAMAAGGMDTLPHNGAVITLLAVTGLTHREA
YKEIFGITIIKTLAVFFVVGVYMMFSIV
>BCE33L1635 sugar ABC transporter, permease
MEDLSIKVVEQKNTHIQKKYKKKKKLDYIWAYVMIAPTMLGLFIFYMWPI
LQNIYFSFTAWDAFGSYEWIGLENYKKMFTDQDLGKAFQNTFIYIVLTVP
ISIFLSIILAVLLNQNIKGKSLYRTLYFLPVITMPAAIAMVWKWIYNSDY
GLLNYMLSCFGIDGPNWLTNPNIALYSIIIVAIWGGIGYNMVIFLSGLQN
IPKTYYEAAIMDGARPITIFFKITLPLLSPVIFFVTIMSLIGAFQVFDLI
FMMIGRTSNVIENTQSIVYLFYQNAFILNEKGYSAAIAVVLLIIILIITA
IQMILQKKWVHYDE
>BCE33L0326 conserved hypothetical protein
MNALYITVEEAAEYLNLPKSYIEELIQQKKIRALFDGEQYLLNKEQFNTH
LEQMEKYKQLVEEILNEPIPEDMDVKDED
>BCE33L1674 multidrug resistance protein B
MASWKRNLMICWLGCFTTAAGMSLVIPFLSFYIEELGVTGTSSIAQWSGL
AFGVTFLMGAIVSPIWGKLGDIHGRKLMLIRASLGMAIIMTLMGFVTDVY
QLVALRFLMGAVSGFLSTAMTFIAAETPKEHSGWAISTISTGGVSGSLLG
PLLGGYLSELIGMRHVFLVTGAFLFLSFLIVFFFLHEENHSAQAKKVQTK
KVWTMVPAKHLIISLFVTTFIIQLANMSVQPIVTLYVKNLVGPQTAHIET
IAGAVMSATGLAVILAAPRLGRLSDHIGPQKTLVVALFAAGIIFIPQAFV
TSAWQLLILRFLLGIAQAGLLPSVQTLLKQHTPTHVTGRIFGYNQSFQFL
GNMIGPILGGQIAAHAGFQYVFFSTSSLLFIACIWVYFHNKNEEVSEKRH
LEVS
>BCE33L4412 acuA, acetoin utilization protein
MSNTLIHKKIYNARNLKTAKGTLIIEGPVSTHNLEMYEFHPDLVAFRPAE
QQYKAIVEISKLPEARLIIARHDQTIVGYVTYLYPDPLERWSEGKMENLI
ELGAIEVVPAFRGCAVGKNLLEVSMMDDYMEDYIILTTEYYWHWDLKQTG
LNVWEYRKVMEKMMNAGGLQWMATDDPEICSHPANCLMVRIGKRVDTDSI
QAFDRLRFHNRFMY
>BCE33L4452 amyX, pullulanase
MLKVKRPFDAYLDEMNKITILLPHAYGTSRTFRLQEGSNVKDLPIAHTIA
LPDATKYECFIEEPLDVGKYYTVRDERNEETDLQIGAVIRTEIFDEKYYY
EGTDLGAVYQKEATTFKVWAPTARLAKVRIYKSDKEYTDHEMHREENGVW
AHTLQGDLAGEKYTFLVCINLIWNEAVDPYAKSVTVNGKYGVVIDLEKTN
VTKRGQLPLLQAMTDAILYELHIRDATIHEGSGVSKKGTYKGLMEEGTTG
QNGTLTGLSHIKDLGVTHVELLPLYCFGGVDEANPSSAYNWGYNPLYYNA
PTGFYATNPSDPYNRIVECKQLIETFHEHGIRVIIDVVYNHVYERELSSF
EKLVPGYYFRHGENGMPSNGTGVGNDIASERKMMRKFIVESILYWLTEYN
VDGFRFDLMGILDVDTINIIEKEVRNIKRDALLLGEGWDLQTPLPLEEKA
TLNNANKMPHIAQFNDQFRDGIKGSTFHINKRGFAFGGHVDRNHLQYIVS
GSLLSMKETGLFLEPVQSINYVECHDNMTMWDKLMRSNEESEEILKKRHV
LATAMVILSQGIPFLHAGQEFYRTKQGNENSYNANDEINQLDWDRKEKEI
ETVNYIKGLIAIRKEHGAFRLQNVDLIKKHMTFLQTSPEVLAYHLEHVES
FGPWKEIVVLFNSSLEAKTVQLPKEETWHVLVNEKQAKIEPISSFRGKEL
RLSPISTYILTIM
>BCE33L4254 aqpZ, aquaporin Z
MLKKAIAEFIGTFVLVLFGTGVAVIGGGIEGIGTLGIAMAFGLSIVAMAY
SIGTISGCHINPAVSVAMFINKRMNAMELCYYVLAQILGGLLGTATLVTI
LQSAKTPLDNLGQNGFGTLGLSGAFLVEFILTFVFILVIVAVTGKKGSSS
LAGLVIGFTLVLVHLLGIPLTGTSVNPARSIAPALFVGGEALSQLWVFIV
APILGGIVAAIVGKFILNTEK
>pE33L466_0350 bgaC, beta-galactosidase
MKSFEIGKDFMLDGEPIKIISGALHYFRIVPEYWDHSLYNLKALGCNTVE
TYVPWNMHEPKEGIFNFEGIADLVKYVQLAQKYGLMVILRPTPYICAEWE
FGGLPAWLLKYKDIRVRSNTNLFLNKVENFYKVLLPMVTPLQVENGGPII
MMQVENEYGSFGNDKEYVRNIKKLMRDLGVTVPLFTSDGAWQEALESGSL
IDDDVLVTGNFGSRSNENLNELESFIKENKKEWPLMCMEFWDGWFNRWGM
EIIRRDGSELAEEVKELLKRASINFYMFQGGTNFGFMNGCSSRENVDLPQ
ITSYDYDALLTEWGEPTSKYYAVQRAIKEVCSDVEQFEPRILPRANYGEI
KLNRKVSLFSTLEKIAKKRHNSYTLTMEDMDQQYGYILYRTFLKGPKNIE
KCKVVDARDRVHLFLNEQLVDTQYRDEIGREVSLDLTKEENTLDILVENM
GRVNYGARLLSPTQRKGISSGVMIDIHLQSNWEHYALEFDNLDEIDFNGQ
WEPNTPSFYEYTFNVQELNDTFLDCSKLGKGFVVLNGFNLGKYWDVGPTG
YLYIPAPLLIKGENNLIVFETEGNYEEELYLRENPIYLDVNYSPLSKA
>BCE33L0860 bglH, beta-glucosidase
MSKVIFPKGFLWGGAIAANQVEGAYVEDGKGLTTVDLLPTGENRWDIMKG
NIHSFTPVEGEFYPSHEAIDFYHRYKEDIALFAEMGFKALRVSIAWTRIF
PNGDDEKPNEAGLQFYEDLFDELLKHDIEPVVTMAHFDVPVHLVEKYGSW
RSRKLVNFFETYAKTIFNRYKDKVKYWMTFNEINMLLHLPFMGAGLAFKE
GDNKKQIQYQAAHHQLVASALAVKACHEIIPDAKIGCMLAAGATYPYTCN
PDDVLRAMEQDRESFFFIDVQARGAYPGYAKRFFKDNNVTIEMEKEDEEI
LKEHTVDYIGFSYYASRATSTDPEVLKSITSGNVFGSVENPYLEKSEWGW
TIDPKGFRITANQLYDRYQKPLFVVENGLGAIDELNDADAVNDAYRIDYL
EKHIIEMSEAIQDGVDIIGYTSWGPIDLVSASTGEMKKRYGYIYVDKDNE
GKGSLKRSKKKSFDWYKEVIKTNGESLES
>BCE33L0859 bglP, PTS system, beta-glucoside-specific enzyme II, ABC component
MKYEKLAKDILKHVGGRENINSVVHCITRLRFQLKDEGKANTEVLKGMED
IVTVMKSGGQYQVVIGNHVSDVYKAVIAAGGFQETEEESASEKKKSSLID
ILSSIFTPILGVLAATGMIKGFNALFVALGWLSNESGTYQILNAVGDSLF
YFFPIFLGYTASKKFGGSPFIGMAIGGALVYPALSGLKASEPLYTLFAGT
MFESPIHITFLGIPVILMNYASSVIPIILAAYFGARVENSLKKVIPDVVK
TFVLPFLTLLIVVPVTFLVIGPIATWAGQFLGQATLWVYHLSPLVAGALL
GAFWQVLVIFGLHWGVVPIGYNNLAVHGIDPILALIFAASFAQIGAVLGV
WVKTKDQKLKTLSIPAFISGIFGVTEPAIYGITLPLKKPFIMSCIAGGVG
GAILGVFGTQAYMTGGLGIFTIPTFISPKDGLTAGFWGAIVSMVVSLLVG
FILTYLFGFTKKQTSTDTEETSNKIAASNDDEVIFSPFHGVVIPLQNIDD
AAFASGALGEGVAIEPSEGKLFSPVSGTISALFPTNHAVGITADSGAEIL
IHIGMDTVKLNGEFFSSHIEQGARVEKGQLLIEFHIAEIQKAGYIVTTPV
VVTNYDRYSMKKTEVEKIQAGDSLLKLGVK
>BCE33L0731 blT, multidrug resistance protein B
MKKPIKEQKMVLVILLSNIFIAFLGIGLIIPVMPSFMNDMGLTGKTMGYL
VAVFAMAQLIASPITGRWVDLYGRKKMIIIGLFIFGVSELLFGLGTDVWM
LYVARVLGGISAAFIMPGVTAYVADITSIQERPKAMGYLSAAISTGFIIG
PGIGGFIAEYGIRVPFFVAAAIAFIACVISIFILKEPLTKEELAEISSNT
KESSFIGDLKKSLHPMYAIAFIIVFVLAFGLSAYETVFSLFSDHKFGFTP
KDIAAIITISSIFGVVVQVFMFGKLVDMFGEKVLIQICLIVGAVLAFVST
VVFNYWIVLLVTCFIFLAFDLLRPALTTFLSKAAGKEQGFVAGMNSTYTS
LGNIAGPAMGGILFDMNIHYPYAFSGVVLIVGLAITFMWREKQLAESFAK
>pE33L466_0298 cbsX, alpha-ketoglutarate permease
MNAISSNKTFMDRMGIPSNLTWGYIGIIVFMIGDGLEQGWLSPYLVEKGL
TLEHAAFLFTIYGITVSASSWFSGVFVQMWGPRKVMTFGLVSFILGSIGF
IGIGIQHMNYSVILICYALRGFGYPLFAYSFLVWVSYSTPQQMLSRAVGW
FWFVFQLGLSVIGAFYSSYMVPKIGEIATLWSALIFVVVGGLFSIVVNKD
KFKAQTVSDNKSSELLKGITIAFENPKVGIGGIVKIINSAAQFGFVVFLP
TYMMKYNFTMTEWLQIWGTLFFVNMVFNIIFGIVGDKFGWVNTIKWFGGV
GCGIVTLALYYVPQMVGHNYWAILFVACCYGATLAGYVPLTALVPSLAPE
NKGAAMSVLNLGSGLSAFVGPLVVTVFIGPLGAGGVMWLFAGLYFFGAFL
THFLTIPKENEMKQDLNTKSGEQFSV
>BCE33L0143 cda1, probable xylanase/chitin deacetylase
MFFFFITSKRNFKHISLIVILSLFTAWLLFLKTYSHESAFSTATGPKVIY
KGDTSKKQVAFTFDISWGDKKAIPILDTLKERDIKNATFFLSAAWAERHP
DVVERIIKDGHEIGSMGYNYTSYTSLETNEIRRDLMRAQDVFTKLGVKQI
KLLRPPSGDFNKATLKIAESLGYTVVHWSNNSNDWKNPGVNNIVSTVSNN
LKGGDIVLLHASDSALQTNKALPLLLQKLKSDGYEQISVSQLISNTSTKS
KDVQ
>BCE33L2211 celA, PTS system, diacetylchitobiose-specific IIB component
MKVLFVCSGGMSSAIVVNALKKEAEKKGMNMEVHAIGTSEVEEEVKNGWD
VVMVAPQVRHRFDSVKKFAEEESIPCGIIPPQAYTPLGGPTLLKTVNDLI
R
>BCE33L0688 celA, PTS system, cellobiose-specific IIB component
MYILLCCAAGMSTSMVVRKMQEEANKQGKAYKIKAVDSELVKLEIKEADV
VLIGPQVKYLFPAVQFLANSYDIPVAIIDQRDYGMCDGLKVLKQAEQLVL
A
>BCE33L4909 celA, PTS system, cellobiose-specific IIB subunit
MNILLCCAAGMSSSLIVTKMEKAAEARGIEVKIWAVSGSEVNSHIDKADV
LLLGPQVRYLLPKMKELCKEKGVPVDVIQSVHYGLCNGEAILQVALSMKP
>BCE33L4903 celB, PTS system, cellobiose-specific IIC component
MQKFIAFMEKYIVPVAGKIGSQRHLAAIRDGFIAVMPLILVGALASLING
FPSEAFQDFMKGLFGETWKQVGGGMWTGSFAILALIIAFTTSYNLAKSYG
VDGLSAGIISFGALIILTPTTPKEGGLNLAWTGAQGLFVAIIVALLVTEV
FRFFVQRNITFKMPDGVPPAVLRSFAAIVPAFVILTVVAGIQLAVKLAGT
SVHEFIFNTIQSPLQSLAGTLPSAIVIVLLVHLLWFFGLHGPNIVGGIIE
PLYLPALEKNMQLFKGGTSAFDVPNIVTKPFFDTFVYLGGSGATLAFLVV
VLLVAKSAQLRGVSRLSIGPGAFNINEPVIFGTPIILNPILFLPFIITPI
VLVITSYTAISIGWVPKTVVMIPWATPPIISGYLVTGGHLSGAILQLFNF
VIAMVIYYPFVVLCDRSVVRTEKAAAQGNNNSVPM
>BCE33L4908 celB, PTS system, cellobiose-specific IIC component
MIRFLEKYVMPVAGKVAEQRHLQAIRDGIILTMPFLIIGSFFLIISALPI
PGYNDFMAGLFGENWQRALGYPVSATFNIMALIAVFGIAYRLGEYYKVDA
LASGALSLVTFLLATPFQVAYIIPSTKESVLVEGAIPAALMGSQGLFVAM
IIALISTELYRFIVQKKIIIKMPETVPPAVTRSFAALVPGFIVVTVIWIV
RLIIENTSFGSIHNIVGQILQEPLSVLGASLWGAIIAVILVHVLWSCGIH
GATIVGGVMSPVWLSLMDQNRVAFQAGQDVPNTITAQFFDLWIYMGGSGA
TLALVVGMLLFARSQQLKSLGRLSIAPGIFNINEMVTFGMPIVMNPILLI
PFILVPVVLTIVSYFAMEWGLVARPSGAAVPWTTPILFSGYLGSGGKISG
VVLQLVNFALAFFIYLPFLKIWDKQKVAEEKGE
>BCE33L2212 celB, PTS system, diacetylchitobiose-specific IIC component
MNKFVTFLDKNLSGPMARLSEQRHLQAIRDGVISALPFIIVGSFFLIVAF
PPLPKDSFISVWALKNQTSILIPYRLTMFIMSLYIAFGIGYNLAKSYKLD
ALSGAQLAVCSLLLTLTPELIDKKGFMLPMTNLGGHGLFVTMIVSILSVE
ILRLCKKNNVTINMPEQVPPSVSRSFEALIPAAFVIIIMSLITVVFKVDV
HYVVDKLAAPLVKAGDSYFGVIIPVFLITFFWSFGIHGVSVVGTVARPLW
DVYLGKNGEAVASGASQFPFIAPEPFYQWFIWIGGSGATLGLVLAMIVFG
RSKYSKALSRTCIVPGIFNINEPVIFGLPIVLNPILIIPFVITPLVTATI
AYAATAMGFVTPTHIMPPWTLPAPIGAYLATGGDWRAIVLVLINIAISFL
IYLPFFKMYDKNMLEIEKNGEGESVNP
>BCE33L0689 celB, PTS system, cellobiose-specific IIC component
MNGFMSFMEQKIMPTTQKIAGQRHLLAIRNGVISTLPLTIVGSFFVIFLN
LPIDAYMEWIAPFRHILDIPFRFTVGLMALYAAFGVGASLANFYQLNQLS
AGLLSVLAFLLASVEPIQITKAVPGVIDAGRYISVGTLSATSLFGAIVTA
LIAVEIYHFMIKHNISIKLPDSVPPAVSNSFAALIPTLAVILLFWGIRYG
LKFDVNTTITYLIAPLKSVLVGNNLFGGLLTVFLIVFFWSFGIHGPAILG
PIIRPMWDSAILENMEVFTATGNAHQLPNLFTEQFIQWFVWIGGSGSTLA
LVIMFMFSKSKFLKELGRLSFVPGLFNINEPIIFGAPIVMNPILIIPFVI
TPLVTTTVSYFAVVSGMIPMMMAKLPFTMLAPIAAIISTDWTIMAGVLVL
VNFVISFVIYYPFFKMYEKQQLAGEEKTECSEQLSS
>BCE33L0687 celC, PTS system, cellobiose-specific IIA component
MADMQTPFALILHGGNARSAALEAIAFARQGDFENASEKMTLASEEISAA
HRIQTDLIQEEARGNYAEISLLLVHAQDHLMNAITVKELAEEFITLHKRM
EEKVIA
>BCE33L4907 celC, PTS system, cellobiose-specific IIA component (phosphotransferase enzyme II, A component)
MDTIETKAFHLILHGGNARSCSMEAIDCAKRGEFTEAEAKLQEALEELKE
AHRVQTDLIQKEAGGEKTEVTLLMVHAQDHLMNAITVKELASEFVELYRK
MSVTE
>BCE33L4902 celC, PTS system, cellobiose-specific IIA component (phosphotransferase enzyme II, A component)
MMTTAEQIPFQLILNSGNARSFAMEALQFAKQGKMAEADEAMVKAKEAIN
EAHHFQTELIQSEARGEKTEISVLLIHAQDHLMNAITVKELAAEFIDLYK
KLEVKGE
>pE33L466_0086 celCCC, endoglucanase
MVEKRTIFTVICACGIGFSSYTNCISAAALDNDTLINNGHKINSSIITNS
SQVSAVAKEMKPFPQQVNYSGILKPNHVSQESLNNAVKNYYNDWKKKYLK
NDLSSLPGGYYVKGEITGNPDGFRPLGTSEGQGYGMIITVLMAGHDSNAQ
TIYDGLFKTARAFKSSINPNLMGWVVADDKKAQGHFDSATDGDLDIAYSL
LLAHKQWGSSGKINYLKEAQNMITKGIKTSNVTKNNSLNLGDWGDKSTFD
TRPSDWMMSHLRAFYEFTGDKTWLNVIDNLYNTYTNFTNKYSPKTGLISD
FVVKNPPQPAPKDFLGESKYTDSYYYNASRVPLRIVMDYAMYGEKRGKVI
SDKVATWIKGKTKGNPSKIVDGYKLDGTNIGDYPTAVYVSPFIAAGTTNS
NNQEWVNSGWDWMKNKKESYFSDSYNLLTMLFLTGNWWKPIPDEKKIQSS
INLEVQSELKEQD
>BCE33L4901 celF, 6-phospho-beta-glucosidase
MTGIKIATIGGGSSYTPELIEGFIKRYDELPVSEIWLVDIEAGKEKLEIV
GNLAKRMVKKSGLPIEVHLTLDRREALKDADFVTTQLRVGLLEARAKDEA
IPLKYDVIGQETNGPGGLFKALRTIPVILDICKDMEELCPNAWLINFANP
AGMVTEAVLRYTNIQRVVGLCNVPIGIRMGLAKLLEVDASRVHVDFAGLN
HMVYGLDVYLDGVSVMDRVLELVTDPEKQITMENIAALNWEPDFIRGLRA
IPCPYHRYYYKTREMLEEEKEASVEKGTRAEVVKQLEDDLFELYKDPNLD
IKPPQLEKRGGAYYSDAACSLITSIYNNKGDIQPVNTRNNGTIASLPHDS
AVEVNCIITKEGPKPIAVGDLPVPVRGLVQQIKSFERTTIEAAVTGDYHK
ALLAMIINPLVPSDKVAKQILDEMLEAHKEYLPQFFKKVEK
>BCE33L0359 chiA, chitinase
MKSKKFTLLLLSLLLFLPLFLTNFITPNVLLADSQKQGQKIVGYFPSWGI
YGRNYQVADIDASKLTHLNYAFADICWNGKHGNPSTHPDNPNKQTWNCKE
SGVPLQNKEVPNGTLVLGEPWADVTKSYPGSGTTWEDCDKYARCGNFGEL
KRLKAKYPHLKTIISVGGWTWSNRFSDMAADEKTRKVFADSTVDFLREYG
FDGVDLDWEYPGVETIPGGSYRPEDKQNFTLLLQDVRNALTKAGAEDGKQ
YLLTIASGASQRYADHTELKKISQILDWINIMTYDFHGGWEATSNHNAAL
YKDPNDPAADTKFYVDGAIDIYTNEGVPADKLVLGVPFYGRGWKSCGKEN
NGQYQPCKPGSDGKLASKGTWDDYSTGDTGVYDYGDLAANYVNKNGFVRG
WNDVAKVPYLYNATTGTFISYDDNESMKYKTDYIKTKGLSGAMFWELSGD
CRTSPKYSCSGPKLLDTLVKELLGGPITQKDIEPPTNVKNIAVTNKNSNS
VQLNWTASTDNVGVTEYEITAGEEKWSTTTNSIAIKNLKPNTEYTFSILA
KDAAGNKSQPTSILVKTDDANTTPPGGNSNATFSVTSNWGSGYNFSIVIK
NSGTTSIKNWKLEFDYNGNLTQVWDSKISSKINNHYVITNVGWNGEIPPG
GSITIGGAGTGTPAELVNASISEN
>BCE33L3483 chiA, chitinase
MLNKFKFIYCTLVIFLLLPLAPFQAQAANNLGSKLLVGYWHNFDNGTGII
KLRDVSPKWDVINVSFGETGGDRSTVEISPVYGTDAEFKSDISYLKSKGK
KVVLSIGGQNGVVLLPDNAAKQRFINSIQSLIDKYGFDGIDIDLESGIYL
NGNDTNFKNPTTPQIVNLISAIRTISDHYGPDFLLSMAPETAYVQGGYSA
YGSIWGAYLPIIYGVKDKLTYIHVQHYNAGSGIGMDGNNYNQGTADYEVA
MADMLLHGFPIGGNANNMFPALRSDQVMIGLPATPAAAPSGGYISPTEMK
KALDYIIKGIPFGGKYKLSNESGYPAFRGLMSWSINWDAKNNFEFSSNYR
TYFDAIPLQK
>BCE33L2421 choA, chitosanase; glycosyl hydrolases family 8; endoglucanase
MNGKRNIFTCISIVGIGLASFSNSSFAASVTDNSIQNSIPVVNQQVAAAK
EMKPFPQQVNYAGVIKPNHVTQESLNASVRSYYDNWKKKYLKNDLSSLPG
GYYVKGEITGDADGFKPLGTSEGQGYGMIITVLMAGYDSNAQKIYDGLFK
TARTFKSSQNPNLMGWVVADSKKAQGHFDSATDGDLDIAYSLLLAHKQWG
SNGAVNYLKEAQDMITKGIKASNVTNNSRLNLGDWDSKSSLDTRPSDWMM
SHLRAFYEFTGDKTWLTVINNLYDVYTQFSNKYSPNTGLISDFVVKNPPQ
PAPKDFLNESEYTNAYYYNASRVPLRIVMDYAMYGEKRSKVISDKVSSWI
QNKTNGNPSKIVDGYQLNGSNIGSYPTAVFVSPFIAASITNSNNQKWVNS
GWDWMKNKRESYFSDSYNLLTMLFITGNWWKPIPDNKKAQNQINDVIYEG
YDN
>pE33L466_0295 csbC, probable metabolite transport protein
MIRVGGEWMYTETKEKKQSPNKMVRKIAFISTFGGLLFGYDTGVINGALP
YMSDSNQLDLNPFTQGLVASSLLLGAAFGALFGGRLSDYNGRRKNILYLA
LLFFISTLGCTLAPNTTLMVICRFILGLAVGGASVTVPTFLAEMSPAETR
GQIVTQNELMIVTGQFLAFTCNAILGNVLGDVGYVWRLMLVIASLPAVVL
WFGMLIVPESPRWLASKGKIGDSLRVLKQIREENQANIELEEIKSALAED
SKLEKSSFKDLSTPWVRRILFLGIGVAIVNQINGVNAIMYYGTEILKNTG
WGTKAALIGNVANGVISIAAMLVGIWLLGRVRRRPMLIIGLCGTTTSLFL
IGFFSFILNGSVMLPYIVLSLTVIFLAFMQGAIGPVTWLTLAEIFPLRMR
GLGMGFSVFWMWIVNFLISLSFPVLLSKIGLSATFLLFGILGLVAIAFVN
KYLPETKGKSLEELEHYFRSYDDQGLENKQAR
>BCE33L2250 csbX, alpha-ketoglutarate permease
MNAISSNKTFMDRIGIPSNLTWGYIGIIVFMIGDGLEQGWLSPYLVEKGL
TLEHAAFLFTIYGITVSASSWFSGVFVQMWGPRKVMTFGLVSFILGSIGF
IGIGIQHMNYPVILICYALRGFGYPLFAYSFLVWVSYSTPQQMLSRAVGW
FWFVFQLGLSVIGAFYSSYMVPKIGEIATLWSALIFVVVGGLFSIVVNKD
KFKAQTVSANKSSELLKGITIAFENPKVGIGGIVKIINSAAQFGFVVFLP
TYMMKYNFTMTEWLQIWGTLFFVNMVFNIIFGIVGDKFGWINTIKWFGGV
GCGIVTLALYYVPQMVGHNYWAILFVACCYGATLAGYVPLTALVPSLSPE
NKGAAMSVLNLGSGLSAFVGPLVVTAFIGPLGVGGVMWIFAGLYFFGAFL
THFLTIPKENEIEQDLNTKSGEQFSV
>BCE33L3844 deoB, phosphopentomutase (phosphodeoxyribomutase)
MNKYKRIFLVVMDSVGIGEAPDAEQFGDLGSDTIGHIAEHMNGLQMPNMV
KLGLGNIREMKGISKVEKPLGYYTKMQEKSTGKDTMTGHWEIMGLYIDTP
FQVFPEGFPKELLDELEEKTGRKIIGNKPASGTEILDELGQEQMETGSLI
VYTSADSVLQIAAHEEVVPLDELYKICKIARELTLDEKYMVGRVIARPFV
GEPGNFTRTPNRHDYALKPFGRTVMNELKDSDYDVIAIGKISDIYDGEGV
TESLRTKSNMDGMDKLVDTLNMDFTGLSFLNLVDFDALFGHRRDPQGYGE
ALQEYDARLPEVFEKLKEDDLLLITADHGNDPVHHGTDHTREYVPLLAYS
PSMKEGGQELPLRQTFADIGATVAENFGVKMPEYGTSFLNELKK
>BCE33L0870 dhaL, dihydroxyacetone kinase
MKKIINKPETLVMEMCNGMVMAHPELELLKKYKVIKKKEMNENKVTLISG
GGSGHEPAHAGLVGKGMLDAAVCGDVFASPSQIQVYQAIKETASKKGTLL
IIKNYSGDIMNFKNGAHLATEDGIEVDYVKVDDDIAVEDSLYTVGRRGVA
GVILVHKIAGAAAEAGMDLGAVKAVAEKAAANVRTIGLALTSCTVPASGS
PTFTLAEDEMEYGVGIHGEPGIKREKMLSADELANRMTNDLVKDLGVKDG
EEIALLVNGFGGTPLQELYLFNNAVTRELAARNIKINRVFVGNYMTSIDM
AGMSLTVMKLDGELKTLLSKECNTPAFKVDGPVESVEYVNVLEETEEKEV
SFELETAEEHAVIKDNVITLNNMIYLVDKMSDIIIKNEVPFCELDTHAGD
GDFGMSVAKGFKQLKREWHSIVEQENVTIGSFLDGCSMIIMEHCGGASGP
IWGGAFRAASKAAGEKRELTVKEFAEMLQAALQGIQSIGERSFGRGAVVG
DKTLVDALAPCVDSWLASASDEVDMKTAFEKGAEAAVKGAEYTKEIVARM
GRAGTVGERSLGYPDAGAHALGVIFTEIAGSLK
>BCE33L0873 dhaL, possible dihydroxyacetone kinase, C-terminal region
MCSYILNIVKTAFEKGAEAAVKGAEYTKEIVARMGRAGTVGERSLGYPDA
GAHALGVIFTEIAGSLK
>BCE33L0868 dhaL, dihydroxyacetone kinase
MKKIMNDVQNIVQDMMHGFYFEHNDKVNYDETNNIIYVKDIEKLKQNVAI
ISGGGSGHEPADIGYVGKGMLTAAVNGSIFTPPTVEQIVMATRLMPKDKS
ILFIIKNFKDDVENFLAAEQIAKGEGRKIDHIIVNDDVSIEDDASFNKRR
RGVAGTVFVQKILGSAALEGHSLEELTALGRSITENLHTLGVALSPANDP
VKGKASFTLNDDEVFYGVGIHGEKGYRKEALSSSEILAIELMNKLKSIYR
WRKGDNFAILINGLGATPLMEQYIFANDIRRLCELEGLHVKFVKVGTLLT
SLDMKGVSLSLLKVEDLDWVKWLKADARVGSW
>pE33L466_0361 ebrB, probable multidrug resistance efflux protein
MDILDKSIGIFDAKYRALTIGIILAVTTVAFEGLAITTIAPNLARNLHAL
HLYGWIFSSFLLAQIVGTMIIGQQINKNGVFTSFVASILFFVIGIVIAAT
SLNMIMLIVGRVFQGFGAGAIITCVYYSITLGYPDKLRTKILAVFSSAYI
LPALIGPYIAGLLAELFSWRVVFWMVLPFIGLAVVLTLPAYRKFSVKEKE
ASKNIRKEGYAVVLAIGTGLLMMGLGSITDWKGMVLSAVGVLFMIQPLRK
LLPGGTFSARKGLPATIASRGLFVACYTATESYVVLALTEVKKMPADLAG
LIVAAGALSWSMAAWIQSKFDAKDHGAGRNKRVTAGICFMVIGVAAVMLA
VGLPGGGIVFAVISQIFIGFGIGLAHPTTGAIALQHANAGEEGEISASLQ
FTDAFSPGLSIGIGGAFIAVSQSLNLGLLTGILLALSLQLFFVILSLSIS
FRIKQTKLASEDDLSIPK
>BCE33L2608 emrB, multidrug resistance protein B
MVEKNNKLGFVVAGLLLGILMASMDNTIVVTAMGTIVGDLGGLENFVWVV
SAYMVAEMAGMPIFGKLSDMYGRKRFFIFGLIVFMVGSALCGTAENITQL
GIYRAIQGIGGGALVPIAFTIVFDIFPPEKRGKMGGLFGAVFGLSSIFGP
LLGAYITDYISWHWVFYINLPLGVLALIFITFFYKESRVHRKQKIDWFGA
ITLVGAVVSLMFALELGGQKYDWDSSFILSLFGGFVILIIAFIFIERKVE
EPIISFEMFKQRLFGMSTIIALCYGAAFMSATVYIPLFIQGVYGGSATNS
GLLLLPMMLGSVVTAQLGGFLTTKLSYRNIMIISAVIMLIGLFLLSTLTP
ETSRALLTVYMIIIGFGVGFSFSVLSMAAIHNFGMEQRGSATSTSNFIRS
LGMTLGITIFGMIQRTGFQDQLEEAFKGMSGGMNTNTLGDSRAILSESAR
SQIPPQILDKIIDALSSSIVQTFMWALVPAGLAFLFIFFMGNERMVIKKQ
QKNKKNETSKA
>BCE33L4310 emrB, multidrug resistance protein B
MSSIVIAGYALFCIIVFFLVNRLLRKKKTKMGEEQVPAVSKIEVSKVETE
EKDIEHKQEPEISNVVELETGKQEEVKQEKEVPKKQMSMPVENVNVKAVV
AVLILGMFVSILNQTIINVALPPLMNEFNVSTSTAQWLITGFMLVNGILV
PISAFLVSRFTYRKLFVAAMLFFTVGSIICATSGNFTMMMTGRVIQAVGA
GILMPVGMNIFMTLFPPHKRGAAMGLLGVAMILAPAIGPTVTGWVIENYS
WNLMFYAMFIIGLIITFLSLKFFTLAQPVSNTKLDIFGVVSSSIGLGSLL
YGFSEAGNNSWTSAEVIISLVIGVIGLALFIWRELTTDNKMLDLQVFKYP
VFTFTLVINAIVTMALFGGMLLLPVYLQNIRGFTPIESGLLLLPGSLIMG
IMGPVAGKLFDKYGIRPLAIIGLAITTYATYEFTKLSMDTPYSVIMTDYI
IRSIGMSFIMMPIMTAGMNALPMKLISHGTATQNTSRQVAGSIGTAILIT
LMTQQTTAHVADYGNMLTTSNPILVDKVHGMGQSLAALAGSAQAGDAMST
QLLFGQISKLSAINGINDAFLIATILAGIAWVLSFFLPSGNKPNRKAGN
>BCE33L0744 emrB, multidrug resistance protein B
MGFWSMHRNIKIRIITSFLTRTVSTMIFPFMAIYFSIKLGSAIAGALLLI
NVMASLVIGLYGGYVGDRLGRKKVMIIGQSIQVISIACMGIANSDYVDSP
WLTFVFMLVNSLGSGLMNPATEAMLIDVSTPENRKVMYSINYWAINLSIA
IGAIFGGLLFENYRLQLFIVLTLVAIITLYVMAVYMEEVYVARKTVEKKN
VLKDMADSYKVVMKDRAFLIFCAASICTLSLEFQINNYLGIRLQKEFETV
HFFFGNGFTFDLTGIRMLSWISAENTILVVLCSALLIKMLKSFNDLKILY
VGLFIYTIGFTILGTSNSLWILLIAGLFQTVGEMMYVPVRQSIMADMVPN
EARGSYMAINGMVFQVAKMNGALGVMLGSFLASWGMSALYFIVGMGSILL
FMKAIGREKYEGEVSQIG
>BCE33L4824 eno, enolase
MSTIIDVYAREVLDSRGNPTVEVEVYTESGAFGRAIVPSGASTGEHEAVE
LRDGDKSRYLGKGVMNAVNNVNEAIAPEIVGFDVTDQAGIDRAMIELDGT
PNKGKLGANAILGVSMAVAHAAADFVGLPLYRYLGGFNAKQLPTPMMNII
NGGSHADNNVDFQEFMILPVGAPTFKESIRMGAEVFHALKAVLHDKGLNT
AVGDEGGFAPNLGSNREALEVIIEAIEKAGYKAGENVFLGMDVASSEFYN
KETGKYDLAGEGRTGLTSAEMVDFYEELCKDFPIISIEDGLDENDWDGHK
LLTERLGDKVQLVGDDLFVTNTQKLAEGIEKGISNSILIKVNQIGTLTET
FEAIEMAKRAGYTAVVSHRSGETEDATIADIAVATNAGQIKTGSMSRTDR
IAKYNQLLRIEDELGEIAVYDGIKSFYNIKR
>BCE33L2256 fba, fructose-bisphosphate aldolase, class II
MPIVQMKDILIKANQENYGVGAFSVANMEMVMGAIKAAEELSSPLILQIA
EVRLNHSPIHMIGPLMVAAAKKATVPVVVHFDHGMTFEKIQETLEIGFSS
VMFDGSHYPLEENIQKTKEIVELAKQYGATVEAEIGRVGGSEDGSEDIEM
LLTSTTEAKRFAEETGVDVLAVAIGNAHGMYNGDPNLRLDRLQEINEVVH
IPLVLHGGSGISPEDFKQCIQHGVRKINVATATFQNVITAVNTAVLNTPY
ADYFTYHQDVIKAAYENVKSHMQIFGSENRA
>pE33L466_0305 fba, fructose-1,6-bisphosphate aldolase
MPLVQMKDILIKAKQENYGVGAFSVANMEMVMGAIKAAEELSSPLILQIA
EVRLNHSPIHMIGPLMVAAAKKATVPVAVHFDHGMTFEKIKETLEIGFSS
VMFDGSHYPLEENIQKTKEIVELAKQYGATVEAEIGRVGGSEDGSEDIEM
LLTSTTEAKRFAEETDVDALAVAIGNAHGMYYGDPNLRLDRLQEINEVVH
IPLVLHGGSGISPEDFKQCIQLGVRKINVATATFQNVITAVNTAVLNTPY
SEYFMYHQDVIEAAYENVKSHMQIFGSENRV
>BCE33L2700 fbaA, possible fructose-bisphosphate aldolase
MTWGFKNRLNTILPDGRAVMLAIDHGYFLGPIHGLEQPLETVKNLLPYTD
SLFLTRGVLSSCIPENCSTPMVMRVSGGATVVGKDLANETIVTPVKEAVK
QNAIGVGVSVFVGSDYETQTVTNLANVVSEAHDYGLPVLGITAVAKELQK
REARFLALASRVCVEMGADIIKTYYCEGFEKITSTCPAPVVIAGGPKLDS
IEDALNITYNALQEGAIGVDMGRNIWQSEHPAAMIQAIHGIVKNGLNVKE
ALELYNDVKN
>BCE33L4688 fbp, fructose-bisphosphatase(fructose-1,6-bisphosphat ase)
MERELALEIVRVTEAAALASAQWMGRGKKNEADDAATTAMRDMFDSVNMA
GTVVIGEGELDEAPMLYIGEELGTGNGPEVDIAVDPLEGTNIVAKGLANA
MAVIAIADKGNLLHAPDMYMEKIAVGPKAAGKISLDDPIEKTIEIVAEAN
NKKIRDLTVIVQERERHQDIIDRVRAKGARVKLFGDGDVGASIATALPGT
GIDLFVGIGGAPEGVISAAALKCLEGEMQARLVPMNEEEEARCREMGLED
PRQLLMLDDLVSGDDAIFSATGVSAGELLDGVKFLGGDLAETYSIVMRYK
TRTVRFIKTHHHLDHKPHLNLDI
>BCE33L3476 fruA, PTS fructose-specific enzyme IIBC component
MKITDLLKRDTVIMNLTASNKEAVIDELVEKLNGANRLNSKVEFKEAILK
RESQSTTGIGEGIAIPHAKTKAVKQPAICFGRSVSGINYESLDGQPAHLF
FMIAASEGANNTHLETLSRLSTLLMDEGFRKQLLEAKDEEELLRLFDEKE
NEKEETDIEVAKPEGNEPYVLAVTACPTGIAHTYMAADSLKAKAAELGIV
IKVETNGSTGIKNGLTKEDIERATAIIVAADKQVEMNRFAGKHVIQVPVA
DGIRKTEKLLNRAVKQDAPIFKGVKEDGKAENTEKENGLGIYKHLMNGVS
NMLPFVVGGGILIALAFSFGGIKAEGPLAELFMSIGGGGTGAFLFLVPIL
AGFIASSIADRPGFMPGVVGGFLAAHANAGFLGGLIAGFLAGYVVLGLKR
LFSGLPVQLEGIKPVLLYPVFGLLITGVVMQKVVIPPVVALNEMLTGWLN
GLNGTNAILLGLILGAMMAIDMGGPINKAAFTFGIAAIEAQNFGVHSAVM
AGGMVPPLAIALATTFFKSKFTEAERKSGLTNYIMGASFITEGAIPFAAA
DPVRVIVSCVVGSSIAGALSMLFQITLPAPHGGLFVIALVNKPVLYIFSI
LIGAVVSALMMGIWKKKVK
>BCE33L3477 fruB, 1-phosphofructokinase
MIYTVTLNPSIDYIVQVNSLELGAVNRAEKDMKFPGGKGINVSRVLHRLG
VKNVALGFTGGFTGRFIKDVLQTEGVITNFIQVNEDTRINVKIKGEEETE
LNGQGPSVTNEQFEQLMKQIESMQKGDCVVLAGSVPASIPTTFYESIAAF
GAEKGIRVVVDASGSALQHVVKNKPFLIKPNHHELGELFGVEISTAEDIL
PYGRKLIEQGVEHVIVSMAGDGALLFTTEGIYEATVPKGVVINSVGAGDS
LVAGFVGKYEQTKDIEKAFQYGVATGSATAFSADLCEKEKVEELLSQVIV
TKR
>BCE33L3478 fruR, transcriptional regulator, DeoR family
MLTPERHQMILQLVKEQKVVKLQQLVERTASSESTIRRDLAQLEKQRLLK
RVHGGAAVLTGKGQEPTMVEKSSKNIQIKQQIAKYAASVVEQGDCIYLDA
GSTTFEMIPFLINKDVTVVTNGLMHIEALVENNIRAYLLGGMMKSRTKAL
IGAMAQESMQKYRFDKCFLGANGVHEQLGFTTPDPEEALLKQMALTLANE
GYFLIDESKFSEVAFAKIANVEEANIITNHLEIDLEKYKRQTNVIEADKQ
>BCE33L1652 fsr, fosmidomycin resistance protein
MQAVSQKNTVETPTIYRILFAISFGHFLNDSMQAVVPALFPILEKTMNLS
YMQVGWIAFALNMTSSIMQPVFGMYSDKKPSPFLLPLGMFSSMLGMIGLA
FAPNFIIVIISVLFIGLGSAVFHPEGARVAYMAAGTKRGLAQAIYQVGGN
TGNSLAPIFTALIFVPLGQIGSLGFTAFAAVGIVLLIFVSNWYRNELATG
AVRRKKRAALEAENAIVSTHIKFVIVLLVFLTFVRSWYGAGIGNFYQFYL
IEHYGLSIKNAQYFVFAFMIAGVLGTFFGGPLADRFGKKTIIVFSMLGSA
PLALLLPHVSLVWVVPLFLCIGFISSSSFSVIVVYAQELVPGKVGMVSGL
IVGLAFGLGALGSVVLGKLADIYSLQFIMLLCSCLPLIGLTSWLLPSDKK
TIE
>BCE33L0320 fucA, L-fuculose phosphate aldolase
MLLQKEREEIVAYGKKMISSGLTKGTGGNISIFNREQGLVAISPSGLDYY
ETKPEDVVILNLDGEVVEGERKPSSELDMHLIYYRNREDINALVHTHSPY
AKTIASLGWELPAVSYLIAFAGPNVRCAPYETFGTKQLAEAAFEGMIDRR
AVLLANHGLIAGANHIKMAFTVAEEIEFCAQIYYQTKSIGEPKLLPEDEM
ENLAKKFEGYGQQ
>BCE33L3084 g6pD, glucose-6-phosphate dehydrogenase, NAD-binding domain
MDSMTFLLFGATGDLAKRKIYPALYKLFSNGNITQSISIIGIGRRVMSDV
EFQTKVEQSLATFSRRSTDDELGVEEFISTFRYCQLNTVNIEDYQDLLSL
VKRRETELNIPENRMFYLSVIPEVFDVIALNIKEIGLWATKGLKRLIIEK
PFAHHVTSAHEFNEKLIEDFDETDIFYIDHYL
>BCE33L0418 galE, UDP-glucose 4-epimerase (NAD-dependent epimerase)
MSKKCLITGGAGFIGSHLAEELVRRGYNVTIVDNFYKGKNKYHDELMKEI
RVIPISVLDKNSIYELVNQHDVVFHLAAILGVKTTMEKSIELIETNFDGT
RNILQAALKGKKKVVFASTSEVYGKAKPPFSEEGDRLYGATSKIRWSYAI
CKTLEETLCLGYALEGLPVTIVRYFNIYGPRAKDGPYAGVIPRFISAALQ
GEDILVYGDGEQTRCFTYVSDAVEATIRAMDEKVNGEIINIGSENEKSIK
EVAEVIKKLTDSSSKIVQVPFEEVYPHGFEEIPNRRPDVTKLKDLVQFQA
KVTWEDGLKETIKWFREEDNG
>BCE33L0531 galE, NAD-dependent epimerase; possible UDP-glucose 4-epimerase
MKKILVTGSLGQIGSELVMKLRDVYGASNVIATDIRETDSEVVTSGPFET
LDVTDGQKLHDIAKRNEVDTIIHLAALLSATAEKNPLFAWNLNMGGLVNA
LEAARELNCKFFTPSSIGAFGPSTPKDNTPQDTIQRPTTMYGVNKVAGEL
LCDYYHQKFGVDTRGVRFPGLISYVAPPGGGTTDYAVEIYYEAIKKGTYT
SYIAEGTYMDMMYMPDALQAIISLMEADPSKLVHRNAFNITAMSFEPEQI
AASIRKHIPTFTMDYAVDPARQTIADSWPNSIDATAAMKEWGFKAEYDLD
KMTTDMLAKLKKKLTAELVMN
>BCE33L3072 galE, UDP-glucose 4-epimerase
MKKILVTGGSGWIGKYVVHFLIQKGYEVHATYNTNQPSHLSCYWHKVNLL
CDEEIEKLIYDIKPSHLIHLAWEAVPPACYVSINNYYWLTSSISLIQHFT
TCGGKRVVVAGTGAEYEWFNGVLFEDSQLLSYKTPYSLCKNALHSWLQTY
AKQTGLSMCWGRIFHMYGPHEQGNRLVSNIITSLLKNEEALCTHGKQSRD
FLHVSDVADALVTVLEHGVTDTINIASGQSVQIKELASIIAKKIGKEHLI
KLGAIPFSKDEPLFVGVNVERLKTEVNWKPTYDLNTGIEETILWWESFIK
KHNGTHH
>pE33L466_0355 galK, galactokinase
MEKKRELALKFAEIFGDQETTQYFSPGRINLIGEHTDYNGGYVFPASITY
GTYGVARRREDDRVLVYSTNFEKLGVIDFTVNELNYDKNDNWANYVKGVL
LTLKEAGHKIDFGFELLVEGTIPNGAGLSSSASLELLVGVVLEHLFNLDV
TRLELVKMGKKVENEFIGVNSGIMDQFAIGFGEEDKAILLDTNTLEYEMV
PVILNDYAIVIMNTNKRRELADSKYNERRAECEEALACLQTKLEIKAFGE
LSKAEFDANQILIGDEILIKRAKHAVYENERTKKAKEALTANDLEEFGKL
LNASHASLRDDYEVTGLELDTLVAAAQKQEGVLGARMTGAGFGGCAIALV
KENEIHAFKNKVYDEYLKVIGYAPVFYVAHIGCGTTVIG
>pE33L466_0354 galM, aldose 1-epimerase
MNITTKDFGAGYTSITITNLNGLQLTVSDLGARITSLKVPTTNGLRELIL
GFDTAKEYLEKDLYIGASIGRVAGRIRNGTFQIDGEIYKVQVDEKTGNTL
HGGTPGFESKKWQYCVGENDDETSVIFHMVSPHGENGFPGNLDIEICYTL
TNTNVWKVETRATSDKDTLFNPTNHVYFNLTGDVAQPVNEHTLWVDSDRF
APLDFESVPIGVKLPVEGTAFDFRKPVKLKKTFSSNFVQKELVDGIDHPF
FLNRPEISQSSVKLTSPDEVVSIEVATKEPSVVIFTANFGENTPLMHGKQ
LANHGGITFETQVCPGAEQFSDFGDMVLRADSIYQTVTEFHII
>pE33L466_0356 galT, galactose 1-phosphate uridylyltransferase
MKISQAIYDFTTLAINNGAIEEVDRIYTHNQLLRLIGESDIGEITSVVET
NPHVLLNTLLGMAMENLSISQNQVNRDMFEALLMDVITPLPSKVNANFQK
AYRKGPKQATDYFFELSKRNDYIKTRAIEKNIQYVAESKYGELEITINLS
KPEKDPKEIMAARNISTSNYPKCLLCIENEGYFGRLNHPGRSNHRIIDIE
LDGEEWGFQYSPYAYFNEHSIVLSKKHRPMKISRETFSRLFSFVETMPHY
FIGSNADLPIVGGSILSHDHYQAGRHIFPMAKANVLKTFELPAYPNTSCG
IVNWPMSVIRLSSLNKEELINASTYIHESWKNYSDESLQICAQSKDGTKH
HTITPIVRRGEEKYEIDLVLRDNNVSEEYPDGIFHPHQDVQHIKKENIGL
IEVMGLAILPPRLIKELHEIELYLLDKGEYVPEIHQKWADELKAQGGYTE
ENIQRFLQIEVAKKFERVLEDAGVYKVNKEGRAGFERFIKELQGMN
>BCE33L4828 gap, glyceraldehyde 3-phosphate dehydrogenase
MTKIGINGFGRIGRNVFRAALNNSEVEVVAINDLTDAKTLAHLLKYDTVH
GTLNAEVSANENSIVVNGKEIKVIAERDPAQLPWSDYGVEVVVESTGRFT
KKSDAEKHLGGSVKKVIISAPASDEDITVVMGVNHEQYDAANHNVVSNAS
CTTNCLAPFAKVLNEKFGVKRGMMTTIHSYTNDQQILDLPHKDLRRARAA
AENMIPTSTGAAKAVALVLPELKGKLNGGAVRVPTANVSLVDLVVELDKE
VTVEEVNAAFKAAAEGELKGILGYSEEPLVSIDYNGCTASSTIDALSTMV
MEGNMVKVLSWYDNETGYSNRVVDLAAYMTSKGL
>BCE33L4324 gap, glyceraldehyde 3-phosphate dehydrogenase
MTRVAINGFGRIGRMVFRQAIKESAFEIVAINASYPSETLAHLIKYDTVH
GKFDGTVEAFEDHLLVDGKMIRLLNNRDPKELPWTDLGVEVVIEATGKFN
SKEKAILHVEAGAKKVILTAPGKNEDVTIVVGVNEDQLDITKHTVISNAS
CTTNCLAPVVKVLDEQFGIENGLMTTVHAYTNDQKNIDNPHKDLRRARAC
GQSIIPTTTGAAKALAKVLPHLNGKLHGMALRVPTPNVSLVDLVVDVKRD
VTVEAINDAFKTVANGALKGIVEFSEEPLVSIDFNTNTHSAIIDGLSTMV
MGDRKVKVLAWYDNEWGYSRRVVDLVTLVVDELAKQENVQHI
>BCE33L0146 garK, glycerate kinase
MEIVMKVVIASDSYKESLKAIEVCEAIERGFEAIFPKAEYVKIPIGDGGE
GTVDSLVDAARGRIISLHVTGPLRERVQAFYGMSKDKKTAFIEMAAASGL
QHVPVKKRNPLVTTTKGTGELILHALDEGAKHIILGLGGSATNDGGAGML
SALGVRFINGKGEVIDPSGGTLHSIVSIDFSQMDSRLKHIKIEAACDVDN
PLVGIRGASFVFGRQKGADEEMMKGLDENLKHYAHILKQYLYCDISKIPG
AGAAGGMGAAVIAVLKGNLRRGIEIVLDYTNFDKHIEGADLIITGEGRID
EQTAYGKAPVGVAERAKHFHIPVIAIGGSVSSNYTAVHEKGIDAVFSITT
SPMTLEEAYKVAEENIEMTAKNIAAVWKIASEKHF
>BCE33L2853 gerAA, spore germination protein
MSWWKSRDKQVKKNNIQSKTKQEYKPSQNTIVHFTNDFASNLELIKQQIG
HNSDVRFRKFNIGRTDIQAGIVFVDGLSDKEIIDKHIMKLLMDDFSDEYK
NESSYVEGTVSKEYIKNKVLTISEVAEVHYIKDLIPKVLIGSTALLIDGL
ADVFILGTTKANKRNIEEPVSEALVRGPRVGFTEVLSDNTSLLRRHCADE
SLSLVKLPVGERAKKELVVAFINDLASTELVDEIKNRIQKIDIDSVLESG
YIEQLIEDNYLSPFPQIQNTERPDRVISALMEGRVAILLDGTPFVLIAPV
TFSMLLQSPEDYYERWLPGTLLRLLRFMTAFVSLFAPALYISFISFHPGL
IPTKLAISIIGSREGVPFPALIEALIMEVAIEVLREAGLRLPKPIGPAMG
IVGGLIIGQAAVEAGIVSPIMVIVVAVTAISSFTIPQYSVGITLRILRFV
AMFCAAIFGLYGVILFFLLLCSHLVKLKSFGVPYTSPAVPYRFSDWKDFM
VRMPLKIMRRRPKIMHTKKTIRKR
>BCE33L0546 gerKA, spore germination protein KA
MTEQKEQQESTGQKHMFPSLPENINYIENKLCHSDDIKKLDLPFQNGKGT
ILYIESLADPNLIHQLALEPLLTRSDLSLDKAFATLNMKKETNLNYGVQL
LLQGKSLYFHEHVDSFCIFETAISLKRDIAEPDNEGIVRGPHTGFVEDLA
TNLTSIRKLIKSPNIVVKYFTLGEEMHTKVAIAYMQNIANDDLVTEVKRR
LETIKTDALMPPGYIQEFIEDTSFSPFPQQLNTERPDRVAANLMEGRVAI
LSDGDPTALIVPVTLFAFYQSPDDYNNRWIVGSFVRMIRLVSFLIAFLLP
AIYIATVAFHPDVLPLELVYTIKASLEKVPLPPIFEALLMELIFELLREA
GIRLPSRVGQTIGIVGGLVIGDAIVKAGLVSYTMIIVVALTAISSFLVPS
NDMSSAVRILRFPLMLLAAIFGYVGISFGLIITFVHLCQLHSFHTPYLSP
VAPMRIKDMKDSFVRLPIWSFWERPHDPKPKKMQRQHVTREEEDGDKHAK
>BCE33L1643 glcK, glucokinase
MGKYVACFDIGGTFIKYAMIDEQGMVHEQGKITTPVQNQKKEILYRICEV
IYEFEKSYKIHSVGVSSCGIIDNIKGEVLYSANILGYSGTKIADYIYSET
GYVASIENDVRSACLGEMWKGVGQGKEHIVLITLGTGIGSGIIINGKMLQ
GVKGLAGELGHMIIVHNGEKCSCGGEGCYERYASTSALIRQYKEASKIQG
LEIGTITGEEIIERMYRGERLAKDVYEQFLQYVVAGLVNITYIFNPELII
IGGGITEQGEPFLKQIQERFHDKIMDIYQNKVEIALASLHNDAGVYGACY
VALNQCEEKSMNI
>BCE33L4014 glcK, glucokinase
MEEKWLVGVDLGGTTIKLAFINVYGEILHKWEIPTNTNEQGKHITLDVAK
AIDKKLEELGELKSKLIGIGMGAPGPVHVASGMIYEAVNLGWKNYPLKDL
LEVETGLPVVIDNDANLAALGEMWKGAGEGAKDLICMTLGTGVGGGVIAN
GEIVHGVSGAAGEIGHITVVTENAFPCNCGKSGCLETVASATGIVRVAMQ
KIQETDKESILRSMLAEEGRITSKDVFEAHGQGDELAGEVVEKVASYLGL
AVANLSSTLNPEKIVIGGGVSKAGDALLEPIQRYFEQYAFSRAVKSTKLA
IATLGNDAGVIGGAWLVKKHKYEAKMI
>BCE33L4467 glcU, glucose uptake protein
MDIFLAILPAIFWGSIVLFNVKLGGGPYSQTLGTTFGALIFSIVVYIFMK
PVLTPTVIGVGIVSGLFWALGQANQLKSIDLMGVSRTMPISTGLQLVSTT
LFGVIVFHEWSTTISVILGVLALVCIIIGVILTSLQSEEEKNAEQAGNFK
RGIIILLISTVGYLVYVVVIRLFNVDGWSALLPQAVGMVLGGILLTFKHH
PFNKYAIRNIIPGLIWAAGNMFLFISQPRVGVATSFSLSQMGIIISTLGG
ILILGERKTKRQLTGIVVGIIFIIAAGIMLGIAKS
>pE33L466_0367 glcU, glucose uptake protein
MILKFSKERLKKMDIFLAILPALFWGSIVLFNVKLGGGPYSQVLGTTFGA
LIFSIAIYMIVQPVLTPVVIGVGIISGLFWALGQANQLKSIDLMGVSKTM
PISTGLQLVSTTLFGVIVFHEWSTIISVILGVLALICIIIGIVLTSLQSK
EEKSEEQAGNLKKGILILLVSTLGYLVYVVIIRLFNIDGWSALFPQAIGM
VLGGILLTFKHKPFNKYAVRNIIPGLIWAAGNMFLFISQPRVGGATSFSL
S
>BCE33L0190 glcU, probable glucose uptake protein
MDILLALLPAIAWGNILLVSVKMGGGAYSQTVGMTIGALFFATIMYVFTQ
PALTMTILIVGFISGLFWALGQVNQLKTVEKLGVSTTVTISTGMQLVATS
IFGVIAFREWTTTTTIILGTIAILLIVVGVVFTSLDDKENAQPPGQLKKG
LLTLIVSTFGYLVYVIIIRWYNIDGWSAILPQAVGMFVGAVVLTSKHKPF
NKYAIRNALSGLLWGTGNLFLLLSLPRVGVATSFPLSQTGIVISTFGAIV
FLGEKKTKRQLIFIALGSVLIIGGAVLLGMTKA
>BCE33L4618 glgA, glycogen synthase
MKTRREEAAREVVEAFRAVGQQVNILFAVSECVPFVKSGGLADVAGALPK
ELKKLGVEVRIILPNYSLIPQKLRDGCTLHKVINVPLGWRNQYCGILKGE
QDGITYYLIDNEYYFKRDSLYGHYDDGERFSYFSKAVLECIPHLDFEVDV
LHSHDWHTAMVNFLLREKYQDNPLYEHIKTVYTIHNLQFQGVFPPEVMYD
LLELGDEYFHSEQLEFYGNVNFMKGGIIASDQITAVSPTYKEEIQYEFFG
EKLDGLLRKYNDKLSGIVNGIDTSVYNPETDSYITAQYDAGSLYEKNENK
RALQRYFGLPEKEDTPIISMVTRLTKQKGLDLVRTVFREIMEEDVQCIIL
GSGDSEYEQFFEWMAYEYPEKVKVYIGFNEELAHQVYAGSDLFLMPSLFE
PCGLGQLIALAYGTIPIVRETGGLNDTVQSYDEETGEGNGFSFTNFNAHD
MLHTVLRAIEFYHDKPVWEQLVKQAMTEDYSWEKSALAYKKLYKGLME
>BCE33L4621 glgB, 1,4-alpha-glucan branching enzyme
MKRDEFHTEKYYESYNIFGAHIVTEDEMRGVRFTVWAPHAKAMSVVGDFN
EWDYEQHKMLQVTEEGIWSLFIPHIEEREIYKYAIETMAGDVIFKADPYA
VYAEVRPNTASVVFDIKGYEWNDKNWSRKKKKKSVYKEAMTVYELHFGSW
KKKEDGTLYSYKEMAEELIPYVVEHQFTHIEIMPLVEHPYDRSWGYQGTG
YYAATSRFGTPHDLMHFVDECHKYGIGVILDWVPGHFCKDAHGLYLFDGT
PTYEYKDKDVQENPVWGTVNFDLGKREVRNFLISNALFWMRYFHIDGFRV
DAVANMLYWNKEGQEQSNEHAVSFLRELNEAVFAENEDFLMTAEDSTAWP
LVTAPTYEGGLGFNYKWNMGWMNDVLKYMECAPEYRKYIHDKMTFSLLYA
YSENFILPLSHDEVVHGKKSLLNKMPGDYWDKFAQLRLLYGYFFTHPGKK
LLFMGGEFGQFDEWKDLEDLDWNLHDFEMHRYMHDYFKELIALYKRSKPL
WQLDHSPEGFQWIDANNNEQSIFSFIRQGDKQEDALVVVCNFTKATYENY
KVGVPDFEYYNEILNSDAEQYGGSGQVNKKRLKAIQEPYHNQAAHVEITI
PPFGVSILRPVKTRKGSKKQDGSKTKVRSNVTSRGKR
>BCE33L4620 glgC, glucose-1-phosphate adenylyltransferase
MAQKQKCVAMLLAGGKGSRLSALTKNLAKPAVPFGGKYRIIDFTLSNCAN
SGIETVGILTQYQPLELHNYIGIGNAWDLDRVSGGVTVLPPYAESSGVKW
YTGTASAIYQNLNYLSQYEPEYVLILSGDHIYKMDYSKMLDYHIEKEADV
SISVIEVPWDEASRFGIMNTNEEMEIVEFEEKPQFPRSNLASMGIYIFNW
AILKEYLEMDARNPESSNDFGKDVLPLLLDEGKKLMAYPFEGYWKDVGTV
KSLWEANMDLLRDETSLNLNDRDWRIYSVNPNEPPQYIAEKAKVEESLIN
EGCVIEGDVKHSVLFQGVTVEEGSMVIDSVVMPGAKIGKNVVIERAIVGS
EMVIEDGTIIRPEKNVDDVVLIAEGK
>BCE33L4619 glgD, glycogen biosynthesis protein
MGEKMLGIINATGSFPSLKKVTGHRSLAALPFGGRYRLIDFMLSNMVNSN
IHSVAVFTSHKNRSLMDHVGSGKQWDLDRKRDGLFLFPPNCQCDQDEFGS
FAHFRRHIDYFLRSREEYVVITNSHLVTALNFQAVLERHIHTAADITEVC
HEEVSLQTYVLKKQLLLDLFESYKDVEQYSLFDVVREKRGKSLHIATYEH
TGYVAIIDSIESYYKHSLEILKPAIWKQLFKKEAPIFTKVKDEPPTRYLK
GAAVKNTMIANGSIIEGEVENSVISRSVKIGKGSIVRNSIIMQKSQIGDN
CIIDGVIIDKDVKIGDGVVLKGNADEPYVVEKGSVQNSTINSYS
>BCE33L4617 glgP, glycogen phosphorylase
MFTHVESFKSAFLEKLETMYGKSFKDSTTRDQYNTLGYMVREYMNSQWIA
TNESYRSGERKQMYYLSIEFLLGRLLGSNILNLGIRDVCEQGLSELGISL
QQLEEVEADAGLGNGGLGRLAACFLDSLASLNLPGHGCGIRYKHGLFDQK
IVDGYQVEFPEQWLLHENVWEVRRHDQAVEVSYFGNVEPLYIDGRLEFRH
TNAEVIMAVPYDVPVVGYETSTVNTLRLWNAEPVPFPQNCKDILKYKRET
EAVSEFLYPDDTHNEGKILRLKQQYFLVSASLQNIVRLHRERYGDLRQLH
EKIAIHINDTHPVLAIPELMRILLDEEKLAWEEAWHITTQTISYTNHTTL
SEALEKWPIHIFKPLLPRIYMIIEEINERFCHELWERYPYEWHRIEEMAI
IAHDLVKMAHLAIVGSHSVNGVAKIHTEILKQREMRLFYEFYPDKFNNKT
NGIAHRRWLMKANPQLTNLISEAIGTEWKKEPIKLQELQLVQYDASFQEK
FAEVKQERKEILAERIHNTMGITIDPNSIFDVQVKRLHAYKRQLLNVLHI
LYLYNRLKEDASFTFYPRTFIFGAKASPGYYYAKKIIKLINELARKVNND
PYVSQYMKVIFLENYRVSLAEDIFPAADVSEQISTASKEASGTGNMKFMM
NGAITLGTLDGANIEIKDRVGDDNCFIFGLTAEEVLHYYQNGGYRASDYY
HHNGHIKKVVDQLTNGFFAQSGAEFEAIYDSLVIQNDEYFVLRDFGPYAE
RQEAVGRAYENRTKWLEMSILNIAQSGHFASDRTILQYSNEIWGIGNTVT
QI
>BCE33L0150 glmM, phosphoglucosamine mutase
MGKYFGTDGVRGVANKELTPELAFKIGRFGGYVLTKDTDRPKVIIGRDTR
ISGHMLEGALVAGLLSTGAEVMRLGVISTPGVAYLTKALDAQAGVMISAS
HNPVQDNGIKFFGSDGFKLTDEQEAEIEALLDKEVDELPRPTGTNLGQVS
DYFEGGQKYLQYIKQTVEEDFSGLHIALDCAHGATSSLAPYLFADLEADI
STMGTSPNGMNINDGVGSTHPEVLAELVKEKGADIGLAFDGDGDRLIAVD
EKGNIVDGDQIMFICAKYMKETGQLKHNTVVSTVMSNLGFYKALEANGIT
SDKTAVGDRYVMEEMKRGGYNLGGEQSGHIILLDYITTGDGMLSALQLVN
IMKMTKKPLSELAGEMTKFPQLLVNVRVTDKKLALENEKIKEIIRVVEEE
MNGDGRILVRPSGTEPLIRVMAEAPTQEVCDAYVHRIVEVVKAEVGAE
>BCE33L0937 glpF, glycerol uptake facilitator protein
MWRDTMSAFLGELIGTALLIVLGGGVCAGVSLKKSFAKDSGWIVITMGWG
LAVAVAAYAVGSISGAHLNPALTIGLAFKGAFPWSDVPGYIAAQMIGAII
GAVIVYLHYLPHWKETEDPGTKLGVFATGPAIPNTFANLLSEMIGTFVLV
FGILAIGANKFADGLNPFIVGFLIVSIGLSLGGTTGYAINPARDLGPRIA
HFFLPIAGKGGSNWKYAWIPVVGPILGGSLAGLFHQVVFEGKQNAALIYV
IIATVIVLAISYMTSKKSGSNTNSRKVA
>BCE33L0571 glpT, glycerol-3-phosphate transporter
MFFTQFFKPAPHAERLPADRVDSEYRKLRLQVFLGIFIGYAGYYFVRKNF
SLAMPYLIEQGFSKGELGVILSAVSIAYGLSKFLMGIVSDRCNPRYFLAA
GLFLSGIINIIFGSFSFITTSIILMFVLQFLNGWVQGMGWPPCGRTMVHW
FSISERGTKMSIWNVAHNVGGALMPSLVTLGLYFFANDWKSIFYFPGILS
ILVGIYVLITMRDTPQSCGLPSIEEHTGEYPPDEKVQDRERELSVKEILF
TYVLNNKFLWYIAIANVFVYFVRYGVVDWAPTYLVEEKSFTHSSSRTAYA
LYEWAGIPGTLLCGWMSDKLFKGRRAPAGILFMVGVFIAVLVYWLNPPGN
PMVDSIALVAIGFLIYGPVMLIGLHALDLAPKKAAGTAAGLTGFFGYLGG
AAFASAAMGFIVDAFGWDGGFILLLASCVLAMFFLALTLKTGSAKPKKA
>BCE33L4955 glpT, glycerol-3-phosphate transporter
MFKWLKPAPAIERLPADMIDRVYRLLRIRVLIGISVGYAAYYLVRSNFTL
SSTYLVQEYGFSTAEIGLLGSVMAIVYGFSKFFMGNLSDKAFAQRFIAVG
LFLSGLVNICFGFASSFGMIVTLLVVNGIVQGMGAPPCSIVMTKWFSKKE
RGTKTGIWNISHNVGGMLVPPLVGIGVGIFGENHWQGGVFIFPAIIAMII
SVLVWINAKDTPESEGLPPIDEYRNDYENLEKADNANKMSPKEILMKYVV
KNKFVWFLCIANAFVYLIRFGVINWVPLYLTTVKGFSKNEAHAAYAIFEG
MAIPSSLIVGLLSDKLFKGKRMPLCIISMVGVVIGTFVYWQATSILVVSI
AVSIIGCLIYVPQFLIGLSAMELVPKFAVGTTVGMCGLFGYVGGSLVANA
AIGVIVDRSGWDGCFILLLTGAILSTIFLFIVQRGHESKASKVA
>BCE33L2109 glpT, GlpT transporter; possible quinolone resistence protein
MERLWTKSFIQMTFAMLFLFTAFYLLVPTLPLFIKEIGGNESQVGLMMGM
FTIAAVVIRPIIGGMLDQYGRRSFIIFGLIFFGLTMYSYNLASTIVLLAV
LRVIHGVTWAVSTTAVGTAITDIIPDSRRGEGMGWYGMAMTIAMAIGPMI
GLSVVQNYSFHGLFLLATLLSFMAVLLSLMAKMPFTPQKEKGKMQLFEKS
VLSITIVVFFLSFAYGGITTFLPLFASSIDVNPGTFFLVYAIVLTVVRPI
SGKLLDKYGEVFIILPALCITVIAIVVLTISNNLIGVVIAATLYGVGFGS
AQPALQAAMLTIVDPSKRGVANASFFTAFDLGIGLGAILLGVVSQMFGYR
ILFAGSAISGLIAFIIFVVFVKQRLGKKEFA
>BCE33L3081 gnd, 6-phosphogluconate dehydrogenase; 3-hydroxyisobutyrate dehydrogenase
MQVGLIGLGKMGLNLGKNLMDHKHEVAAFDLNASAVEEMKEYGATGASSL
NELVQSLQSPRVLWVMVPHAVVDSVIDEVTPLLSKGDILIEAGNSHYKES
IRRYEQLKKDGIHFMDAGTSGGMEGARNGACYMIGGDQEAWDIVEPIFRD
TAVENGYLYAGKAGSGHFLKMVHNGIEYGMMAAIGEGFEILEKSEFDYDY
EKVSRVWNNGSVIRSWLMELTENAFSKDAKLDEIKGVMHSSGEGKWTVET
ALDLQTATPVIAMSLLMRYRSLDNDTFTGKVVAALRNEFGGHAVEKK
>BCE33L0157 gnd, phosphogluconate dehydrogenase, decarboxylating (6-phosphogluconate dehydrogenase)
MEKLQIGVVGVGVMGKSLALNFESKGYSVALYDISKEKVDETIEENRGKN
LVGTHIVEEFVNSLESPRKILLMVNAGEITDKAIDSLVPHLDKGDILIDG
GNTYFVDTIRRNKRLAEEGINFIGAGVSGGEEGALKGPSIMPGGQKDAYE
KVKDMLENISAKVNNEPCCSYIGPNGAGHYVKMVHNGIEYGDMQLICEAY
FFLKQTLDLTAEEFHEIFAEWNKGELNSYLIEITADIFKKKDEETGKPLV
DVILDTAGQKGTGKWTSQSALDLGISLPIITESVFARCISALKEERVNAS
KVLSGPKNKTAIGVEKAELIEAVRQALYMSKICSYAQGFTQLKAASEEYD
WNLDFGSISMLWRGGCIIRAAFLQNIKEAYETNTDLPNLLLDPYFKEIVE
SYQGGLRQIISMAVQQGIPIPAFSAAISYYDSYRTAKLPANLLQAQRDYF
GAHTYKRVDKEGTFHTKWI
>BCE33L3078 gntK, gluconate kinase (2-dehydro-3-deoxygluconokinase)
MVRSKYMIGVDIGTTSTKSVLFSTDGSVIASHGIEYPLYSPTPETAEQDP
EEIFRAVIHTIKETVQSSSVQPNDILCVSFSSAMHSIIAVDEKGKPLTRC
ITWADNRSASWAEKIKNDMNGHEIYLRTGTPIHPMSPLSKLVWLQNEQAE
LFAKTYKFISIKEYVFYKLYKEYVIDYSIASATGMFNLKSLKWDEEALYV
AGITDDKLSKLVPTTHSLTGLDEELANEMNVLVSTPFVVGASDGVLSNLG
VNAIDPGVVAVTIGTSGAIRAVTNRPVTDPKGRIFCYALTEDHWVIGGPV
NNGGMIFRWARDQLGTSEIELAKRLGKDPYEVLTEIAAKVNPGSDGLLFH
PYLAGERAPLWNANARGSFFGLGLHHKKEHLIRAVLEGVIYNLYTVLLAL
KELIGEPKKIQATGGFARSELWRQMMADIFHQDVYVPESFESSCLGAAIL
GLYSLGEVDTLHVVSEMVGANFHHEPNMESVEKYKDLTPIYIRLSRQLEE
EYESIAAYQKKWV
>BCE33L0155 gntK, gluconokinase
MSSYMLGIDIGTTSTKAVLFTEKGEVIQTENIGYPLRTPDISTAEQDPEE
IFQAVLQAISNITKQHSDKNPSFISFSSAMHSVIAMDENDQPLTPCITWA
DNRSEAWAHKIKDELNGHAVYRRTGTPIHPMSPLSKITWIVNDHPEIAIR
TKKYIGIKEYIFKKLFDQYVVDHSIASCMGMMNLKTLDWDEEALKIAGIT
SAQLSKLVPTTKIFSNCNPDLAQKIGIDSQTPFVIGASDGVLSNLGVNAI
RKGEIAVTIGTSGAIRTIIDKPQTDKKGRIFCYALTEKHWVIGGPVNNGG
MVLRWIRDELASSEVETAKRLGIDPYDVLTKIAERVRPGADGLLFHPYLA
GERAPLWNPDVRGSFFGLTMSHKKEHMIRAALEGVIYNLYTVFLALTECM
DGPVTRIQATGGFARSDVWRQMMSDIFASEVVVPKSYESSCLGACILGLY
ATGKIDSFEIVSEMVGSTYKHTPKEEATKEYRQLLPIFINLSRALEDDYT
RIANYQRNLIK
>BCE33L2004 gntP, gluconate permease
MELIIILLALSLLMFVAYRGFSVILFAPIFALFAVFLTEPSFVLPFFSNI
FMEKMVGFIKLYFPVFLLGAIFGKVVEMSGIADSIAKTIIELVGEKRTIL
AIVLMGAILTYSGVSVYVVVFAVYPFAAKLFRQANIPKRLIPGTIVLGAV
TFTMDALPGSPQIQNVIPTTFFKTDIYAAPILGIVGAIFVLTLGLLYLES
RRKKAKAAGEGYYGFNDGNTEMAASLQVEQKDMPLLKSLEITRAQQAIAF
IPLILVGVMNKVFTIMIPKWYPNGFDFSAIGMKAFGKVELSAVVGIWSVE
LALIIGIVTTLLLYWKRVVTGFQAGLNTSIGGALLATMNTGAEFGFGGVI
AALPGFAIMRDGISATFTNPLVNGAVTTNILAGITGSASGGMGIVLSAMG
DKFIAAANQFDIPLEVMHRIVSMASGGMDTLPHNGAIITILTVTGLTHKQ
SYKDIFAITVLKTVAVFLVIAFYTVTGIY
>BCE33L4594 gntP, gluconate permease, GntP family
MDIYLLIVTLLAIAIVILGVSWWKWHAFISLTVASLFLAIMSGLNLTKIV
TAYESGVGSVLGHLVGILALGTILGKMMSDSGAGMQVADFFIRFFGVKKL
PWAMLFAGFVIGIPVFFEVGIVILLPLVISIRKTTKQNILLIALPVIAGL
SIVHGLVPPHPGAMTAIGIYNANLGKVLLYSLLIALPTAIIAGPIFAKWV
HKRVIPENEPELIRVTTVSTDLPSRKVSFFIILLPVVLMILSVVAPYISL
PKKMTEFFVFIGSPVIALLISCFAAFYLLGMRQGINKKMIKKLTDESLLP
VGSIILIIGAGGGFKQILIESGVGTAIAQMAEHISLSPIVLAFMVAGLIR
IATGSATVALTTAAGIVSPVIQHMSGVNLEMLVIATGAGSLMFSHVNDAG
FWLVKEYLGLTVKETFKTWTVLETLLSFIAFGFALVLNMFL
>BCE33L0156 gntP, gluconate permease
MPLVIVAIGILALLLLIMRFKLNTFISLIIVSVGVALALGMPPEKIFKTI
EAGLGGTLGHLALVFGLGAMLGKLLSDSGGAQRIAMTLVKKFGEKNIQWA
VVTASFIIGIALFFEVGLVLLIPIVFAISRELKVSILYLGISMAAALSVT
HGFLPPHPGPTAIAGELHANIGEVLLYGFMIAVPTVVLAGPVFTKLAKKL
VPEAFTKTGNIQSLGEQKVFKLEETPGFGISVFTALLPVLLMAVATIITL
LQKTMGFKDNSLLATIEFIGNADTAMLISLLVAIYTMGLARNIPIKNVME
SCTTAISNIGMMLLIIGGGGAFKQVLIDGGVGNYVAELFKGTSLSPILLA
WIIAAILRISLGSATVAALTTVGLVIPMLGQSDVNLALVVLATGAGSLIA
SHVNDAGFWMFKEYFGLSMKETFATWTLLETIVSVAGLGFTLLLSLFV
>BCE33L2234 gpm, phosphoglycerate mutase
MIKLVLIRHGQSLWNLENRFTGWTDVDLSENGLSEAREAGAILKKNGYTF
DVAYTSVLKRAIRTLWIVLHEMNLAWVPVHKSWKLNERHYGALQGLNKDE
TAQKYGEEQVHIWRRSIDVRPPALTEDDPRYEMNDPRYKALKKGEFPLTE
CLVDTEKRVLDYWHSEIAPKLKNGNKVIISSHGNTIRSLVKYLDNLSSDG
VVSLNIPTSIPLVYELDENLRPIRHYYLSMDGEVPEGEIPKHISF
>BCE33L1571 gpm, phosphoglycerate mutase family protein; possible fructose-2,6-bisphosphatase
MTIIYFVRHAHSTYTKEERERPLSEKGHLDAENVTHLLKDKHIDVVISSP
YKRAIQTVQGIANTYHVSIEIEEDLRERLLSSEPVADFNDAIENVWEDWS
FAYEGGESNDVAQRRAVICMQNILKKYEDKNIVIGTHGNIMVLLMNYFDS
KYDFQFWKTLHMPDVYKLTFDNNRFISAERIQSTDYQINNL
>BCE33L4696 gpmA, phosphoglycerate mutase
MKKIIVIRHCSATGQERDAELTTDGKNQANTLATFLLEQHPQIDHIISSP
FVRAIDSIRPYALQANLPIQKDERLAERLLSDVPMDDWMQKLESTFTNID
IAFSGGESTKQAMDRAISLIEDILQLNHTTTLLVTHGNLLTLILKHFDHT
IGFNEWRTLTNPDMYEITIDEQCRLKRLWEAPSK
>BCE33L4825 gpmI, 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MRKPTALIILDGFGLREETYGNAVAQAKKPNFDGYWNKFPHTTLTACGEA
VGLPEGQMGNSEVGHLNIGAGRIVYQSLTRVNVAIREGEFDKNETFQSAI
KSVKEKGTALHLFGLLSDGGVHSHMNHMFALLRLAAKEGVEKVYIHAFLD
GRDVGPKTAQSYIDATNEVIKETGVGQFATISGRYYSMDRDKRWDRVEKC
YRAMVNGEGPTYKSAEECVEDSYANGIYDEFVLPSVIVNEDNTPVATIND
DDAVIFYNFRPDRAIQIARVFTNEDFREFDRGEKVPHIPEFVCMTHFSET
VDGYVAFKPMNLDNTLGEVVAQAGLKQLRIAETEKYPHVTFFFSGGREAE
FPGEERILINSPKVATYDLKPEMSIYEVTDALVNEIENDKHDVIILNFAN
CDMVGHSGMMEPTIKAVEATDECLGKVVEAILAKDGVALITADHGNADEE
LTSEGEPMTAHTTNPVPFIVTKNDVELREDGILGDIAPTMLTLLGVEQPK
EMTGKTIIK
>BCE33L0957 hit, HIT family protein
MNHTADNCIFCKIIDGQIPCSKVYEDEHVLAFLDISQVTKGHTLVIPKVH
KQDIFALTPEIASHIFSVVPKIANAIKAEFNPVGFNLLNNNGEKAGQTVF
HFHLHLIPRYGENDGFGAVWKSHQNEYTMENLQNIASTIANSVK
>BCE33L1669 ilvD, dihydroxy-acid dehydratase
MRSDMIKKGFDKAPHRSLLKATGLKDEDFDKPFIAICNSFIEIIPGHKHL
NEFGKLVKEAVRAAGMVPFEFNTIGVDDGIAMGHIGMRYSLPSREIIADS
VETVVNAHWFDGMICIPNCDKITPGMMMAALRINIPTVFVSGGPMAAGKT
SKGEVVDLSSVFEGVGAYQSGKISEEELKDIEDHGCPSCGSCSGMFTANS
MNCLCEVLGLALPGNGSILAIDPRREELIKEAAEKLKILIERDIKPRDIV
TEEAIDDAFALDMAMGGSTNTVLHTLALAHEAGLDYDMSRIDAVSRRVPH
LCKVSPASNWHMEDIDRAGGISAILKEMSRKEGVLHLDRITATGQTLRGN
IAHAEIKDKEVIHSLENPHSEEGGLRILKGNLAKDGAVIKSGATEVKRFE
GPCVIFNSQDEALAGIMLGKVKKGDVVVIRYEGPRGGPGMPEMLAPTSAI
AGMGLGADVALLTDGRFSGASRGISVGHISPEAAAGGTIALLEQGDIVCI
DVEERLLEVRVSDEELDKRKKEWKRPEPKVKTGWLGRYAQMVTSANTGAV
LKVPNFD
>BCE33L2133 imrB, drug resistance transporter
MKAKINPKVVVSIVYITAMFMAAMDATIVNVALQTISKELQVPPSAMGTV
NVGYLVSLAVFLPISGWLGDRFGTKRIFLTALFVFTTASALCGIANDITS
LNIFRIIQGAGGGLLTPVGMAMLFRTFSREERPKISRFIVLPIAVAPAVG
PIIGGFFVDQMSWRWAFYINLPFGIMALLFGLLFLKEHIETTAGRFDSLG
FILSAPGFAMIIYALSQGPSRGWISTEIISTGIAGTVFITLFILVELKVK
QPMLDLRLLKEPVFRKMSLISLFSSAGLLGMLFVFPLMYQNVIGVSALES
GLTTFPEAIGLMISSQIVPWSYKKLGARKVISIGLICTAIIFVLLSFVNH
DTNPWQIRALLFGIGIFLGQSVGAVQFSAFNNITPPSMGRATTIFNVQNR
LGSAIGVAVLASILAGFGNNSVQHNAHSDFFPYQAALIGSAILLLVALLF
SLRLSDKEVMSKKKEKMLSVTKKEKALVNE
>BCE33L2257 iolB, myo-inositol catabolism protein
MLGKLGELNEGYNVLTEMNGQCSDMLMDIGIYKMSNGKEELLFDDKNETA
VLLLEGAIRLEWEGKEQIIQRQSVFEENPWCLHVAKNVKVTITALSDSEV
LVQKTDNDQEFASKLYTPNECQSVVAGEGVWEGTAQRVIRTIFDYNKAAY
SNMVVGEVISYPGRWSSYPPHHHDQPEVYYYRFNKPQGFGCAMVGEDAYR
VVHNSFITIPGELDHPQATAPGYAMYFCWMIRHLENNPWNDRIMEEEHKW
LLEPNAKIWPEKE
>pE33L466_0306 iolB, myo-inositol catabolism protein
MLGKLGELNEGYNVLTEMNGQCSDMLMDIGIYKMSNGKEELLFDNKNETA
VLLLEGAIRLEWDGMEQVIQRQSVFEENPWCLHVAKNVKVTITALSDSEV
LVQKTDNDQEFASKLYTPNECQSVVAGEGLWEGTAQRVIRTIFDYNNAAY
SNMVVGEVISYPGRWSSYPPHHHDQPEVYYYRFNKPQGFGCAMVGEDAYR
VVHNSFITIPGELDHPQATAPGYAMYFCWMIRHLENNPWNDRIMEEDHKW
LLEPNAKIWPEKE
>BCE33L2252 iolC, carbohydrate kinase; myo-inositol catabolism protein
MNPLIFKENRPFDLIAVGRLCVDLNANETQRPMEETRTFTKYVGGSPANI
AIGAARLGLQTGFIGKVSDDQMGRFITGYLKDNKINTDQIRIDCTGAVTG
LAFTEIKSPEDCSILMYRDNVADLNLDPTEVSEDYIKQSKALLISGTALA
KSPSREAVFLALEYARKHDVVVFFDVDYRPYTWQSEAETAVYYNLAAEKS
DVIIGTREEFDMMEKLLNYEQSNDQVTAERWFSHYAKIVVIKHGGDGSIA
YTRDGQSHRGGIFKTKVLKTFGAGDSYASAFIYGLIQGLEIPQAMRLGGA
SASIVISKHSCSDAMPTRAEISAFMETAEELV
>pE33L466_0300 iolC, myo-inositol catabolism protein
MNPLIFKEDCPLDLIAVGRLCVDLNANETQRPMEATRTFTKYVGGSPANI
AIGATRLGLQTGFIGKVSDDQMGRFITRYLQDNNINTDQICIDRTGAVTG
LAFTEIKSPEDCSILMYRDNVADLNLDPTEVSEDYIKQSKALLISGTALA
KSPSREAVFLALEYARKHDVVVFFDVDYRPYTWQSEAETAVYYNLAAEKS
DVIIGTREEFDMMEKLLNYEESNDQVTAERWFSHHAKIVVIKHGGDGSIA
YTRDGQSHRGGIFKTKVLKTFGAGDSYASAFIYGLMQGLEIPQAMRLGGA
SASIVISKHSCSDAMPTRAEISAFMEIAEEIV
>BCE33L2255 iolE, myo-inositol catabolism protein
MFKENTVKLGIAPIAWTNDDMPELGAGNTFEQCISEMALAGFNGSEVGNK
YPRNTVVLKKSLALRNLEIASAWFSTFLTTKPLEETVEEFIKHRDFLHDM
GAKVIVVSEQGHSIQGLMDVPLFKNKPVFTEEEWNKLADGLHHLGKLAQE
KGLHIVYHHHMGTGVQTTAEIEKLMDMTNPALVSLLFDTGHLVFSGEEPL
YILKKYLPRIKHVHLKDIRQEVVDTVKENELSFLQAVKNGAFTVPGDGVI
GFDEVFTILANSDYQGWFVVEAEQDPALANPFEYALKARKFIQEKAGL
>pE33L466_0303 iolE, myo-inositol catabolism protein
MFKENTIKLGIAPIAWTNDDMPELGAENTFEQCISEMALAGFNGSEVGNK
YPRNTVVLKKSLELRNLEIASAWFSAFLTTKPLEETVQAFIKHRDFLHDM
GAKVIVVSEQGHSIQGLMDVPLFKNKPVFTEEEWEKLADGLHHLGKLAQE
KGLHIVYHHHMGTGVQTTAEIEKLMDMTDPELVSLLFDTGHLVFSGEEPL
YILKKYLSRIKHVHLKDIRQEVVDAVKESDLSFLQAVKNGAFTVPGDGVI
VFDEVFTILANSDYKGWFVVEAEQDPALANPFEYALKARKFIQEKAGL
>BCE33L0142 kbaA, kinB signaling pathway activation protein
MNSRKWVRLFFTTLFLGGISTVIIGFVLEWDKYAKFFQNLDGKEILAVSF
WLMGVGFIFSVISQMGFFAYLTIHRFGLGMFRSSSLWNIVQLFFIAFVLF
DFVYLRSVLIANGEVSLGNNILVAGVLFMFGAIVAYIKSKETNKKAFVPA
LFFMVVVTILEWVPALRINDTDWLYLMVIPLLLCNAYQLLILHRLIGKTS
KSA
>pE33L466_0341 kdgA, bi-functional protein: 2-dehydro-3-deoxyphosphogluconate aldolase
MKRVTVLNKLKKSGVIAVLRAHTKDEALKVTEAVINGGITGIEVTFSVPQ
AEEVVRKIRELHSDCEELVIGAGTVLDAITARMAILAGAEYIVSPAFDKE
TAEICNLYQVPYLPGCMTITEISTALKAGVDIVKLFPGSSYNPSFINAVK
GPLPQVNIMPTGGINIENMHLWFERGCVAIGVGGDLLAPAQNGDYAKVSE
LAREYVDKLAEIRKGA
>pE33L466_0342 kdgK, 2-dehydro-3-deoxygluconokinase
MGRILTLGEIMLRLSTNEGTRITEANYFKAHYGGSEANVAINLANFNHQV
SFASKVPSNLLGKAVQQHLQNYGVDTSNLLKGGLRLGTYYLERGTGKRAS
LVLYDRTYSSFAQMKNVEWNIDDLFKNVSLFHVSGISLALSDSMTNLILG
LIKEAKKRQIKVSFDINYRSNLWNYERASKTLNKILPYVDYCSAGKKDAL
YLIGIPENKTQQSDLEYYYEQMHNKYPNIEVFYSTLRDVHSASSNDLQGT
LWKNHFLYTSKVYHINPIVDRVGGGDAFVAGILHGLLKEKDPDYTVSFAT
AASSLKHTIHGDCNQFSILEVEEFMRNESGNIIR
>BCE33L4596 kdgK, 2-dehydro-3-deoxygluconokinase; carbohydrate kinase, PfkB family
MRKKIAAFGEVMMRLQVPGYELLSQANTLHYSFSGTGVNVAAALSNLGHE
GLLISTLPENSVGDAALSYIQKLGVQTSLVSRGGKYVGMYFLENGFGARA
SRVTYSNRLESSFNTACKEMYQFEEIAKEIDIVHFCGITLAMNDTVRHHM
KSLAKAVKENGGTVVFDCNYRPSLWGEDGYEQAKPHYEEMLGLADIVMMN
EKDAMFVLGMKTEETEREAQLVDLIPKVAETYSIATIAGTHRSINSDNTH
SLRGFICKDGTFTFAKTLTFSVYDRIGAGDAYTSGIIHGEIEEFAPEKAV
SFASAAGMLAHTIVGDTPMSSEKDILRAMTASVGDVER
>pE33L466_0343 kduI, 4-deoxy-L-threo-5-hexosulose-uronateketol-isomer ase
METRYTHSPMDIRHYSTDQLRQEFLIERNFAPGEVILTYTHNDRMIFGGV
TPTEKPLSIELSTELGVSYFLERRELGVINIGGPGSIIIDGTEESMKKQD
GYYIGKETREVVFKSDDQSNPAKFYCVSVPAHHKYRNVRISIDEIKPMET
GDSATLNKRKIYQYIHPNVCESCQLQMGYTILEPGSSWNTMPCHTHERRM
ETYLYFDMKPDTRVFHFMGKPDETKHLVMKNEQATISPSWSIHSGVGTSD
YTFIWAMCGENITYSDMDMVEMDQLK
>BCE33L1642 lacC, tagatose-6-phosphate kinase, phosphofructokinase I
MIATITLNPSVDMRYELGELKLNKIHRTKDYEKTAGGKGINVSRVLRLLG
EEVTGAGLLGGSNGEFIRKRLRDLSIIDEFVSVKEETRNCIALITKKSAS
ATEVLEAGPAISEDEIALFIKKYERIVKDFEFIVASGSLPKGIPNSFYQQ
LAQKAAENGKKFILDTSGEPLLHGIQGKPFLIKPNRQEICQLLQKKRVSQ
EEMIAEATKICEGGVQYVLLSLGREGAILITKDESIRAIISEIKTINAVG
SGDAMVAGITLALAKGYGIKDALRFSVACGMANAAEEITGYIQLKNVENF
YNEITIV
>BCE33L1641 lacD, tagatose-bisphosphate aldolase, fructose-bisphosphate aldolase, class II
MLVSTQFILRNAQEQGYAVPAFNIHNLETLKAVIESAVELRSPVIIAATP
GTIKYMGKEYLLHMIEAARKQYEIPISLHLDHHEDISDIKNCIDSGVRSV
MIDASHHPFEENVQIVQEVSLYAKQYGVTVEAELGQLSGIEEDIKVENSI
YTDPYQAKEFVERTNIDSLAVAIGTAHGLYKGEPKLDLQRLINIRKQVNI
PLVLHGASGLSDSLVQETIRLGICKVNIATELKIAFGTALRHYLHSHPEE
NDPRKYFSDAIMAMKRVVADKIKMCKSLNRV
>pE33L466_0345 levD, PTS system, IIA component
MDILILSHAGVANGLKKAAQMILGEQKNLHALELTEENGITYFSDQLQEF
LERWSENQSNKLLIFADLKGGTPFNQAVFWASKLKLNQRISIISGVNLPI
VIEAIYCNQEKSLEELSKDLIEGAKNGIDIPEMEIDSVNALDE
>pE33L466_0348 levE, PTS system, IIB component
MEGIVHIRVDDRLIHGQVATRWATGLRVNRIMIIDDKVAVNDDEKSILRM
AAPAGVNTSILTFEKGLNNVKNGNYKGQRVLLIVKTPEILVQLMNGGLAL
IEVNIGNMSSRPGTTQIKKSISMTENEKVAVQQLLSQGVKVTAQMVPEES
DASIEGFLN
>pE33L466_0346 levF, PTS system, IIC component
MVSVEWWQIVLITLYSGFAIYDGNNTTFGFVKPTMAGFFAGLILGDIQTG
LIVGGTLNLLVLGVGNFGGASIPDYMTGALLGTAFTVMSGQDAKFGATLA
IPIGLLMVQLDVLARFTNTFFQHKAEKLVAEGKFKKASYMNLWGIVPTSL
SRMIPVFLALVFGAKFVQAIVDNIPKWLMGGLQVAGGLLPALGIAILLKY
LPIKQNIAFLIIGFFLAAYLKVPVLGVALIGLAMAIIYFQTFMKDSDYAT
DDGGMGDE
>pE33L466_0347 levG, PTS system, IID component
MRLMMEEWEMSKNIVDKDLNKVFWRWYFFGQTGWNYEKMQGLGYYYSIYP
LLESIYSEEEERKRAAINQLQFFNTNNSTAPVILGLDVALEKEKGIESID
TVASLKTGLMGPLAGIGDTLFFVIPTTIVGSIASYLALEGNPIALILWIL
FGCVRLGFMRFFVWTGYKEGAKLVGELGNRLKKITQSANILGITVVGALI
PSVVKATFGYEFTKGEVTLKLQDLANQIMPGLAPALVVFLTYWLLGRKKM
NSTRVIFLLIFIGIIAYNLKIFV
>BCE33L4904 licB, PTS system, lichenan-specific IIB component
MNILLCCSAGMSTSLLVTKMEAAAKARGLEGKIWAVSGDAVKTNIDQADV
LLLGPQVRYMLSSMKTLADERNVGIDVINPMHYGMMNGEAVLDHALTLKK
>BCE33L0686 licT, transcription antiterminator, BglG family
MTKVHQRLISILEEFLEEKSMLNRAFLASRLHVSTKTIQKDIKLLNDILE
ENGAKIESQRGTGYELEIIQTKKFEEFCVSLFQKQTEKVPTSYEERIAYI
LQRILTTEGYVKLSQLAEEIYVSKSTVNLIMKDVTDICGRYQLQIEKRPY
YGIRIVGEEFHIRSCLSQYGLPRYDHTPFHEQFEQSDTYLSLPHIPLIRS
VILKYIEEGTIYLSDIEIDNLVIHIAIALKRCEDQHYMKGLNAEQAELIR
KKEYAIAKQIVGDLEKELHLSFPEEEVLYVTMHLLSTAVTSKDRYENVEE
LLGKDLYAFMQHILFKVAEERNLIFYYDEELLFGFGVHLKTLLNRLKYKL
NTRNPLLAEVKKNYPYAFEIAVLVGDIIGEYTGESIPESEIGYIAIHFGG
AMSRLQEQNQKKRCLLVCATGQGSAQLLKYKILSQFRDKLEIVGITGYYQ
LKVEDLYKEKIDCIISTIHIPSGLPVPIIKVNSIFDDKEIKSIGQQLFTH
VNNSVQQYMKEDLIFLNHSASTKEEVIQFLCEKAAEKNYVPEHFYDSVME
RENTSPTAVGNLVAIPHPMQLLSAETFLMFCTLEKAVDWGDKKVQVIILF
SVKRNNNEDLQRLYDFLYDIMSSQITIEKLTHAEGIEDFQEVLLSI
>BCE33L0734 lmrB, lincomycin resistance protein
MGNQQTTAENSNIRALPIITSFLIAGFIGLFSETALNMALKDLITGFDIL
ETTAQWLTTGYLLTLGILVPISGLILQWFTTRQLFIASLIFSIIGTLIGA
IAPTFSVLMIARIVQAVGTALLLPLMFNTILVIIPPHKRGRAMGIIGLVI
MFAPAVGPTVSGLILKTLTWHWIFWISLPLLIIALVFGTFFMQNVTKLTK
PRIDIFSIILSTIGFGGIVFGFSSAGESGGWGSSHVILSLVIGVVGLIAF
SLRQMKMDEPMLDLKAFKYPMFVIGLLLILVCMMVLLCTMMILPLYLQTS
LALSTFAAGLMLLPGGIINGILSPVMGGLFDRFGPKWLVIPGLVIVACAL
YGFSTLTLETSTGFIVALHIALMVGISMIMMPAQTNGLNQLPPELYPHGT
AIMNTLQQVAGAIGTAVGISILSSGSRSFLQTVSDKENPLNQVLAFTNGV
QNTFIFAIIVVIVGLIISFFIKRVNVEQRA
>BCE33L3324 lmrP, multidrug resistance protein B; transporter permease
MKGKLKHIHPLGMSIILGTLFARFATSMSIPFLAIYLTTVKGVSAGMTGA
IIGTSALVGVFASFIGGNLSDQFGRKTIMIWSMIVWVFVFIGFSLADHVL
SFFLLNALNGLCRSFFEPTSRALLSDLTKPEYRLLVYNLRYGAINVGVAI
GPIVGLQIGSAKSTIPFLVAAGVYVLYTVILAFQFKKYPLEQKEVNEEKP
VTMLNALRILRKDVVFLVALVGIILSNCGFSHLTTTVSQYFANAHIFQDG
VKLFSYMLALNAVVVVVIQYPVIQMCKKYTPLASIMVGTLFVSGGLFGFG
IVESMLGTAICTIIFTIGEVLMFSMTDVFIDDIAVSHLKGTYFGAMGFSG
IGAVIGPWFGGVLLDYYGYQNGFVVFSALAIFSTVAFPVLLITKGLLKKR
YDRNSNMEVHAK
>BCE33L3769 malC, maltosaccharide ABC transporter, permease
MQTSMEPANGLNGSKHRKMATMLSIIPGVGQMYNKQFVKGLIFLVLTGSF
IVAFADLLNMGLWGIVTLGTEVPRDHSVFLLVEGILALIVIVFGLGIYAF
NLYDAYQNGKKRDIGTPLNSVKEQYRNLLDQGFPYLMVSPGFLLLIFVVV
FPIIFVILIGFTNYDLYHSPPAKLVDWVGFKNFIDIFTLPMWRETFLSVF
SWTVIWTFVATTLQVALGIFLAIIVNQPGIKGKAIIRTIFILPWAVPAFV
SILVFSGMFNETFGAINNQVLALFGIEKIAWMTDPFWAKIALIMIQTWLG
FPFVFAMTTGILQSIPGELYEAATVDGATAWQQFRKITLPLVLYATAPIL
ITQYTFNFNNFSIIYLFNGGGPAVAGQDAGGTDILISWIYKLTMTSAQYG
KAAALTMILSLIVITVALWQFKKTKSFQEEDMM
>BCE33L3768 malD, maltosaccharide ABC transporter, permease
MNIKRQKMLRLSLSYLVIFVMCAIIFYPLLWIIGSSFNPGDSLSGSSIIP
QNATLDHYRKLLDLENSNYLLWYKNTLKVSVLTMIFSVLAISFTAYAFSR
YRFVGRKNGLLTFLILQMIPNFAALIALYVLAQLTGLIDTHLALILIYVG
GAIPMNTWLMKGYFDTIPKELDESARMDGAGHFRIFWQIIMPLAKPIVAV
VALFTFIGPFTDFILASIILRTPENYTLAVGLYEMVAKKFGNEFTTFAAG
SVLIAIPISILFLSLQKYFISGLTAGGTKG
>BCE33L3772 malL, oligo-1,6-glucosidase
MEKQWWKESVVYQIYPRSFMDSNGDGIGDLRGIISKLDYLKELGIDVIWL
SPVYESPNDDNGYDISDYCKIMNEFGTMEDWDELLHEMHERNMKLMMDLV
VNHTSDEHNWFIESRKSKDNKYRDYYIWRPGKEGKEPNNWGAAFSGSAWQ
YDEMTDEYYLHLFSKKQPDLNWDNEKVRQDVYGMMKFWLEKGIDGFRMDV
INFISKEEGLPTVETEEEGYVSGHKHFMNGPNIHKYLHEMNEEVLSHYDI
MTVGEMPGVTTEEAKLYTGEERKELQMVFQFEHMDLDSGEGGKWDVKPCS
LLTLKENLTKWQKALEHTGWNSLYWNNHDQPRVVSRFGNDGMYRIESAKM
LATVLHMMKGTPYIYQGEEIGMTNVRFESIDEYRDIETLNMYKEKVMERG
EDIEKVMQSIYIKGRDNARTPMQWDDQNHAGFTTGEPWITVNPNYKEINV
KQAIQNKNSIFYYYKKLIELRKNNEIVVYGSYDLILENNPSIFAYVRTYG
VEKLLVIANFTAEECIFELPEDISYSEVELLIHNYDVENGPIENIPLRPY
EAMVFKLK
>BCE33L4651 manB, probable phosphomannomutase
MNWKQEFSRWLSYAELDAELKEQLENMKQDEKKIEDSFYKNLEFGTGGMR
GELGAGTNRLNVYTVRKATQGLAKFIEKLGEEAKKRGVVVAYDSRHKSPE
FAMEVAATLGAHGITTYVFESLRPTPVLSFAVRHLHTVSGIVLTASHNPP
EYNGYKVYGEDGGQLPPKEADELISYVNAVEDELTVEVADVEQLKADGLL
HIIGQEVDDAYAAELNNVIINKEMVQKVGKDLKIVFTPLHGTSNLSVRRG
LAEVGFTDVTVVKEQELPDPNFSTVKSPNPEEHAAFEYAIRDGEKVGADV
LIATDPDADRLGVAVRNHDGEFQVLTGNQTGALMLDYLLSQKKENGTLPE
NGVVLKTIVTSEIGRTIAKAYGLDTVDTLTGFKFIGEKIKQYEESGQYEF
QFGYEESYGYLIRPFCRDKDAVQSVLFACEVAAYYKSQGKTLYDGLLEVF
EKYGFFREDLVSLTLKGKDGAEKIQEMMATFRENPPKEVAGLTVVAVEDY
KASIITSLQDGHKEEIHLPKSNVLKYQLEDGSWFCLRPSGTEPKIKFYFG
VQDNSLQNSEQKLLTIKEDIMNRL
>pE33L466_0066 mef, macrolide-efflux protein
METAMNNSGGSFGKFLLLWSGQFISAIGNGLTSFGLSIYVFEQTGRASLM
ALVTLLAFMPSLLLSPVAGVLADRYDRRLLMVLGDSLSMLGLIFILICML
GGEAQIWQICVGVTISSIFSSMLDPAYKATVTDLLTEEEYTKASGFVQVA
GSAKYLISPIIAGFLLTVVDIKLLLVIDICTFFVTVASTLAVRKGLISKK
NAQENSFTRELKEGWDAVSKKRGVLVLVMMSSVLTFFLGFIETLSVPMIL
AFADSAVVGTVETTVATGMLVSSVLIGFIPIKKGFIKVLFISLFCEGIFM
AVFGLRENIVLLCISGFLFFAMMPFANTTLDFLVRTNIDNSVQGRAWSVI
GLISQLGFIAAYTLSGVLADYVFTPLLVDGGLLADSMGEIIGTGSGRGMG
LLIIIAGILLCVTSVFLYNLKSVKKLENRDGVVTCVLQNNP
>pE33L466_0414 mef, probable macrolide-efflux protein
MKSLKSIIHNKNLCIVLGSQLVFQLGIWFGTIGNLQFLQIHIKSHVLQAF
FLVIGGVLGVIIGPYAGRYIDSTSKLKVLQLVGLMRIASVLSMLVAIYTG
SIYWMVIYSIGIGCSASFFNPTIQTILPTLVKEDDLITVNAININIITLS
RIFGAVLAGLLLTVAPLYTLFIIALIAYVILYFINFLLVIPNNARLNPKK
LKTNFKDIFPIIIKNHSIKVVLTLSIIPLIFISGFNLFVIEIGKGQPGSI
MGILYFMEGVSILIAGLFIKKVIKRYQKQVRILLFTCCLMGIAQILLSLT
NFYLTIFSFSIFGLAYGMFNPLLYTYAQQKVPSNIHGRFFSFKTMLDRTI
MQLCLVLIGFLLDQIGYKSLMILLGISTLTLVFSIIINFKVNPKIYTNEN
KNNYSDV
>BCE33L1416 mgsA, methylglyoxal synthase
MKIALIAHDKKKDDMVSFAYAYKPIFEQHELFATGTTGLRIMEATGLVVT
RYQSGPLGGDQEIGAMIAKNDLDMVIFFRDPLTAQPHEPDVNALLRLCDV
YAIPLATNMASAEMLMHALERGDLDYRKLRK
>BCE33L1632 msmX, multiple sugar-binding transport, ATP-binding protein
MAELVLNHIFKLYDNKTTAVSDFNLHIQDKEFIVFVGPSGCGKSTTLRMI
AGLEDISDGSFYIDGKLMNDVAPKDRDIAMVFQNYALYPHMSVYDNMAFG
LKLRKLPKDEINRRVTEAAKILGLEDYLKRKPKALSGGQRQRVALGRAIV
RDAKVFLMDEPLSNLDAKLRVSMRSEISKLHRRLNTTTIYVTHDQTEAMT
MASRLVVMKDGIIQQVGTPKEVYDTPENVFVGGFIGSPAMNFFTGTLKDN
YFHIENIRFKVPEGQLKKLQKKGYNKKTLILGIRPEDIHDEPIVLQSSPD
STVEINVEVAELLGAETMIHGKLENQSFVARINARSELKAGDKLSVAFSL
TKTHFFDSETELRIRNN
>BCE33L3811 nagA, N-acetylglucosamine-6-phosphate deacetylase
MKTQVVINAKIYTGQEVVENGFIRYAETIKEIGLMAQYVSQENETVLDGA
GKIVIPGMIDVHIHGGYDIDAMDANSDGLVTLGKEMLKEGVTTYFPTTMT
QAPEAIEAALHAAKEAKEKGAHFEYIHLEGPYVSKKRAGAQPLEHIVPAN
IEQFKQWQEASGNLIKLVTYAPEEEGALEFEQYLAETGVVGTMGHTDAID
AQLKNRNITHATHLYNQMRGLHHREPGVVGHVLLNPDVMVEVITDGIHIH
PDMVKLAYKLKGPKKVSVITDAMRAKGLEDGLYELGGQPVHVKDGSARLE
DGTLAGSILKMDQAFRNVIEFTGCSIEDAVLMTSVNQAEEFGLNNKGALA
VGKDADFVVMNEDLHVYDTVRLGIHMKEGK
>BCE33L1640 nagA, N-acetylglucosamine-6-phosphate deacetylase
MNYYVKASMYLLEDGVREGGYLHIVNGYFLKHVEEIVDGALVMDFEGSII
SPGFVDTHIHGVAGHDVMDSTYESLNNISIMLLENGVTSFLPTTLTGYSE
NTMKALKNIAHAKKRGVEGANIIGAFLEGPCFTEVYKGAQNSKYFIDPTI
EMLEEWIVASEGTIKKIAMAPERKGTIACIHHAVKKNIHVAIGHTNANYE
ICQNAIQAGATIFVHTFNGMKGLHHREPGVVGAVLSTEHVYGEIIVDGHH
VHPSVVNILYKCKGYDKTCLVSDCMRAGLLGDGTYNLGEFVVQVQDGIAR
TEAGSLAGSTLRFIDGVKNIEKWTNASLWECVHMGSLIPAKSIGVDNEIG
SIAPGKRADFLILTEDLDLIGTVVGGEMKYKKNKERI
>BCE33L3810 nagB, glucosamine-6-phosphate isomerase
MNILVVKTPEELAEAGYKLIEEVVKTKENPTLGMATGSSPLGIYAEMRKN
KLDTSRVTTVNLDEYVNLPHEDKNSYHYFMQEQLFDHLPFKQTYVPNGMA
SDLEEECKRYEGILAANPVDLQILGIGENGHIGFNEPGTPFNSPTNIVEL
TESTRQANLRFFEKEEDVPTHAITMGIGSIMKAKQILLVAMGSKKAEAVK
ELLQGAYSEACPATVLQRHPNVTVIADQEALSLCSEAIADEHRQVFTISD
LLSDSRVGETAN
>BCE33L0411 nagE, PTS system, N-acetylglucosamine-specific EIIBC component
MLQFLQRIGKALMLPIAVLPAAGLLLRLGQEDVFNIPVMAQAGAAIFDNL
ALIFAIGVAIGLSVDGSGAAGLAGAIGYLVLQNTTNALSKTYSAAELNDK
LKSVQDLVGSVDPTKLADTMTKVSKAAALTPKINMAILGGIIAGVVAGLL
YNKFHKIKLPEWLGFFAGKRFVPIITSIVMLLLGLVFGQIWPTIQSGIDA
VAHGIVNLGSIGAGLFGLLNRLLIPIGLHHVMNTYFWFVLGDFTNAAGDI
VHGDIARFFAKDPSAGMFMTGFFPVMMFGLPAACFAMIAAAKPEKRKMVT
GMLGGLALTSFLTGITEPIEFSFMFLSPVLYGIHAVLTGLSLFITTTLGI
HDGFSFSAGAIDYVLNFGIATKPLLLAGIGLIYAAIYFVVFYFLIKKFDL
KTPGREDEEEMAEGEEAPVAGSIGETYVAALGGKENLTVIDNCATRLRLQ
VKDAGQVNEAALKRAGAKGVMKLSNTSVQVIVGTNVESVADDMKKHV
>BCE33L0684 norA, quinolone resistence protein, major facilitator family transporter
MYTPLSSSYCKPFQIYVVKKYISPSHSLLFESAFFKEKTISIIHNNYQSI
HLYFTSFFHSCVVFPQICQFFTSKIVVRFQGTFLDCFIGQYIYSKEKRNF
YIGDEYMGEAILVKREPLWTKEFFALILANLCMFLGFQMLIPTLPVYVKE
IGGTSSNIGFVVGMFTVAALFVRPLTGNALQKFSKKIILMIGTAICLLAM
GSYLFASTVFLLLAVRILHGAGFGITTTTYGTVVSDLIPQARRGEGMGYF
GLSGTIAMALGPLIGLWLMQTYNFTILFLCALSCTIVSLILTKLLQIKKS
PQPPKQISGTFLDGFIERKALLPSLLILCITLMYGGIGSFITLFATEVGI
ADISLFFLFNALAIAVTRPFSGKLYDAKGHSFVIIPGVIITFAGIILLSY
TTTIPSLIIAAACYGSGFGAIQPALQAWMIDRVAPHRRGVATATFFSAFD
LGIGAGAIIFGFIAHFTNYATVYRYSSLLLIAFLFIYITSVKKQKHGDKN
TEKAAG
>BCE33L2997 norA, quinolone resistence protein, major facilitator family transporter
MQSEKLWTKDFLGTCFSSLFLFLTFYMLMTTLPVYVIDGLKGKPEEIGLV
ATVFLISSVLCRPFTGKWLDDLGRKKILFISLSLFLAATVMYFGAQSLFL
LLALRFLHGIGFGMATTATGTIVTDVAPAHRRGEALAYFGVFMSLPMVIG
PFLGLTIISHFSFTVLFIVCSVFSLLAFLLGLLVNIPHEAPVSKQKQEKM
KWKDLLEPSSIPIALTGFVLAFSYSGILSFIPIYAKELGLADIASYFFIL
YALVVVISRPFTGKIFDRFGENVLVYPAIIIFTIGMFILSQAQTPFWFLG
AGMLIGLGYGTLIPSFQTIAISAAPNHRRGSATATYFSFFDSGIGFGSFI
LGIVAAKSSYHNMYFIAAIIVAFTLLLYYGLHGRKQKFKKQRTDGQISA
>BCE33L3771 nplT, neopullulanase
MLKEAIYHRPKDNYAYAYDEKTIHIRIRTKRDDVQSTTLIYGDPYEWKDG
KWISSSTPMKKTGSTALFDYWFISIEPKFKRLRYGFELKNDTDTLIYAER
GFFSTTPNDDVGNFFCFPFIHANDVFKAPSWIKDTVWYQIFPERFANGDH
TLNPENTLPWGSAEPTPTNFFGGDFAGIIQNLDYLVKLGISGIYFTPIFK
AHSNHKYDTIDYMEIDPQFGTKETFKELVQACHTHGIKVMLDAVFNHSGY
FFDKFQDVLQNGEQSAYKEWFHIHEFPIRTEPLPNYDTFAFTPYMPKLNT
AHPDVKEYLLEVGRYWVREFNIDGWRLDVANEVDHNFWREFRSEIKALNS
EVYILGEIWHDALPWLQGDQFDAVMSYPVTNALLSYFANDSIKANEFMKQ
ITESLHSYSMNVNEAAFHLLDSHDTPRILTTCNGDKNKLKLLYVFHLSFI
GSPCIYYGDEIGMDGGMDPDCRKCMVWDTEEQDHTLFTHVQTLISLRKQY
KAFGGHGTFQFIEANDEYNYISYTKTYEDETIFFVLNPTNSDITAALPLH
VTGKKIINIYTNEEFSAEASVLQVTLPPYGFSILKW
>BCE33L4896 pdaA, polysaccharide deacetylase
MIKRVFQYIILFLTITMYASPHAGATTIPPAEHHPNTEPTSSTKKIAYLT
FDDGPNKYTTQILNILKEKNGKATFFVIGGKVPHYKKTMQRLIKDGHYIG
LHSMSHDVKRLYTGDPSALITEMEQTQNIVQQVTKLNTHLVRVPYGSMPY
LKKNYRDALVSAQYKMWDWTIDTYDWKSYDNPSAILERVRNQSDEQVEVI
LMHDSSVTLQILPQVIDYLQSQGYKLLPYNPSSHLKVNFWKDTRL
>BCE33L1778 pdaA, polysaccharide deacetylase
MYYFYSPEGFAPYQWGLERDVSYAYMPYSLFYYGDYIRTLPYTYIPQSYE
VQMKADERGSWTPFSWVEKYAYAFSGPYNKAEVALTFDDGPDLEFTPKIL
DKLKQHNVKATFFLLGENAEKFPNVVKRIANEGHVIGNHTYSHPNLAKVN
DAEYRNQIIKTEEILNRLAGYAPKFIRPPYGEILEDQLKWATEQNFMIVQ
WSVDTVDWKGVSADTITNNVLGNSFPGSVILQHSTPGGHLQGSVEALDKI
IPQLKTKGARFVTLPSMFQTSKERK
>BCE33L4340 pfk, 6-phosphofructokinase
MKRIGVLTSGGDSPGMNAAIRAVVRKAIFHDIEVYGIYHGYAGLISGHIE
KLELGSVGDIIHRGGTKLYTARCPEFKDPEVRLKGIEQLKKHGIEGLVVI
GGDGSYQGAKKLTEQGFPCVGVPGTIDNDIPGTDFTIGFDTALNTVIDAI
DKIRDTATSHERTYVIEVMGRHAGDIALWAGLADGAETILIPEEEYDMED
VIARLKRGSERGKKHSIIVVAEGVGSAIDIGKHIEEATNFDTRVTVLGHV
QRGGSPSAQDRVLASRLGARAVELLIAGKGGRCVGIQDNKLVDHDIIEAL
AQKHTIDKDMYQLSKELSI
>BCE33L5065 pfoR, membrane protein; possible regulatory protein
MAILQGLALLLVVLCLFTLFSYRAPYGMKAMGALANAAIASFLIEAFHRY
IGGEMFHNKFLQSVGEASGSMSGVAAAILVALAIGVSPVYAVLIGIATSG
FGILPGFFAGYVCAFVVKFLEKKLPAGVEFLAILFIAAPISRGMAMLMDP
LVNATLGKIGSMISVATTESPIIMGIMLGGLITVISTSPLSSMALTAMLG
LTGLPMAIGSLAVAASAPMNFIFFKRLKICSKKDTIAVAIEPLTQADVVS
ANPIPIYATNFVGGALAGIITSLFQLVNNAPGTASPIPGLLVLFGFNDVV
KVTIAAVLCGIVTTIVGYIGSILFRKYPIRSADEIRGISSEEKVA
>BCE33L2661 pgd, peptidoglycan N-acetylglucosamine deacetylase
MHNGIRMTTLVKRAMLICAGVLFTYEAALGSTHTALASTEDEAKSVQLVS
EIQSSLAPKEAPKQYNGQVRKVAYLTFDDGPGKYTAELLDMLKKENAKAT
FFLIGSNVKAFPDLVKREDAEGHYVGMHSMTHNYKKLYTEGHYVDEMKED
QGLIAGVLGKSPVLTRPSYGSMPGLNEALRNKVVENGLKVWDWTIDSLDW
RYNKMPVDAASAKIVENVINGANKPTEVILMHDIHPQSVKAVPGIIKGLK
EKGYELEAYSENEHFPLNFWHDNRM
>BCE33L4630 pgi, glucose-6-phosphate
MSTHVTFDYSKALSFIGEHEITYLRDAVKVTHHAIHEKTGAGNDFLGWVD
LPLQYDKEEFARIQKCAEKIKNDSDILLVVGIGGSYLGARAAIEMLNHSF
YNTLSKEQRKTPQVLFVGQNISSTYMKDLMDVLEGKDFSINVISKSGTTT
EPALAFRIFRKLLEEKYGKEEARKRIYATTDKARGALKTLADNEGYETFV
IPDDVGGRFSVLTPVGLLPIAVSGLNIEEMMKGAAAGRDDFGTSELEENP
AYQYAVVRNALYNKGKTIEMLVNYEPALQYFAEWWKQLFGESEGKDQKGI
FPSSANFSTDLHSLGQYVQEGRRDLFETVLKVGKSTHELTIESEENDLDG
LNYLAGETVDFVNTKAYEGTLLAHSDGGVPNLIVNIPELNEYTFGYLVYF
FEKACAMSGYLLGVNPFDQPGVEAYKKNMFALLGKPGFEELKAELEERLK
>BCE33L4827 pgk, phosphoglycerate kinase
MNKKSIRDVDLKGKRVFCRVDFNVPMKEGKITDETRIRAALPTIQYLVEQ
GAKVILASHLGRPKGQVVEEMRLTPVAARLGELLGKDVKKADEAFGPAVQ
EMVAAMNEGDVLVLENVRFYAGEEKNDAELAKEFAALADIFVNDAFGAAH
RAHASTAGIADYLPAVSGLLMEKELEVLGKALSNPERPFTAIIGGAKVKD
KIGVIRHLLDKVDNLIIGGGLAYTFVKALGHEIGLSLCEDDKIELAKEFM
QLAKEKGVNFYMPVDVVITEEFSETATTKIVGIDSIPSNWEGVDIGPKTR
EIYADVIKNSKLVVWNGPMGVFEMTPFAEGTKAVGQALADAEGTYSVIGG
GDSAAAVEKFGMADKMSHISTGGGASLEFMEGKELPGVVCLNDK
>BCE33L1849 pgm, phosphoglycerate mutase
MKTTVYVTRHGETEWNVAKRMQGRKNSALTENGILQAKQLGERMKDLSIH
AIYSSPSERTLHTAELIKGERDIPIIADAHFYEISMGIWEGQTIDDIERQ
YPNDIQLFWYEPHLFQSTSGENFEAVHKRVIEGMQILLEKHKGESILIVS
HAAAAKLLVGHFAGIEIENVWDDPFMHSASLSIIEFEEDKGEVKQFADIS
HFQ
>BCE33L3503 pgm, phosphoglycerate mutase
MNTYIYMVRHGESPKLDGGERTRGLTEKGSLDVHRVTDILKTEGIDTFIS
SPYKRAVLTIEKTANLYEREILIYENLKECMFSSGDQVISDKEVYPLVKK
MFSNPDFARTEGESYTDCQRRVVKVLREILMDFQGQKIVIGTHGLVMTLM
MNYFDEQYDFEFLMNTSKPDIYKMEFNEEQLMNVERLWKAK
>BCE33L1096 ppnK, probable inorganic polyphosphate/ATP-NAD kinase 1
MKFTIMSKGDQSSDTLASTMKEYLLDFGFIMDEQEPDIVISVGGDGTLLY
AFHRYYNRLDETAFVGVHTGHLGFYADWLPTEVEKLVIAIAKTPFQVVEY
PLLEVIIRYMNGSKESQYLAMNEATVKSAEGTLVTEVEIRGEYFETFRGD
GLCISTPSGSTAYNKALGGAIIHPSIEAIQIAEMASINNRVFRTVGSPLV
LPKHHTCVLKPTAGMNLQITVDHLTMVHQDVKSIQYRVANEKVRFVRFRP
FPFWKRVRDSFVADK
>BCE33L4386 ppnK, inorganic polyphosphate/ATP-NAD kinase
MADRRNLFFFYGDDKAKLVEKMKPIYRILEENGFTILDHPKNANAIVSVG
DDATFLQAVRKTGFREDCLYAGISTKDEISFYCDFHIDHVDTALQEITKN
EIEVRKYPTIEVDVDGSTSFHCLNEFSLRSSIIKTFVVDVHVDDLYFETF
RGDGLVVSTPTGSTAYNKSLRGAVVDPLIPCFQVSELASLNNNTYRTLGS
PFILNHERTLTLKLRPDGNDYPVIGMDNEALSIKQVEKAVVRLSDKQIKT
VKLKNNSFWEKVQRTFL
>BCE33L2825 ppsA, phosphoenolpyruvate synthase
MSSFVLDFQEIEKGQLSLVGGKGLNLGELSNIQGIEVPEGFCVTTVGYEK
AIEQNENLQTLLQQLTKLKLEDRAQIGEMSKEIREVIMAVQIPSDVVEAV
AHYLSRFGNEHAYAVRSSATAEDLPYASFAGQQDTYLNIIGKEAILQHVR
KCWASLFTERAVMYRMQNGFKHNQVSICVVVQKMVFPEASGILFTADPIT
SNRKVLSIDASFGLGEALVSGLVSADNYKVIEGKIVDKVISTKKVAIYAL
KEGGTETKQINSAQQKIQTLSEQQILQLAQIGRQIEAYFGYPQDIEWCLV
DNAFYIVQSRPITTLYPIPEENDEGNHVYISVGHQQMMTDAMKPLGLSFF
LLTTNAPMRKAGGRLFVDATQRLASPASRDYLINTLGKSDPLIRDALTTI
IERDDFITLLPDEEKKEKSASKSKLPVSSQPEIENDPAIVTELIRNSEAS
LEELKQNMQLKSGVDVFDFILEDIQQLKKVLFNPQSIAVIMAGMNASTWM
NEKMEQWLGEKNAADTLSQSVQNNITSEMGLALMDVADAIRPYPEVITYL
QHVENDSFLDEFVQFKGGEKAREAIDAFLNKYGMRCSGEIDITKTRWSEK
PTTIIPMILNNIRDFEYGASKRKFEEGLQEALKKEEELVDRLQQLPDGKQ
KVEETKRMIRNIRNFIGYREYPKYGMINRYFIYKQALLKEAEQLVQSGVI
HEVDDIYYLTFEELHEVVRTKKLDYEIIHKQKNDYKLYEKLTPPRIMTSD
GEIITGKYKRENLPADAIAGLPVSSGVVEGRARVILNMEDANLEEGDILV
TAFTDPGWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKL
IKDGQRIRVHGTEGYIEVL
>BCE33L2113 prpB, carboxyvinyl-carboxyphosphonate phosphorylmutase; possible methylisocitrate lyase
MAWVVNKQSTQEELANRFRALVEANEILQIPGAHDAMAALVARNTGFSAL
YLSGAAYTASKGLPDLGIVTSTEVAERARDLVRATDLPVLVDIDTGFGGV
LNVARTAVEMVEAKVAAVQIEDQQLPKKCGHLNGKKLVTTEELVQKIKAI
KEVAPSLYIVARTDARGVEGLDEAIERANAYVKAGADAIFPEALQSEEEF
RLFNSKVNAPLLANMTEFGKTPYYSAEEFANMGFQMVIYPVTSLRVAAKA
YENVFTLIKETGSQKDALSNMQTRSELYETISYHDFEELDTGIAKTVLSE
DQ
>BCE33L0344 ptsG, protein-N(pi)-phosphohistidine-sugar phosphotransferase (enzyme II of the phosphotransferase system) (PTS system glucose-specific IIBC component)
MKITSFDFWQKFGKALLVVVAVMPAAGLMISIGKLIGMSAGDINAVHTIA
RVMEDIGWAIITNLHILFAVAIGGSWAKDRAGGAFAALLAFVLTNRITGA
IFGVNAEMLADSKAKVSSVLAGDLIVKDYFTSVLGAPALNMGVFVGIITG
FLGATLYNKYYNYNKLPQALAFFNGKRFVPFVVIVWSTVTAIVLSLLWPF
IQSGLNEFGRWIAASKDSAPIVAPFVYGTLERLLLPFGLHHMLTIPMNYT
ELGGTYTMLTGSKVGQVVAGQDPLWLAWITDLNNLLANGDTKAYNDLLNN
VVPARFKAGQVIGSTAALMGIAFAMFRNVDKEKRAKYKPMFLSAALAVFL
TGVTEPIEFMFMFIAPVLYVVYAITTGLAFALADLINLRVHAFGFIELIT
RTPMMVNAGLTRDLINFVIVSLVFFGLNFTLFNFLIKKFNLPTPGRAGNY
IDNEDEASEGTGNVQDGSLATKVIDLLGGKENIADVDACMTRLRVTVKDL
DVVAPEAQWKQNGALGLIVKDKGVQAVYGPKADVLKSDIQDMLGA
>BCE33L3806 ptsG, PTS system, glucose-specific IIABC component
MFKKIFGVLQKVGKALMLPVAILPAAGILLGFGNAFQNPQLTNVIPALKA
DWFVMVAKIMEQSGDIIFANLALLFAVGVAIGLAGGDGVAGLAAFVGYLI
MNKTMSVFLEVDKLVKVTSSGADPVKIGFTDPAYANVLGIPTLQTGVFGG
IIVGIVAAYCYNKYFNIELPSYLGFFAGKRFVPIATATFSLVVGIIMCFV
WPYIQGGLNTFSHQMIDANRTLAAFIFGLIERSLIPFGLHHIFYSPFWFE
FGQYTNAAGELIRGDQKIFMAQLKDGVELTAGTFTTGKYPFMMFGLPAAA
LAMYHEARPENKKLAAGILGSAALTSFLTGITEPLEFSFLFVAPVLFGIH
AVFAGLSFMTMQILGVKIGMTFSGGLIDFMLFGVLPGRTAWWWVIVVGLV
LAVIYYFGFRFAIRKWNLKTPGREVANANDGAGKAEAGELPREVLVALGG
KENIASLDACITRLRVQVNEQKNVNKDRLKELGAAGVLEVGNNIQAIFGP
KSDTLKSQIHDIMSGRTPHVEKEEPVKVEEAPQKVDANETIVSPIEGKIL
PITEVPDQVFSGKMMGDGFAIEPTEGTVVSPVNGEIVNVFPTKHAIGIQS
EGGKEILIHFGIDTVKLNGEGFEALVAQGDKVKQGQPLLKVDLAFVKENA
PSIITPIVFTNLQQGQQVELKKDGNVKKGENAIIDIQ
>BCE33L3805 ptsH, phosphocarrier protein HPr
MEKIFKVTSDSGIHARPATLLVNTASKFGSDINLEYNGKNVNLKSIMGVM
SLGIQQNAEIKITANGDDAAQALAAIEETMKNEGLGE
>BCE33L4845 ptsH, phosphocarrier protein HPr
MVQKRVQVSLKNGLQARPAALFVQEANRFHADIFIEKDGKTVNAKSIMGI
MSLAIGTGSMITITTEGSDAEEALEALAAYVQ
>BCE33L3804 ptsI, phosphoenolpyruvate-protein phosphotransferase
MTLNIQGIAASSGIAIAKAFRLENPEFNIEKKSITNEAAEIARLEAALEK
AKTELEAIKDHAFAELGADKAAIFEAHLLVLNDPELVNPVKDKVTSEKVN
AEFAMDEVASMFISMFENMDNEYMKERAADIRDVTKRVLAHLLGINFSNP
GTISEEVIIIAEDLTPSDTAQLNRKYAKGFTTDIGGRTSHSAIMARSMEI
PAVVGTKVVMEKIQNGDIVIIDGLDGEVIVNPSEETLRSFEEKKAKFEEQ
KAEWAKLKDQATVTSDGHHVELVANIGTPNDVQGIIDNGGEGVGLYRTEF
LYMGRDNLPTEEEQFEAYKAVLEGVKEGQPVVVRTLDIGGDKELPYLHLP
KEMNPFLGYRAIRLCLDEQDVFRTQLRALLRASVYGNLKIMFPMIATLDE
FRQAKAILLEEKAKLVEAGTTVSDSIEVGMMVEIPASAVLADQFAKEVDF
FSIGTNDLIQYTMAADRMNEQVSYLYQPYNPSILRLVKMVIDAAHKEGKW
AGMCGEMAGDSLAIPLLLGLGLDEFSMSATSILPARTQLSKLSKVEMETL
AEKALMMSTAEEVVELVKSI
>BCE33L2463 pulA, pullulanase
MTKRLINKSVLLLTIIVMLSSVYSFQNVKAVSNSKTTEVIIHYKEQSGNT
KDWNLWIWGENSNGKSYEFTGEDEFGKYAKINIDGDYNRLGFIIRTSEWE
KDGGDRWIENIKDGRAEVWILSGDEKVYNSKPSSDLSIQKATIDSFHEIT
VTTNVPFHIKEKKIEMEGIKIKSISPYDINSGDITNKVKIITDQKIDLKQ
TYKVKIENLADTNTEIGKVIRTEEFDKLFYYGGNDLGNIYTPQHTKFRVW
APTASEAKLVTYKKWNDKIGTEINMQQGEKGTWKAELKGNQKGLYYTYKV
KIGDKWTEAVDPYARAASVNGDKGAVVDLEETNPKRWNTNKKPKLKNPED
AIIYELHVRDLSIQPESGIKQKGKYLGVTEKGTKGPEGVKTGLDHMKDLG
VTHVQLLPIFDYASVNEEKVNEPQYNWGYDPKNFNVPEGSYSTNPYEPTV
RITELKQMIQTLHDNNLRVVMDVVYNHMYNAAESNFHKLVPGYYYRYNED
GTFANGTGVGNDTASERKMMRKFMIDSVTYWAKEYNLDGFRFDLMGIHDY
ETMNEIRKAVNQIDPSIILHGEGWDLNTPLAAELKANQKNAEKMKGIAHF
NDNIRDGLKGSVFEEKENGFVNGKENMEDRIKKGITAGIDYDTNSSTYLD
PEQVLTYVEAHDNHTLWDKLELTNPGDSEEARKQMHKLSSSILLTSQGIP
FLHAGQEFMRTKYGDHNSYKSPDSINQMDWLRRAAFNNEVDYMKGLIELR
KKYPAFRMTSAEQIKTHVSFIDAPKNTVAYTIEGNKNEYFTVAHNANRES
VEISLPSKGPWKVLVDGKQAGSKPLYVVHDNKIKVPALSSLVLKTEKPIK
>BCE33L3030 pykA, pyruvate kinase
MTIDRVCTIGPASNNKETLAQLINNGMKIVRLNLSHGTHESHKDIIRLVK
SLDASIKILGDVQGPKIRLGEIKGEQITLQAGDSFMLRTQPGTGSNREAS
IDYEGIANDVKVGSRILMNDGEVELIVEKVSTDKIETKVKTGGNISSHKG
VNLPGAIVSLPAITEKDKKDIQFLLEEDVDFIACSFVRKPSHIKEIRDFI
QQYKETSPNLIAKIETMEAIENFQDICKEADGIMIARGDLGVELPFQFIP
LLQKMMIQECNRTNTYVITATQMLQSMVDHSIPTRAEVTDVFQAVLDGTN
AVMLSAESASGEHPVESVSTLRLVSEFAVHVKKDGPFVMKDVLELLHKSL
DE
>BCE33L4339 pykA, pyruvate kinase
MRKTKIVCTIGPASESIEKLEQLIEAGMNVARLNFSHGSHEEHGARIKNI
REASKKTGKTVGILLDTKGPEIRTHDFVDGQAELVTGAEVVLSTEQVLGT
AEKFSVSYAGLYDDVDPGSRILIDDGLIELEVIEKADGNIRTKVLNSGTV
KNKKGVNVPNVSIKLPGITEKDVKDIIFGIEQKVDFIAASFVRKAADVLE
IRELLEEHNAQYIQIVPKIENQEGIDNIDSILEVSDGLMVARGDMGVEIP
PEEVPLVQKRLIKKCNVLGKPVITATQMLDSMQRNPRPTRAEASDVANAI
FDGTDAIMLSGETAAGQYPVEAVTMMANIAVRVEKSLQYEDMFKKRIKEF
TPTITDAISQSVAHTALALDVAAIVAPTESGYTAKMISKYRPKSPIVAVT
SDEQVGRRLALVWGVQAFMAEKRAASTDEMLDTAIQTGMDAGLIGLGDTV
VITAGVPVAETGTTNLMKIHVVGEEVAKGQGIGRKAAKGKVVVAKTAAEA
VANVNEGDILVTTSTDKDMIPAIEKAAALVVEEGGLTSHAAVVGVSIGIP
VIVGVNGVTATLKNGQEVTVDAARGIVYNGHAEVL
>BCE33L3793 rbcL, ribulose-bisphosphate carboxylase (ribulose 1,5-bisphosphate carboxylase, large subunit)
MSGIIATYLIHDDSHNLEKKAEQIALGLTIGSWTHLPHLLQEQLKQHKGN
VIHVEELAEHEHTNSYLRKKVKRGIIKIEYPLLNFSPDLPAILTTTFGKL
SLDGEVKLIDLTFSDGLKKHFPGPKFGIDGIRNLLQVHDRPLLMSIFKGM
IGRNIGYLKTQLRDQAIGGVDIVKDDEILFENALTPLTKRIVSGKEVLQS
VYETYGHKTLYAVNVTGRTFDLKENAKRAVQAGADILLFNVFAYGLDVLQ
SLAEDDEIPVPIMAHPAVSGAYSASKLYGISSPLLLGKLLRYAGADFSLF
PSPYGSVALEKEEALAISKYLTEDDVFFKKSFSVPSAGIHPGFVPFIIRD
FGKDVVINAGGGIHGHPNGAQGGGKAFRTAIDATLQNKPLHEVDDINLHS
ALQIWGNPSHEVKL
>BCE33L0577 rbsA, ribose ABC transporter, ATP-binding protein
MRIEMKNISKAFNGNPVLKNAQFMIETGEVHALMGENGAGKSTLMKILTG
VYKRDGGTITIDGQERTFKNAKEAEEYGIAFIHQELNILPNLTVAENMFL
GKELMYGKTGILRTRQMNAIAQQQLAELGLHVKGAMLAGELSVGQQQIIE
IAKALMTNASVIIMDEPTAALTDREIETLFTVINKLRKEGVSFVYISHRM
EEIFSICDAITILRDGEYVGKRSIPETSFDEVVSMMVGRSIGERYPERNS
QISDVIFEMRNGTKKGKFENVSFQVRKGEILGVAGLMGAGRTDIMKSIFG
YEPLDSGQIFINGQEVKIDSPIDAIRQRIAFITEDRKSEGLVLDFSIREN
LALPNLESLSKGSVLSNELEQQFTADMMKLLNVKASSGEQAVKSLSGGNQ
QKVVIAKWLGIHPQLLILDEPTRGVDVGAKKEIYSIMNKLTEEGDAVIMV
SSELPEVLGMSDRVLVIHEGKVGGILEKDEASQESIMALATGGE
>BCE33L0579 rbsB, ribose ABC transporter, ribose-binding protein
MKKWLLILVACMMVITAGCSMEPPEWAKDSSDKGRNKTIKVGFSVSTLNN
PFFVTLKKGAEKKAKESGIELIAVDAQNDAAKQTNDVEDLIQKGVDVVVI
NPTDSDAVASAVSAANAANVPVITVDRVANSGKVVSHIASNNIEGGQMAS
DYIRELVGEGANVAELEGIPGSSAARERGKGFHNVADKSLKVVAKQAADF
DRAKGLSVMENILQANGDIKAVFAHNDEMALGALEALKSAGKTDVVVVGF
DATEDAVKAVNDGRMAATVAQKPELIGEKAMQTAKEITQGKKVDKSIPIE
LELIKKNK
>BCE33L0578 rbsC, ribose ABC transporter, permease
MAKKGNVLQQLGSLIGLALIIVVITALNPAFIEIPNLFNILRQVSINALI
AFGMTFVILTGGIDLSVGSILALSSALVAGMMASGMDPFLAMAVGLLAGL
VMGIVNGIIIAKGKVAPFIATLATMTIFRGLTLVYMDGRPITGLGDHLMF
QMFGRGYFLGIPVPAVTMMIAFAVLYFILKKTTFGRRTFAIGGNEEAAAL
SGINVTRIKVMIYGLSGILAALAGIVLTSRLDSAQPTAGTSYELDAIAAV
VLGGTSLSGGRGWIVGTFIGVLIIGVLNNGLNLLGVSSFFQQVVKGLVIL
LAVLIDRRKEA
>BCE33L0576 rbsD, ribose ABC transporter, permease
MKKHGVLNSEIAAVLASLGHTDTIVIADCGLPIPDGVKRIDLAVEIGKPS
FLDVLQVVADDMAIEKVTLAEEVINNNAEIKKEIELKLIEPVFEYVCHEQ
FKEHTKKAKAIIRTGEATPYANVILHAGVIF
>BCE33L0575 rbsK, ribokinase
MPNIAVIGSISMDLVAVSKKRPKAGETVIGEAFHTIPGGKGANQAVAAAR
LGANVAMVGAVGDDNYGTVVKKNLENERVFIDYVVPVTDTATGIAHIVLA
EEDNSIVVVQGANALVNESIVNRSKDLLIKADMVVLQLEIPLETVKYVLA
ICEEHKIPVMLNPAPAQVLSEDILEKATYITPNEHECRIVLDDFTSPIED
LLAKYPNKLLMTEGSNGVRFHNGAEIVHVPSIAVDVVDTTGAGDTFNGAL
AVALSEGETLQKAIRFANIAGGLSVTKLGAQGGMPTRDRVREVQVIVG
>BCE33L3070 rfbG, CDP-glucose 4,6-dehydratase
MASSSFWNKKKVFITGHTGFKGSWLTLFLTSLGAEVVGFSSHPPSIPNLF
EQGNVAKECITIHGNITDYDSLFHTLKQHNPDILFHLAAQPIVTTSYKNP
IETFKTNVLGTVHVLEAAKHIESIRGIINVTSDKCYENDGSGNQAFVESD
RLGGFDPYSASKACAEIVATSYHKSFFRTNTQKLASVRAGNVIGGGDWAE
DRLFPDIIRAYLQDDTLTIRNKNAIRPWQHVLDPLHGYILLAEKLWTDAE
YAEAWNFGPLNEPNRTVHDVIQSVIKLWNKQLTITSPSTNAPYESPVLTL
DSTKAVNKLNWTPKLSTDNAIAWTVDWYKQYASGENIESFTRQQIDAFKN
L
>BCE33L4168 rhaT, permeases of the drug/metabolite transporter (DMT)
MNRINRMYVIMLFVPLFWGGSFATAEHVLTEIPPITAATIRFGLAGCILI
GIVFMKSEWNTGLLLKNWKGLLFVSLTGIFGYNVFFFMGLNYTSTLNGSL
IIATMPVFVTLGAILFFKESWSIKVGISLILSLIGVIVVITSGSLDTLMS
LSFNKGDLLFIAALICGVLYSLTGKKVMRGVSPLLTTMSMTVLGTVFLAG
LSLYEDGWGKVGAFSLQGWIEMLYMVICGTLIGYIVFNKGVEELGASKAS
MYLNLTLTPIVATSISVVLYGAAVTWQQIAGMIIVLIGVYIATVKSNKDI
KKLSHNQYASK
>BCE33L3619 rpe, ribulose-phosphate 3-epimerase
MIKIAPSILSADFSKLGEEIKDVEKGGADYIHVDVMDGHFVPNITIGPLI
VEAIRPITSLPLDVHLMIENPDNYIPTFAKAGADIITVHVEACPHLHRTI
QLIKSHGIKAGVVLNPHTPVSVIEHVLEDIDMVLLMTVNPGFGGQKFIHS
VLPKIKQVAEMVKERNLEVEIEVDGGVNAETARLCVEAGANVLVAGSAVY
NQKDRGEAIRIIRG
>BCE33L5017 rpi, ribose 5-phosphate isomerase (ribose 5-phosphate epimerase)
MKVVIASDHGGMNIRKELVSLLEELNIEYIDLGCECEAGSVDYPDFAFPA
AEMVANGEVDRGILVCGTGIGMSIAANKVNGIRCALVHDTFSARATREHN
DTNMLAMGERVIGAGLARDIAKIWLTTEFEGGRHENRVGKIKTYEAK
>BCE33L2521 rpiA, ribose 5-phosphate isomerase
MDLKQIAGEYAATFVKDGMKIGLGTGSTAYWTIQKLGQRVKEGLSIQAVP
TSKETEALAQQLNIPLISLNDVQSLDLTIDGADEIDSNLQLIKGGGGALL
REKIVASSSKELIIIIDESKVVTRLGTFPLPIEIIPFAWKQTESKIQSLG
CQTTLRLKNNETFITDNNNMIIDCIFPNHIPTPSDLHKRLKMITGVVETG
LFVNMTSKAIIGTKNGIQEL
>BCE33L0719 scrA, PTS system, sucrose-specific IIBC component
MRKEERMAKEISEQLGGVKNIRGIAHCMTRLRLTLQDESKVNMDLLKKVE
GVMGVIEDETLQVVVGPGTVNKVAAEMEGLTGLRIGEVADHHLEDLGQEM
KSEIKKKNNTPVKNFLRKIGSIFIPLIPGLVASGIINGVANFAKNAGADP
NATWLQMLLLIGGGIFTFLGILVGWNTAKEFGGTPVLGAIAGILIFNPAM
ANVKLFGEALVPGRGGLFAVIFAAWLMVVVERQVRKAVPNAVDIIITPLI
TVLVVSIVTMLAIQPVAGFLSEGITSGINGILSIGGAFAGAVLAGTFLPL
VMVGLHHGLTPIHMEFINQTHVTPLLPVLAMAGAGQVGAAIAIFVKTKNK
RLRNVIKGALPVGFLGIGEPLLYGVTLPLGKPFLTACLGAAVGGAFQAVM
KTAALGIGVSGLSLIPLIADNKYLLYFLGLVVAYTFGFIFTYFFGFKEEM
AENI
>BCE33L4839 spoVAC, stage V sporulation protein AC
MSSKDKNLTPVQQEYKKFEQEREPKRPVLKNCIKAFFVGGFICFIGQLIS
TFYITYFDFTERSAGNPTVATLIFISMLLTGFGIYDRFGQFAGAGTAVPV
TGFGNSVIAACIEHRTEGFVLGVGGNMFKLAGSVILFGVFSAFVIALIKT
ILVQWGGL
>BCE33L3825 spoVAC, stage V sporulation protein AC
MTGRKLKDDYVNKVKEYHPKPNYFINCVKAFLVGGLICTIGEVLMKFYIH
YFHFSEQEAGNPTVATLVLLSAILTGCGVYDKIGQFAGAGSAVPVTGFAN
SMASAALEHKSEGIVLGVATNMFKLAGSVIVFGVVGAYVIGLIRYTFKIF
MS
>BCE33L3718 suhB, myo-inositol-1(or 4)-monophosphatase
MQEVWKDIDAHAKQWIRDAGEHLMASMKKALIIETKSNAADLVTNMDREI
EQFLIGKIKETFPHHNILGEEGYGDEVTSSDGVVWLIDPIDGTMNFVHQK
RNFAISIGIYENGIGKIGLIYDPVHDELYHALKGAGAFCNEVPIPLLQRG
TVEQGVVALNAIWLTDNPLLNMESMMALVKKARGTRSYGCAALEMVYVAT
GRIDAYVTPRLSPWDFGGGQIIVEEVGGKVTTFSGTPLSIVEKSSVLVAK
PGVYEEVLSFISK
>BCE33L4966 tagG, teichoic acid translocation permease; teichoic acid ABC transporter, permease
MSAIKTILKEQYENIYLIHRLSLYELKQAYAGNLLGILWVFLNPFTQIGV
YWLIFGLGIRGGAPVNGVPYFVWLVCGLVPWFFISTTILQGSNSVHSRLS
TVSKMNFPLSIIPTYVVLSQFYTHCILVMFMLVISLVSQGWHMINIFTLL
YGMFSVTIFLIALGFITSTLSTMLRDVHLFIQSLTRMLFFLTPIFWEPKE
NMPEAFLFLVKINPFYYILEIYRSALVYNQSSIVFSGYTLYFWGTVVILF
IIGSMVHIKFRKQFVDYL
>BCE33L4965 tagH, teichoic acid export ATP-binding protein
MNYTVKFQNVTKKYKMYNKPSDKLKDLFRKQEDGVFHYALSNVSFEVPKG
EIVGIIGLNGSGKSTLSNLIAGVTMPNKGKIDIKGSAALIAISSGLNGQL
SGIENIELKGLMMGLTKEKVKEIIPQIIEFADIGKFINQPVKTYSSGMKA
RLGFAISVNINPDVLVIDEALSVGDQTFTNKCLKKMNEFKEKGKTIFFIS
HSLNQVNSFCTKAIWLYYGQVREYGDVNDVVANYRAFLKEYNQMSMEDRK
KFQEEQVLQFQHGLLQDYAKETLTNPRRLKGERRKYKKKNRVILGISLAL
MAGIISVGVYYKDIFPIKQDTQHVKQAVQGEDTNEAKQDKRQRVEENMYM
VKSNGINIRKEASASSEKLAVANFGDIITIFDDNKSKEKDAEWIQVSLSK
GEIGWVSTKFIEPFKSNDSIIEDAKLADITALLKRVYGENMASAPTYFGK
TLNELKATYPQPLNPLPSMAGKTIVKDGNIQFGILQDKVVEVVFQDISMS
IAKLHELLGKESLSNDVEKNYFYETKSYYIAARSDQTHREIQSISIVKK
>BCE33L3080 tal, transaldolase
MKFFIDTANLEDIKKAYKLGVLAGVTTNPSLVAKEGIKFEDRIAEICQAV
PKVESVSAEVTPDAVTAEEMIAQAEELIKINGGDEKVTIKLPMTLAGLEA
CRYLTEKGVKTNVTLIFTVNQALLAARAGATYVSPFLGRLDDISEDGVLL
VAKIAELFDVHQLDTQIIAASVRHPDHVTRVAMAGAHIATIPYKVIEQLA
MHPLTDQGIEKFAADWAKAPKL
>BCE33L0580 tal, transaldolase
MKFFIDTANINEIKEANALGVLAGVTTNPSLVAKEGVDFHERIREICNVV
EGPVSAEVISLEADKMIEEGKELAKIAPNVVVKVPMTTEGLKAVKAFSDL
GIRTNVTLVFSAVQALLAARAGATYVSPFLGRLDDIGHNGMDLIRQIAEI
FAIHGIETEIIAASVRHSVHVTDAALNGAHIATIPANVIASLVKHPLTDQ
GIEKFLADWEKTQEK
>BCE33L0173 tcaB, drug resistance transporter Bcr/CflA subfamily; possible bicyclomycin resistance protein
MNEVNQEIYKPVKTNRLWMILVLGTLTAIGPLSIDMYLPSLPKLTDDLQT
GASLAQLTLTACLLGLSVGQLFVGSISDIYGRRKPLIIALIIYVASSLLC
AVAPSIWTLVLLRFLQGASGSAGIVISRAMVRDMYSGSEMTKFFSLLMLV
NGAAPILAPIIGGQLLQFTTWRGVFIVLGAISVFMLISATFVLRETLPPE
ERETGGLSGTLATYGKLLKDRLFMGYALSQGLVTAAMFAYISGSPFVLQN
IYGASPQQFSLFFAINGIGIIIASQVTGRLAGKVNEKTLFVSGIIIAAVG
GLSLLLTILLGIGLIGVLCSLFLVVSSVGVVSTTGFSLAMRNQKQAAGTA
SALLGLLQFISGALVAPLVGIGGSNTALPMGIVIAICEIGAVLCYLFMAR
RSEKQFELQARQNLEV
>BCE33L0948 tetB, metal-tetracycline/H+ antiporter
MVDHSSQNADKLLGVLVVTLIFSVMNGTMFNVALPEIGKEFNLVPSEVSW
IMTSYMVVYAVGSIVMGKLADKYRLKDLLTYGLLIFALGSLLGLLATEYW
VIILGRVIQAAGASVLPATAMIIPVRYFAPEKRGRALGTSAVGLALGNAL
GPVAAGLITSFGSWRLMFVLSLLPLLTLPFFRKYLDNAKGKAGSIDILGG
GLLAVSVAFFLLAITQMQVLLFLGGFAMLAFFILRIRKAKEPFIKPILFK
NKNFSIGLLLAFMTTAMSFSMTFMTPQFLSAVNGLTPSNIGFVLVPAAIA
SAIMGRKGGRVADTRGNFALVFIASVFIFLAFSLLSTFIGVSAFVIALIL
IFGNVGQTFMQISMSNTISQTLSKEETGVGMGLLSMINFISGAMAMSVVG
KLLDKGSTSLKLNPFVANEAANMYSNIFGVMSLWILFVVVLYRLQFGMGA
STLNMTNKGSKNL
>BCE33L3388 tkt, transketolase
MSHSIEQLSINTIRTLSIDAIEKANSGHPGMPMGAAPMAYTLWTQFMKHN
PNNPTWFNRDRFVLSAGHGSMLLYSLLHLSGYDVTMDDLKNFRQWGSKTP
GHPEYGHTAGVDATTGPLGQGIATAVGMAMAERHLAAKYNRDAYNVVDHY
TYAICGDGDLMEGVSAEASSLAAHLQLGRLVVLYDSNDISLDGDLNRSFS
ESVEDRYKAYGWQVIRVEDGNDIEAIAKAIEEAKADEKRPTLIEVRTTIG
FGSPNKSGKSASHGSPLGVEETKLTKEAYAWTAEQDFHVAEEVYDNFRKT
VQDVGETAQAEWNTMLGEYAQAYPELANELQAAMNGLLPEGWEQNLPTYE
LGSKAATRNSSGAVINAIAESVPSFFGGSADLAGSNKTYMNNEKDFTRDD
YSGKNIWYGVREFAMGAAMNGIALHGGLKTYGGTFFVFSDYLRPAIRLAA
LMQLPVTYVFTHDSIAVGEDGPTHEPIEQLAALRAMPNVSVIRPADGNES
VAAWRLALESTNKPTALVLTRQDLPTLEGAKDDTYEKVAKGAYVVSASKK
ETADVILLATGSEVSLAVEAQKALAVDGVDASVVSMPSMDRFEAQTAEYK
ESVLPKAVTKRFAIEMGATFGWHRYVGLEGDVLGIDTFGASAPGEKIMEE
YGFTVENVVRKVKEML
>BCE33L3082 tkt, transketolase (glycoaldehyde transferase)
MIQNINQLAVNTIRTLSIDAINAANSGHPGLPMGAAPMAYALWANHLNHN
PNHPKWFNRDRFVLSAGHGSSLLYSLLHLAGYDVSIDDLKNFRKLNSKTP
GHPEFGHTSGVEATTGPLGQGIANAVGMAMAEAHLAAKFNKDGHSIIDHN
TYALVGDGDLMEGVAYEAMSMAGHMKLGKLIVLYDSNEISLDGELNIAFS
EDMQKRVESAHWQYIRVEDGNDVDAITKAIQLAKDNADQPTLIEIRTIIG
YGSPKVAGTNKAHGNPLGLEEATATKQVYGWHYEEDFFVPEEVTAHFNEL
KQKGIEKENGWNEQFNLYRESNPALADELEKAITGEVLIEAKDILSFDTE
KTISTRVASGEAINHYVKSIPSIFGGSADLSHSTMTDIKGEAVYAVESYA
GRNIYFGVREHAMGAAANGLALHGGVKPFVSTFFVFNDYLRPSIRLAALQ
KLPVTYVFTHDSIAVGEDGPTHEPIEHLAALRAIPGLTVIRPSDANETAS
AWAYALQQTDGPVVLVLSRQNLPVFNETKANIENLSKGAYVLTQTNENPD
VILIATGSEVSLAASAKAKLEEDNVSVRIVAMPSWELFDHQSKEYKESVL
PSSVTKRVSLEMGVSLGWERYVGQEGNILSIETFGASGTGAEVMNLFGFT
TENVVQITKNVLNS
>BCE33L4826 tpi, triosephosphate isomerase
MRKPIIAGNWKMNKTLSEAVSFVEEVKGQIPAASAVDAVVCSPALFLERL
VAATEGTDLQVGAQNMHFEKNGAFTGEISPVALSDLKVGYVVLGHSERRE
MFAETDESVNKKTIAAFEHGLTPIVCCGETLEERESGKTFDLVAGQVTKA
LAGLTEEQVKATVIAYEPIWAIGTGKSSSSADANEVCAHIRKVVAEAVSP
EAAEAVRIQYGGSVKPENIKEYMAQSDIDGALVGGASLEPASFLGLLGAV
K
>BCE33L0542 treB, protein-N(pi)-phosphohistidine-sugar phosphotransferase (PTS system, trehalose-specific IIBC component)
MGKDYRKTAEEVLQYIGGKDNIEQAAHCVTRLRIALKDESKIDNDKLQSV
SLVKGAFHNAGVFQIVIGPGDVDRVYAELITLAGMKEATVADVKDSGNQK
LNPAQKFVKVFSDVFMPILPAIVTAGLLMGINNLLGAKDLFFDGKNLLDV
YPNLGGLWDLINMMANTAFVFLPALVGWSATKRFGGSPILGIVMGLMLVH
PALLNAWEYGKAATGLDGQKIEYFNILGLFQIEKVGYQGQILPVLVAAFV
LSKVEIFLKKHVPNAIQLLVVPITTIVVTGVLALGIIGPVTRHIGDLLTV
GLVGVYETVPVVGAVLFGALYAPLVITGMHHMFIAIDLQLIAQHGGTFIW
PMIALSNIAQGSAALAMFWISKNQNDKSMASTSAISAYFGITEPAMFGVN
LRNKFPFYAAIIGSAVAAIFITLNGVLAPAIGIGGLPAFISIIPKSIPMF
IVGMVIAVVIPFTLTWLFAKRVKQK
>BCE33L0543 treC, alpha,alpha-phosphotrehalase (trehalose-6-phosphate hydrolase)
MKDWHKSVVYQIYPKSFNSYYNKETGDIKGVTEKLDYLKELGVDYIWLTP
IYQSPQNDNGYDVSDYYSIDSSYGTMEEFEELLEEAKARNIEIMLDIVVN
HSSTEHKWFKEAKKDKNSPYRNYYIWRDEKNNWQSKFGGSAWKYDEKTKQ
YFLHLFDETQADLNWENEKLREEVYDMMRFWLDKGVTGFRLDVINLISKD
QQFLNDDGSTATSDGRKYYTDGPRVHEYLQEMNRNVFEGKDVLTVGEMSS
TTIDNCIKYSNPDRNELSMTFSFHHLKVDYPNGDKWTKADFDFIKLKEIM
SNWQIEMQKGGGWNALFWCNHDQPRIVSRFGNDEKYRNESAKMLATAMHM
LQGTPYIYQGEEIGMTNPNFESIEQYRDVESLNIYDIKLEEGLSKEEIIG
ILKQKSRDNSRTPMQWNEDVNSGFTTSTPWISVAENFKEINVEKVLEDKD
SVFYHYKKLIELRKTYDVITEGEYAILDENDPKIWAYTRTTESEVLLVIN
NFYGEEITYSVPAHVQLDGMKQEVLLSNYKDSSKDITKLNLRPYESIVYR
YTK
>BCE33L2975 ydbB, conserved hypothetical protein
MISEMNDDQIQLFKANGDFIWHEHPNTDKLFIVLEGEMFIDFRDGQVKIS
KGEMFIVPRGVEHKPFTEKESHIMLVEPKKEMD
>BCE33L2655 yjlA, conserved hypothetical protein
MKAIAVGILASFFFAFTFVLNRAMDLEGGSWIWSASLRYYFMVPMLLLIV
MYRGNLKQLFQYMKNNPKEWLVWSIVGFGLFYAPLSFAGAFGPGWLVAST
WQITIVAGILLTPFFAVDPLHKKLPMKELVMSGIILCGVVLMQVEHASSL
GIRETVLCVVPVLIAAFAYPLGNRKMMQVCKGELDVFQRVLGMTLASLPF
WFLLSGYEVSTGGLPSSSQVFQCFIVAVSSGLIATVLFFFATDLVKDDPQ
KLATVEATQSGEVLFALVGELILLSAPIPSSLSWIGMSLVIIGMILHSYV
AVVVKKEEKITA
>BCE33L2656 ykkA, conserved hypothetical protein
MKDLYIDKNMNPQVAILYATVTDTFKRLQKLVEGTDEKELSFKGTENNEN
SIGQLLQHLAVVDLHWVYRLKGEPVPLALDNIYGPMLNEAGELPSLRKHT
LQQLMQDYEAVQHMFYEECMKLTENDLTREVFYEKGENATIRWGIWHIAD
HNRYHQAHISQLRKLYRARMHTR
>BCE33L1626 yndJ, conserved hypothetical protein; possible membrane protein
MKNIIVGLACYIIFLICEWSNVNPVEAIILLSILLFIPMSFCIIDKRARN
GSYLLFYKSVSFLYPIAAICAMLAFVTNQYIFAIIWFVYTGIVALFGINR
LLERGWTPLEETAIDSAFIYLFLGGFWFFASVAKLSIMHFSSDIILLTAA
HFHYSAFLLPLSAGLIGRKREKSSKVYDAIMFTIAISPMTVAIGITYSRV
FEFFAVCLYLCAIYGYSIYVWKAKFNAISAKILLIISSSTLMVTIMFSLI
YSYGNLKHVMTITIAQMVWIHGVVNGIGVALPAFVGWMIEKSVPNYKYYG
KPMSRLRGKATVGEAFLHNRNVIDSKEYKGLVDKMNDFHSGIFDRAKIPV
SIIRFYENTTEYELQSHIKWTRWFRPVAFCYEKISKRIGQIHLGMGGKWE
PMYGSIVGVIDEKDGRENVRAWLRKNKAEESIFVALYSKHIYKNETYMNI
ALPLPYSNMTGILKLRNDNNDLMITSKLRRNGKGDEGIYLHTRFFTIRLP
LAETFIIKKGTNQMLEANHKMWIFGVKFLEIDYEIKKIERK
>BCE33L2679 yndM, conserved hypothetical protein
MNDFTVVLIKFISCIIAFSIGLALFFPATFVQIISFSLFVTIVSYMFVDK
IILNRIGNTGAIMSDFLLTYLSVWIFGNILLDNYMQIAWGSILSAIVFTL
SEVIVHRFSSSRTRHHNDNIHINRRFAYGTEFAEEQNILDKDKKK
>BCE33L2510 ywrE, conserved hypothetical protein
MDTSTILIIIIGLGIGGYFLEQFLRRKLNMEKRGFFGYKHVNSLHVKLEI
GLIIIYVISSCYYMFKFENAKMAYVMFTYLGISWTLRAWMEWKYDRKSKE
YILSITGMISFILMLSILFYFVPPAT
>BCE33L1025 yxxF, transport protein; possible drug/metabolite exporter
MFNKKSMPAIKMILSMSIFGSIGFFSVQTGLPSFELVFVRCICATIFLAL
CWLVTGQYKTEKWNKKEVIQILACGIFLVFNWVFLFKAFEVMSITIAISV
YHLAPIIVLMIGSIVFKERLTMFAVLSIVICFIGTVLVAGVDGNVSLEKL
MSSGMVWALLAALFYAFTTLLGKGIQHTSAYAMTFLQTFLGIFLLLPFVD
FGKFQGLTEMNWMMITATGLIHTGFVYYLFFDSLRDLSTRMISVLVFLDP
AVAILLDTVFTGFRPTSMQVVGIILIFVGMAFTFQKTKDEEIIVEEKSYS
>BCE33L3083 zwf, glucose-6-phosphate 1-dehydrogenase
MESMTFVLFGATGDLAKRKIYPALYNLYRDQKLPKKISVIGLGRREVSHV
DFQKRIKESIETFSRHREEGTPELEGFLDNFRYCPLDVSKPEDYERLLQV
VREREEELHIKGNRMFYLSVAPEFFETIALNIKESGLDKTDGWKRLMIEK
PFGHDLISARELNDKLSRTFEEDEIYRIDHYLGKPMIQNLEALEFANPVL
QSIWNKEHIANVQITASETVGVEERAGYYDQAGAIRDMVQNHMLQILMMT
AMNLPEKVNACEIREEKRKVMEALRKVKKEDVQNHIIRGQYGAGEINGGQ
VVAYKEEPGVNPSSNIDTFVAARLWIDNPFWTGVPFYIRTGKRMKEKSTR
IVIEFKNTLKQQYQDSNPNAAPNLLIIEISPGENVSLQLNSKNPLKNGEI
EPIRINFTCEQADVGVPEAYERLIHDAVSGDATFFAHWREVELSWEWVQP
ILEAFEENLLPLHEYKSGSYGPEPSNELLQESGFKWWLDQETKK